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1 Introduction
1.1 Radiation therapy with ion beams
Nowadays in the European Union 58 % of all cancer patients are diagnosed at the stage of a localised primary
tumour and about 40 % can be successfully cured by means of surgery (22 %), radiotherapy (12 %) and a
combination of the two modalities (6 %) [Gad94, Ver94, Sch96]. However, current local or loco-regional
tumour treatments still fail for 18 % of all patients, corresponding to about 280 000 deaths per year in
Europe. Since surgery is commonly considered to have reached the limits of its potential for cancer curing,
there is a strong clinical demand for improving radiotherapy techniques.
More than 100 years of experience from the first therapeutic trial with X-rays in 1896 [Hal94] have shown
that the clinical results of radiotherapy are improved when a high dose of radiation with enhanced biological
effectiveness is precisely delivered to the tumour while sparing as much as possible the surrounding healthy
tissue and critical organs [Wam89]. Over the last 5 decades external radiotherapy with photon and electron
beams has increased the conformity of the dose applied to the tumour by replacing traditional sources like
X-ray tubes (energy ≤ 200 keV) or radioactive isotopes e.g. 60Co (average photon energy of 1.25 MeV) by
modern high-energy (4− 20 MeV) linear accelerators delivering irradiation from several directions. The lat-
est most innovative technique yielding highly conformal dose delivery is intensity modulated radiotherapy
(IMRT) [Web01], which uses dynamic geometrical field shaping in order to produce a spatially non-uniform
photon flux for each of the several beam portals applied to the patient. Despite these advances and the
promising results of the very modern and not yet widely used but rapidly growing IMRT technique, the
therapeutic effectiveness of conventional electromagnetic radiation is intrinsically constrained by its phys-
ical and radiobiological properties. The unfavourable depth dose profile and the lateral scattering (very
pronounced for electrons) restrict the achievable physical selectivity for high precision irradiation of deep-
seated tumours growing in close vicinity to critical organs. The low biological effectiveness is inadequate
for the treatment of radioresistant tumours, despite all attempts to improve radiation response by means of
coadjuvants like hypoxic cell sensitisers or local hyperthermia [Hal94].
Heavy charged particles like protons and heavier ions (4He− 16O nuclei) can overcome the limitations
of conventional electromagnetic radiation due to the more selective energy deposition in depth (figure 1–1).
Ions heavier than protons additionally offer a further reduced lateral scattering and an increased biological
effectiveness especially in the region of the sharp dose maximum [Kra00]. The first proposal to use accelerated
protons and potentially light ions for therapy because of their superior depth dose distribution dates back
to 1946 [Wil46]. However, it took a rather long time to see ion therapy applied in a hospital environment.
Most of the therapy units were based on nuclear physics accelerators, like the pioneering and no more
active one at Lawrence Berkeley Laboratory (LBL), USA, where proton and heavier ion treatment was
started in 1954 (p), 1957 (He) and 1975 (Ar, Si, Ne) [Tob58, Chu93, Cast94], as well as the Harvard
Cyclotron Laboratory (HCL), USA, which has the longest and most extensive experience in proton therapy
since 1961 [Sis01]. The first dedicated hospital-based facilities have been the Loma Linda University Medical
Center (LLUMC), USA, operating proton therapy since 1990 [Cou94], and the Heavy Ion Medical Accelerator
in Chiba (HIMAC), Japan, which took up heavy-ion treatment in 1994 after the shutdown of the LBL
accelerator in 1993 [Kan99] and replaced the Berkeley neon ions by carbon ions, which seem to offer an
optimal compromise between physical selectivity and enhanced biological effectiveness [Bla94]. Since then
new proposals and facilities have been fast growing worldwide [Sis01], especially in Japan [Yam01]. However,
due to the higher complexity and costs of heavy ion therapy, they have been mostly addressed to proton
therapy, which still offers better physical selectivity but not superior biological effectiveness than conventional
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Figure 1–1: Comparison of dose depth profiles of photons from different radiation sources with carbon ions
in water [Kra00]. Variation of the ion energy allows the sharp dose maximum to be precisely located within
the tumour.
radiation [Lin95]. Moreover, the principles of the beam delivery in clinical use at all the hospital-based ion
therapy centres are based upon highly reliable but not optimal passive devices (e.g. scattering foils, absorbers,
collimators and boli) for shaping the beam and conforming the irradiation to the target volume. An improved
tumour-conformity by shaping the beam via magnetic deflection has been only partially realised by means
of the spot scanning technique at the experimental proton therapy facility at the Paul Scherrer Institute
(PSI), Switzerland [Ped95]. Hence, the full potential of ion therapy has not been yet completely exploited.
The German pilot project of an experimental carbon ion therapy unit running at the Gesellschaft fu¨r
Schwerionenforschung Darmstadt (GSI) since December 1997 [Cre01a] represents the worldwide first and still
unique attempt to fully exploit the heavy ion advantages and demonstrate the safe and routine clinical appli-
cation of novel techniques. The three most advanced innovations are: (i) three-dimensional (3D) conformal
beam delivery based on 2D intensity controlled raster scanning in combination with active energy variation
from the accelerator [Hab93], (ii) radiobiologically oriented inverse treatment planning [Kra¨00a, Kra¨00b]
and (iii) in-situ therapy monitoring by means of positron emission tomography (PET) [Eng99a]. Supported
by the promising clinical results never observed before [Deb00], the participating institutions of the GSI
pilot project (GSI Darmstadt, German Cancer Research Centre Heidelberg – DKFZ, Radiological University
Clinic Heidelberg and Research Centre Rossendorf – FZR) have made a proposal for a hospital-based ion
beam facility to be built in Heidelberg, Germany [Gro98]. This centre will deliver particles from protons
up to oxygen ions in order to investigate the clinical impact of different ion beam modalities with a large
number of patients. On the basis of the GSI experience the Heidelberg project represents also a model for
the other five dedicated ion beam facilities proposed in Austria, France, Italy, Spain and Sweden, according
to the ENLIGHT (European Network for Research in Light Ion Therapy) coordination activity recently pro-
moted by the participating countries together with ESTRO (European Society for Therapeutic Radiology
and Oncology) and CERN (Conseil Europe´en pour la Recherche Nucle´aire). The presented work contributes
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to the GSI and Heidelberg projects and addresses the problem of local dose quantification from PET data
as well as the possible extension of in-beam PET monitoring to other projectiles than carbon ions, starting
with the lightest: the protons.
1.2 Monitoring of ion beam therapy by positron emission tomography (PET)
The higher physical selectivity of ion therapy demands higher precision in the monitoring of the applied
treatment, especially in delicate clinical situations. The complete stopping of the ions in the patient prevents
the application of electronic portal imaging methods used in conventional radiotherapy [Ant02]. The potential
benefit from the favourable dose depth profile (figure 1–1) requires accurate estimation of the ion range in
the inhomogeneous patient tissue which determines the position of the dose peak. Slight errors may result
in severe underdosage of the tumour volume and overdosage of the surrounding critical structures. The
treatment planning algorithms rely on calibrations of X-ray computerised tomography (CT) data leading
to 1 % − 3 % uncertainties in range calculations [Che79, Scha98, Ja¨k01a]. During fractionated therapy
additional unpredictable range deviations can occur because of minor inaccuracies in the positioning of the
patient or local anatomical changes with respect to the information of the planning X-ray CT, typically
acquired several days before starting the therapy. Despite the introduction of safety margins around the
target volume allowing for range uncertainties [Che79, Ja¨k01b], tools for the visualisation of the particle
distribution within the patient during the irradiation are strongly desirable. Presently PET is the only
technically feasible method for this purpose.
For heavy ions the application of positron emission imaging to measure the end-of-range of a β+-
radioactive beam (e.g. 19Ne) injected to the patient in a low-dose exposure prior to the therapeutic ir-
radiation with the stable isotope (e.g. 20Ne) was proposed in Berkeley at the end of the 1970s [Tob77]. Using
this approach a very accurate (< 1 mm) range verification is obtainable due to the strong similarity in the
penetration properties of the radioactive and stable ion beam. For this reason a planar coincidence γ-ray
camera for 2D imaging was constructed and installed directly at the treatment site at LBL [Lla84]. Despite
the first promising tests, the system has been never used in clinical routine because of the too high detector
activation probably caused by secondary particles produced in the passive beam shaping devices [Lla88].
Based on this experience at HIMAC a commercial PET scanner was chosen in order to monitor off-line
(i.e. at a remote diagnostic site) the “autoactivation” [Tob71] of the stable therapeutic 12C beam after the
treatment [Tom94]. Due to the reaction cross sections and the time interval of about 5 min between the
irradiation end and the PET scan almost only 11C nuclei produced in projectile and target fragmentation
reactions are imaged [Tom97]. Range information is deduced from the pronounced activity peak formed by
the 11C projectile fragments stopping shortly before the end point of the primary 12C ions [Tom94]. At GSI
the first and still unique tomographic in-beam positron camera was realised by FZR [Paw96, Paw97]. The
limited angle double head system employing commercial detector components allows to monitor the dose
application simultaneously to the 12C ion tumour irradiation [Eng99b]. The 3D imaging capability fulfills
the requirement to verify not only the ion range (deduced from the 11C projectile fragments) but also the
extremely conformal lateral dose deposition (mainly deduced from the target fragments) achieved by the
novel raster scan system. The on-line solution avoids to lose the significant β+-activity contribution from
short-lived emitters (mainly 15O and 10C) as well as to introduce possible changes of the patient position
during the transport to a remote PET scanner. Recently an in-beam planar positron camera has been devel-
oped and installed at the new secondary beam course of HIMAC in order to check the range of a low-intensity
11C pencil-like beam delivered to the patient before applying the entire treatment with the same radioactive
ions [Kana02]. However, this 2D imaging system resembling the LBL approach will be combined with an
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off-line commercial PET scanner for volumetric acquisition [Kana02].
For protons the applicability of PET techniques to range control and therapy monitoring is more chal-
lenging, due to the lack of projectile fragmentation. Similar considerations apply also to light ions with
Z < 6 (He, Li, Be, B) which produce no or only insufficient amounts of β+-radioactive projectile fragments.
Pioneering and very preliminary investigations on the potential of 2D on-line imaging of β+-emitting target
fragments (mainly 11C, 15O and 10C) induced by proton irradiation of phantoms and animals were carried
out in Brookhaven at the end of the 1970s [Ben75, Ben78]. Starting from the beginning of the 1990s the
topic was again addressed in preliminary phantom experiments using an on-line two-dimensional array of
scintillating detectors of low spatial resolution operated in coincidence as well as a commercial off-line PET
system [Lit93, Lit99]. In the same years simulation studies [Del94] as well as off-line PET measurements after
proton irradiation of phantoms [Paa93, Oel96] and even of one patient [Vyn93] were done by various groups.
Despite the common agreement on the potential usefulness of PET imaging for proton therapy monitoring,
no definitive conclusion on the clinical feasibility and effectiveness was drawn. The lack of activation in the
few last millimetres of penetration due to the energy threshold of about 15− 20 MeV for the proton induced
nuclear reactions as well as the poor spatial correlation between β+-activity and dose depth profile were
recognised as a nontrivial complication for the extraction of range information and dose localisation [Oel96].
Nowadays PET has not yet been exploited in clinical routine for quality assurance of proton therapy. Alter-
native approaches using radiographic imaging of high-energy transmitted protons [Mof75, Han81] for indirect
range verification prior to the therapeutic irradiation have been explored and are currently under clinical
development at PSI [Schn95]. However, on-line PET techniques still offer the unique and very appealing
advantage of direct verification of the applied treatment without any additional radiation exposure of the
patient beyond the therapeutic dose.
1.3 Aim and outline of the thesis
This thesis contributes to the three topics listed in the following:
- dose quantification from in-beam PET data,
- random coincidences during in-beam PET data acquisition,
- applicability of in-beam PET to the monitoring of proton therapy.
They aim at the further development and improvement of the in-beam PET method, already in clinical use
for quality assurance of carbon ion tumour therapy at the experimental treatment unit at GSI Darmstadt,
and they also address the preparation of the equipment for the planned dedicated ion beam cancer therapy
facility at Heidelberg.
The first issue responds to the main medical demand on quantification of local dose deviations in case
of detection of discrepancies between planned and applied treatment by means of PET, as already observed
during the clinical experience of in-beam PET monitoring of carbon ion therapy at GSI. The developed
approach for a PET guided dose quantification is however limited in feasibility and accuracy by the technical
capabilities of the in-beam positron camera currently in use at GSI. The increase of counting statistics
represents a critical issue for this problem. Hence, the second topic deals with basic investigations on the
physical reason for the high in-beam noise significantly reducing the amount of valuable events recorded by
the positron camera simultaneously to the dose application. This understanding is in fact the necessary basis
for an improved and dedicated data acquisition scheme for the novel tomographic in-beam PET scanner to
be developed and installed at the planned ion beam facility of Heidelberg [Cre01b]. This next generation in-
beam positron camera is primarily intended for the quality assurance of carbon ion therapy as a continuation
of the GSI activity. However, beams of protons, 4He (or 3He) and 16O nuclei will be delivered to the same
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treatment site. Therefore, this work has also initiated the investigation on the possible extension of PET
imaging to these projectiles, starting from the protons as the lightest and most thoroughly investigated ion
relevant for therapy. This latter topic can have a more general impact due to the larger number of patients
treated with protons (' 30 000) than with heavier ions (' 3 500) worldwide [Sis01]. With respect to the
former investigations of previous groups, more definitive conclusions on the clinical feasibility and usefulness
of PET monitoring in proton therapy are sought on the basis of the clinical experience in the PET control
of carbon ion therapy at GSI as well as the experimental availability of the unique 3D in-beam PET scanner
installed there.
The thesis is organised as follows. The second chapter reviews the physical rationale of ion therapy
and briefly describes the carbon ion therapy pilot project at GSI Darmstadt, with more emphasis on the
clinical implementation and results of in-beam PET monitoring. The third chapter shows the implemented
solution for local dose quantification from in-beam PET data acquired at GSI and its clinical impact. The
fourth chapter addresses the problem of random coincidences during in-beam PET acquisition and presents
the experimental evidence for the failure of standard random correction techniques due to the typical mi-
crostructure of the beam extracted from a synchrotron. Chapter 5 contains the promising simulation study
and comprehensive phantom experiments carried out at GSI which support a favourable application of in-
beam PET to the quality assurance of proton therapy. The conclusions and outlook are summarised and
discussed in the last chapter.
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2 Tumour therapy with ion beams
2.1 The physical basis of ion beam therapy
The goal of radiotherapy with external beams is to deliver a dose distribution precisely localised in the
tumour volume and with sufficient biological effectiveness in order to inactivate the tumour cells, whereas
sparing as much as possible the surrounding healthy tissue and critical structures as well as the entrance
skin.
As already pointed out in the original proposal of R. R. Wilson [Wil46], the main argument for particle
therapy is the superior physical selectivity due to the relatively low energy deposition, i.e. dose, in the entrance
channel (plateau) and a steep increase and fall-off towards the end of the ion path. The resulting sharp and
narrow – few millimetres wide – maximum, well known as Bragg-peak in memorial of W. H. Bragg [Brag04],
can be accurately adjusted in depth by proper selection of the ion energy. This allows to concentrate a higher
dose in a deep-seated tumour and keep at the same time the radiation burden to the healthy tissue in front
of and beyond the tumour lower than it would be possible in conventional radiotherapy with photons and
electrons. Hence, the characteristic Bragg-curve is also referred to as inverse dose depth profile in contrast
to the energy deposition of conventional photon radiation, having a maximum close (≤ 3 cm in water) to the
entrance followed by an exponential decay (figure 1–1). Besides the favourable depth properties, the dose
delivered by ions is well confined in space also in the lateral dimension due to the low angular scattering
which decreases with increasing ion charge and mass number [Lin95]. However, in most practical clinical
cases extended tumour volumes demand the very well localised dose distribution of mono-energetic pencil-
like (i.e. of small cross section and low divergence) ion beams to be widened in both longitudinal and lateral
direction. The longitudinal modification is accomplished by a proper superimposition of several Bragg-peaks
of different depth, i.e., ion energy (figure 2–1) obtained either via passive energy degraders or active energy
variation from the accelerator. A lateral spread of the dose distribution is achieved either by broadening
the transverse beam profile by means of scattering systems or by exploiting lateral magnetic deflection of
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Figure 2–1: One-dimensional spread-out Bragg-peak (solid line) calculated on the basis of the
FLUKA [Fas01a, Fas01b] simulation code by stopping 17 pencil-like proton beams of different energies and
intensities (dashed lines) in organic plastic.
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well-focussed pencil-like beams [Chu93]. From figure 2–1 it is evident that the overlap of several Bragg-
peaks leads to a reduction of the peak to plateau dose ratio with respect to the single mono-energetic case.
However, the resulting dose depth distribution well known as “spread-out Bragg-peak” (SOBP) is still by
far better than that for conventional radiation. Moreover, the entrance dose can be reduced further without
changing the tumour dose by exploiting multifield irradiation techniques (i.e. delivering several portals from
different directions).
In addition to the excellent physical properties, ions heavier than protons exhibit also an increased biolog-
ical effectiveness towards the end of their path in comparison to reference radiation, mostly 250 kVp X-rays or
60Co γ-rays. The reason is the higher ionisation density at the microscopic scale along the individual heavy
ion tracks in the Bragg-peak region [Kra97]. At the cellular level this results in the production of clustered
and complex DNA (deoxyribonucleic acid) damages more difficult to repair than those due to an exposure to
sparsely ionising radiation (e.g. photon and electrons). Furthermore, the lethal cell damages induced by high
Z ions are mainly due to direct ionisation processes rather than mediated by radical production. This leads
to an almost unchanged radiation response under oxic and anoxic conditions [Alp98], which makes heavy
ions more effective in the treatment of radioresistant hypoxic tumours which do not respond strong enough
to conventional radiation [Lin95]. All these radiobiological properties can be exploited in order to enhance
the radiation damage selectively in the target volume when using the appropriate ion type. In particular,
carbon ions seem to offer the greatest ratio of tumour to entrance biological effectiveness [Bla94, Kra00] in
combination with a high physical precision. However, according to the aim of this work only the relevant
electromagnetic and nuclear interactions underlying the physical properties of therapeutic ion beams will be
described. In fact, despite the initial proposals to use positron emission imaging also for studying metabolic
and perfusion processes of radioactive isotopes injected in the patient [Lla84], the clinically implemented
PET monitoring of heavy ion therapy has been limited to the control of the primary particle range and the
localisation of the delivered dose with respect to the treatment plan. Hence, radiobiological issues and func-
tional information on the tumour response to the therapy have not been yet accessed by the non-conventional
application of PET techniques to quality assurance of heavy ion therapy. The same is expected for the ex-
tension of PET monitoring to proton therapy, where radiobiological considerations are not yet taken into
clinical account. Furthermore, recent investigations have shown an increase of the biological effectiveness
of protons only for energies lower than 1 MeV [Bel89], which is well below the energy thresholds for the
production of positron emitters to be imaged by PET.
2.1.1 The stopping of ions in matter
In the energy interval of clinical relevance ranging from about 70−500 AMeV (A – mass number) initial kinetic
energy down to rest, ions lose and transfer most of their energy to the traversed medium in Coulomb inelastic
collisions with atomic electrons. The rate of average energy loss per unit path length is known as electronic
stopping power and is well described above about 1 AMeV by the Bethe-Bloch formula [Bet30, Blo33]:
−
dE
dx
= 2pir2emec
2Ne−
Z2
β2
[
ln
(
2me c
2 Wmax β
2
I2 (1− β2)
)
− 2β2 − 2
C
Zt
− δ
]
(1)
where Z and β are the particle charge and velocity (scaled to the speed of light c), respectively, re and me
are the electron classical radius and rest mass, respectively, Wmax is the largest possible energy loss in a
single collision with a free electron, well approximated in the non-relativistic limit by 2mec
2β2, Ne− and I
are the electronic density and ionisation potential of the medium of atomic number Zt, whereas C and δ are
the energy and absorber dependent shell and density corrections, respectively. Equation (1) can be extended
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Figure 2–2: Electronic stopping power of different ions of therapeutic interest calculated in water as a
function of the energy on the basis of the ATIMA code [Schw91].
to lower energies provided that the particle charge Z is replaced by an effective charge Zeff keeping into
account the mean charge redistribution due to dynamic loss and capture of electrons from the target for ion
velocities comparable to the electron orbital velocity (' 0.008 c). The functional dependence of Zeff on the
particle speed can be well approximated by the semiempirical formula [Bar63, Betz72]:
Zeff = Z
(
1− e−a β Z
−
2
3
)
(2)
with a ' 125 in the original proposal of [Bar63].
The functional relation between the electronic stopping power and the particle energy is shown in figure 2–
2 for different ions of therapeutic interest. From the dominant 1/β2 ' 1/E energy dependence in equation (1)
it follows that the energy loss rate increases as the kinetic energy of the particle diminishes along the
penetration depth, with a much steeper rise at low residual energy values corresponding to the last few
millimetres of the particle path. At the end of the track, however, the stopping power drops due to the
rapid reduction of the ion effective charge Zeff at very low energy values according to equation (2). Hence,
the distribution of the ionisation density induced by a heavy charged particle along its path shows a rather
constant plateau followed by a sharp maximum towards the end, corresponding to the already discussed
Bragg-curve. The stopping power describes the loss of energy by the incident particle, whereas the absorbed
dose refers to the spatial pattern of energy deposited to a medium either directly by the primary ions or by
secondary particles (mostly electrons). In most practical conditions secondary electron equilibrium prevails,
that means the energy carried in and out of a volume of interest by secondary electrons is on average the
same. Under this assumption the macroscopic dose D delivered by a fluence Φ of mono-energetic heavy
charged particles to a medium of density ρ can be directly linked to the average energy loss dE/dx of the
ion:
D =
Φ
ρ
dE
dx
(3)
The description of the heavy charged particle penetration in a medium as a continuously slowing down
process at an energy loss rate mainly given by the electronic stopping power allows to calculate a well defined
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Figure 2–3: Dose depth profiles in polymethyl methacrylate (PMMA) calculated by means of the
FLUKA [Fas01a, Fas01b] code for the same number of primary protons at increasing initial energy val-
ues but the same momentum spread of ± 0.1%.
mean range R for a given initial energy E0:
R =
∫ 0
E0
(dE
dx
)−1
dE (4)
This integral yields a very close approximation to the finite average path length travelled by an ion in a
material. In reality, however, statistical fluctuations of the energy loss around its average value occur [Boh15,
Ahl80] and cause a small spread of range values around the mean. This phenomenon is known as range
straggling and is responsible for the larger width of the Bragg-peak measured for an ion beam with respect
to the calculation based on the average energy loss of a single particle. The range straggling increases with the
penetration depth in a given material, resulting in Bragg-peaks of larger width and smaller height for higher
initial energies of the same ion type (figure 2–3). For different ion species the range straggling approximately
varies as the inverse of the square-root of the mass [Lin95]. Therefore, at the same penetration depth heavier
ions exhibit a narrower Bragg-peak (figure 2–4) with a steeper distal fall-off and a fragmentation tail beyond
the maximum due to nuclear reactions, as described in section 2.1.3. In tissue range straggling amounts to
about 1% of the mean range for protons and only to 0.3% for carbon ions [Lin95]. Hence, the impact in
practical therapeutic applications is smaller or comparable with the unavoidable momentum dispersion of
the beam from the accelerator and delivery system.
2.1.2 Lateral scattering
In addition to inelastic collisions with the atomic electrons, heavy charged particles passing through a medium
experience also repeated elastic Coulomb collisions with the atomic nuclei, although with a somewhat lower
probability [Leo87]. The total recoil energy imparted to the target atoms in these interactions is very small
in the energy range of interest (E ≥ 10 keV) and has been therefore neglected in the previous description
of energy loss processes. However, the transfer of momentum can lead to a deflection of the particle from
its incident direction. After several scattering events a lateral spread and divergence is produced in an ion
beam. The net angular distribution of the outcoming particles after a thick absorber with respect to the
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Figure 2–4: Dose depth profiles in PMMA calculated by means of the FLUKA [Fas01a, Fas01b] and POS-
GEN [Has96] Monte Carlo codes for protons and carbon ions at energies of 112.33MeV and 212.12AMeV
(± 0.1 % momentum spread), respectively, corresponding to a similar mean range of about 82mm.
incident direction can be interpreted as the result from several highly probable deflections by small angles
as well as rare large-angle single scattering events. The most comprehensive theory of multiple Coulomb
scattering within the small-angle approximation is due to G. Molie`re [Mol48]. However, the central part
of the distribution containing very small angular values can be well approximated by a Gaussian shape
originating from the statistical repetition of multiple scattering events at small angle (< 10◦) deflections. A
good estimate of the standard deviation σθ [rad] is given by the empirical formula [Hig75]:
σθ =
14.1 MeV
βpc
Z
√
x
Lrad
(
1 +
1
9
log10
x
Lrad
)
(5)
where p is the momentum of the particle and Lrad and x are the radiation length and mass thickness of
the traversed medium, respectively. It follows that multiple Coulomb scattering increases as the particle
energy decreases. Furthermore, at energies corresponding to similar penetration depths the lateral deflection
is more pronounced for lighter ions. A comparison is given in figure 2–5 for different particles of therapeutic
interest. Beams of ions heavier than protons show a well confined lateral broadening (≤ 1 − 2 mm) at
typical penetration depths of relevance for therapy. However, even protons exhibit much less deflection than
electrons because of their considerably higher mass. This produces a much sharper fall-off of the lateral dose
distribution which can be very useful for delicate irradiation fields adjacent to critical structures.
2.1.3 Nuclear reactions
Unlike conventional radiation species, heavy charged particles can interact with the matter also via the strong
nuclear force. The primary quantity for a heavy ion (i.e. nucleus-nucleus) collision is the total reaction cross
section σR, defined as the total (σT ) minus the elastic scattering (σel) cross section for nucleons incident on
a nucleus:
σR = σT − σel (6)
At low energies (≤ 20 AMeV) nuclear reaction cross sections typically show a strong energy dependence
caused by compound nucleus effects [Ahl80] and resulting in pronounced maxima. At larger energies the
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Figure 2–5: Lateral deflection in water of several ion beams of therapeutic relevance calculated according
to [Hab94] and adjusted to the experimental data shown in [Lin95].
dependence becomes smoother and cross sections approach above about 1.5 AGeV asymptotic values mainly
determined by geometrical factors and resembling the energy-independent form proposed on the basis of
cosmic ray data [Bra50]:
σR = pir
2
0(A
1/3
p + A
1/3
t − b0)
2 (7)
where Ap and At are the mass number of the projectile and target nuclei, respectively, r0 is the proportionality
constant in the expression for the geometrical nuclear radius r = r0A
1/3 whereas b0 is the overlap or
transparency parameter.
As a consequence of nuclear interactions, the fluence distribution of the primary particles is exponentially
attenuated in depth x according to the expression:
Φ(x) = Φ0e
−NσRx (8)
where Φ0 is the initial fluence and N is the atomic density of the medium. From equation (8) and (3) follows
that the dose delivered by the primary ions is reduced with increasing depth due to nuclear reactions, as
shown in figure 2–6. However, total reaction cross sections alone are not sufficient for a proper description
of nuclear interactions and their impact on therapeutic beams, which is not limited to the attenuation of the
primary particles especially for ions heavier than protons. Whereas nuclear recoils give typically negligible
contributions to the dose delivery [Pag02, Kar02], secondary nucleons, particles and fragments produced in
nuclear reactions can considerably affect the spatial pattern of energy deposition and must be carefully taken
into account.
Fragmentation reactions are the dominating interactions in the energy interval and for the material
composition of interest for therapy. Nuclear fragmentation is a complex process typically consisting of two
steps, where first partially excited prefragments are produced within ' 10−22 s in the collision and then
the final products are formed after de-excitation by nucleon evaporation and photon emission in about
10−21 − 10−16 s [Hu¨f85]. A recent comprehensive work on fragmentation cross sections [Sih93, Sil98, Tsa98]
proposed a semiempirical systematics for proton-nucleus partial cross sections and a scaling approach for
the extension to nucleus-nucleus reactions. The systematic regularities of the partial cross section σpart for
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Figure 2–6: Dose depth distribution in PMMA calculated on the basis of the FLUKA [Fas01a, Fas01b]
code for a 175MeV proton beam including or neglecting nuclear reactions. The reduction of the peak to
plateau dose ratio in presence of nuclear reactions is found to be about 35 %, in agreement with previous
studies [Lai96, Med97].
the generation of a given product (Z,A) from a target nucleus were observed first by Rudstam [Rud66] and
formulated as:
σpart = σ0e
−P∆Ae−R|Z−SA+TA
2|3/2 (9)
where σ0 is a normalisation parameter and the factor −P∆A describes the cross section reduction as the
mass difference ∆A of target and product increases. The more complex term e−R|Z−SA+TA
2|3/2 reproduces
the statistical distribution of cross sections for the production of various isotopes of an element of atomic
number Z resulting from the stochastic nature of the nuclear evaporation process: the parameter R describes
the width of the Gaussian-like distribution and S is related to the peak position, which shifts towards greater
neutron excess for heavier products according to the T factor. Silberberg and Tsao [Sil73] have based their
semiempirical formulae for proton-nucleus partial cross sections on Rudstam’s equation (9) with additional
factors introducing a dependence on the specific product nucleus as well as on the energy of the incoming
proton. A different equation has been proposed only for the special case of peripheral collisions (i.e. only a
partial overlap of the interacting nuclei) leading to products with small ∆A values [Sil73]. Scaling the proton-
nucleus systematics for the calculation of projectile-fragment production cross sections in nucleus-nucleus
reactions is theoretically founded on the so-called weak-factorisation property [Ols83]:
σpart = γ
f
p γp,t (10)
which decouples the probability of projectile and target interaction (given by the term γp,t) from the prob-
ability for production of the projectile fragment f (related to the term γfp ) in the partial cross section.
Following equation (10) the scaling procedure proposed in [Sih93] has been based on a scaling factor Sc
corresponding to the γp,t term estimated from a geometry based expression resembling equation (7). The
resulting partial cross section σpart(Zp, Ap, Zt, At, Ep) for the break-up of nuclides (Zp, Ap) colliding with a
target (Zt, At) at an energy per nucleon Ep has been expressed as [Sih93]:
σpart(Zp, Ap, Zt, At, Ep) = ScL∆1σpart(Zp, Ap, p, Epro) (11)
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Figure 2–7: Bragg-curve of 270AMeV carbon ions measured in water at GSI (open circles) and com-
pared with calculations (lines) including the separate contribution from nuclear fragmentation (dashed line)
after [Kra00]. The total dose beyond the Bragg-peak is due to fragments only.
where σpart(Zp, Ap, p, Epro) is the partial cross section for the break-up of nuclides (Zp, Ap) colliding with
a proton at a properly scaled energy Epro and L, ∆ and 1 are correction terms keeping into account
deviations from proportionality due to nucleus-nucleus cross section enhancement for the lightest products
(Li, Be and B), large ∆A differences and single-nucleon stripping, respectively. The formula originally
deduced for projectile fragmentation cross sections can also be extended to target fragmentation reactions
by exchange of projectile and target according to the invariance of the cross section for inverse kinematics.
In therapeutic applications peripheral collisions in which fragments are stripped of only few nucleons are
by far the most frequent reactions. In the proton case only target fragmentation is possible. Neglecting the
heavy target fragments which stay almost at rest in the interaction place, the most important effect of these
reactions on the energy deposition is the production of secondary particles, mostly protons and neutrons
liberated in (p, xp′) and (p, xp′yn) reactions. From this yield only the secondary protons are found to give
a significant dose contribution (up to 10 % of the total dose at 160 MeV [Pag02]) in the proximal part of
the Bragg-curve because of the lower energy spectrum with respect to the attenuated primary beam. For
heavier ions projectile fragmentation is the most important process leading to the build up of secondary
particles along the penetration depth. Because of the reaction kinematics, projectile fragments travel nearly
in forward direction at almost the same velocity as the incident particle [Gre75] and may therefore cause
further fragmentation reactions, while the target nuclei remain approximately at rest at the interaction point.
Fragments with Z < Zp having a longer range of the primary ions give rise to an undesirable dose deposition
beyond the Bragg-peak (figure 2–7). Furthermore, the angular emission of the fragments can contribute to
an additional lateral spread of the beam particularly evident at the distal side of the Bragg-peak, where the
primary projectiles are stopped and the dose deposition is due to nuclear fragments only [Kra00]. Hence, in
the case of heavy ions nuclear fragmentation reactions are responsible for the deterioration of the physical
selectivity in the longitudinal and transversal dimension especially around the very important Bragg-peak
region. The amount of fragments produced increases with increasing mass and charge of the primary particle
and is therefore one reason for discouraging the application of ions heavier than neon to therapy. For carbon
ions the fragmentation is still within an acceptable limit, especially when using active beam delivery systems
(figure 2–7) to avoid projectile fragmentation before entering the patient.
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It should be noticed that nuclear reactions are by far the most complex process in the interaction of
ions with matter. Therefore, the availability of realistic calculation models for accurate description of
fragmentation is a critical issue in radiotherapy, especially for ions heavier than proton (cf. figure 2–7).
Although several codes developed for detector design and nuclear safety purposes like GEANT4 [Ago03] and
FLUKA [Fas01a, Fas01b] are currently capable of describing ion transport in matter including atomic and
nuclear processes, details of nucleus-nucleus collisions may be missed in the energy range and for the mate-
rials of therapeutic interest. Hence, dedicated solutions using direct experimental information and tailored
to particular applications in radiotherapy (e.g. treatment planning or PET monitoring) are often necessary
in order to achieve the desired high precision, as addressed in the following.
2.1.4 Production of positron emitters
For heavy ions the drawback of nuclear fragmentation is more than compensated by the possibility of therapy
monitoring by means of positron emission tomography. Fragments stripped of few neutrons and travelling
at almost the same velocity as the parent projectiles may be β+-radioactive isotopes of the primary stable
beam stopping nearly at the same penetration depth according to the range dependence:
R =
A
Z2
f(β) (12)
where f(β) is a function of the ion velocity following from equations (1) and (4). In the case of carbon
ion therapy, 11C and 10C are the most abundant β+-emitting projectile fragments with useful half-lives
(1222.8 and 19.3 s, respectively) for PET imaging simultaneously to the tumour irradiation or shortly after
the end of the treatment (11C only). Since the stopping process is faster than the radioactive decay, even
in on-line monitoring these projectile fragments give rise to a clear and pronounced β+-activity maximum
shortly before the Bragg-peak. As shown in figure 2–8 the peaked signal is superimposed onto a background
originating from β+-emitting target fragments, mostly 11C and 15O. Due to the half-life of 121.8 s the spatial
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Figure 2–8: Depth distribution of positron emitters produced in PMMA by 105 12C ions at 270.55AMeV
according to the POSGEN simulation code [Has96], which uses cross section calculations based on equa-
tion (11). The main contributions from projectile and target fragments are separately shown. The expected
dose depth distribution is additionally depicted by the dotted line.
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Figure 2–9: Partial cross sections for the production of 11C and 15O nuclei in the interaction of 12C ions
on 12C and 16O nuclei, respectively, implemented in the POSGEN code [Has96] and based on equation (11).
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Figure 2–10: Experimental cross sections for the (p, pn) reaction on 12C and 16O nuclei leading to the
production of 11C and 15O β+-emitting target fragments, respectively [Nuc00].
distribution of 15O can be detected on-line only. Since the activated target nuclei stay almost at the place
of interaction, their spatial distribution contains further useful information on the lateral localisation of the
beam and of the dose delivery to be assessed by PET. However, according to the nuclear composition of
the tissue and the partial reaction cross sections (figure 2–9), only a small fraction of the stable beam and
of the tissue is activated. This results in a relatively low β+-activity count rate which demands special
requirements in the sensitivity of the PET detector and a reduction of background sources (e.g. due to
passive beam shaping systems), as it will be discussed in section 2.3. An alternative to therapy with stable
beams is the use of primary positron radioactive ions. This results in a strong activity signal carrying direct
information on the stopping point of the primary projectiles, as recently demonstrated at HIMAC [Kana02].
On the other hand, there is no real clinical advantage in performing therapy with a β+-radioactive beam at
the expense of nontrivial production and shielding problems.
In the case of protons only β+-emitting target fragments are produced along the penetration path until
the energy drops below the threshold of nuclear reactions, which typically corresponds to few millimetres
residual range in tissue. Cross sections are lower than for heavier ions (figure 2–10), but the reduction is
compensated by the higher proton fluence required to apply the same therapeutic dose at the lower stopping
power due to the lower charge and mass, according to equations (1) and (3). The question on the amount
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of useful information that can be extracted from the distribution of β+-activated target nuclei induced
by proton irradiation will be addressed in Chapter 5. As already mentioned in the introduction, similar
considerations can be extended also to light ions up to boron.
2.2 The GSI pilot project
After more than 15 years of radiobiological research with ions at GSI Darmstadt, a pilot project has been
started in 1994 by GSI in collaboration with DKFZ Heidelberg, Radiological Clinic of Heidelberg University
and FZR Dresden with the aim to install an experimental carbon ion therapy unit at the only accelerator
complex in Europe capable of delivering heavy ions at the energy necessary for treatment of deep-seated
tumours. The facility became operational in December 1997 and up to December 2003 205 patients mainly
suffering from chordomas and chondrosarcomas in the head and neck region have been treated safely. In
order to investigate the clinical impact of ion beams to the maximum extent, new technological developments
have been introduced into clinical routine.
The novel, completely active beam delivery system allows to achieve excellent dose-to-tumour conformity
(typically with only two opposite portals) by combining intensity controlled magnetic steering in the lateral
direction with active energy variation from the accelerator (88− 430 AMeV). The particular time structure
of the irradiation delivered by the synchrotron, consisting of repetitions of ≤ 2 s particle extraction (spill)
and ' 3 s extraction pause for a fixed 5 s repetition cycle, allows a pulse-to-pulse variation of the beam
parameters. Hence, in each spill a pencil-like carbon ion beam of well defined focus (2 − 10 mm FWHM)
and intensity (2 · 106 − 2 · 108 ions/spill) is scanned at small step sizes (' 1/3 of the focus) in a TV-like
mode on a tumour slice of a given depth. Modulation of the number of ions, i.e. of the dose delivered
at each scan position is mandatory due to the partial and inhomogeneous pre-irradiation of the proximal
(i.e. closer to the origin of the radiation in contrast to distal) slices. The control data for the accelerator
and raster scan, namely beam energy, focus, intensity and lateral position, are defined by inverse treatment
planning [Kra¨00a]. The dedicated software developed at GSI is based on accurate analytical models for all the
relevant interactions of the primary ions and the resulting fragmentation spectrum in water, with corrections
for tissue inhomogeneities on the basis of the X-ray CT of the patient and experimentally verified [Ja¨k01a]
calibration curves between the ion range and CT numbers (or Hounsfield units, HU [Kou82]). The most
challenging issue is the inclusion of a novel radiobiological model describing the complex dependence of
the biological effectiveness on the particle charge, energy, absorbed dose and tissue type [Kra¨00b]. Inverse
planning techniques allow for optimisation of the physical as well as the biological dose. The latter issue is
the most innovative achievement requiring tremendous computational effort due to the intrinsic complexity
of radiobiology for the mixed radiation field generated by heavy ions as well as the further requirements from
the raster scan system, which demands up to tens of thousands of single scanner positions to be determined.
The beam delivery is on-line controlled with feedback during the irradiation by a set of transmission ionisation
chambers measuring the number of ions applied at a given position monitored by a multiwire proportional
chamber [Vos98]. Precision within 2 % in intensity and ± 1 mm in position is achieved. The treatment plan
of each individual patient portal is verified by simultaneous measurements using small volume ionisation
chambers in a water phantom prior to the first irradiation [Kar99]. Mean and standard deviations between
measured and planned dose must be within 5 % for acceptance of the patient plan. Stereotactic fixation
of the patient with orthogonal X-ray verification prior to each dose application further ensures millimetre
accuracy of the tumour position [Hee99]. This applies only to the selected anatomical sites not subject to
the problem of organ motion. However, the complexity of the raster scan system and the high precision
achievable for delicate irradiation of tumours growing in close vicinity to critical organs (e.g. brain stem and
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optical nerve) makes an in-situ monitoring of the dose applied to the patient strongly desirable. This is
accomplished by means of in-beam PET.
2.3 In-beam PET monitoring of carbon ion therapy
2.3.1 Physical background of PET
The non-invasive monitoring of ion beam therapy is a non-conventional application of PET. In contrast to
tracer imaging in nuclear medicine, the β+-activity source originates from nuclear fragmentation reactions
between the projectiles and the target nuclei of the irradiated tissue (section 2.1.4). The produced neutron
deficient nuclei can undergo β+-decay transforming a proton into one neutron with emission of a positron
e+ and an electron neutrino νe, which share the available energy from the reaction:
A(Z, N) → A(Z − 1, N + 1) + e+ + νe (13)
The energy spectrum of the positron is continuous up to maximum possible energy values. For the most
abundant isotopes induced by carbon ion as well as proton irradiation, namely 11C, 15O and 10C (see
section 2.1.4), these values lie between 1 and 2 MeV. This corresponds to ' 4.5 ... 10 mm range in tissue.
Short-lived β+-emitters like 12N (T1/2 = 11 ms),
8B (T1/2 = 770 ms) and
13O (T1/2 = 8.6 ms) have higher
β+-endpoint energies up to 16.7 MeV and a considerably longer positron range. They are however neglected
in the context of this work due to the low production cross section (except 12N projectile and target fragments
induced by 12C ions) and the half-life in the ms region which prevents their detection by the positron camera
developed at FZR, as discussed in the next section. Whereas the neutrino escapes from the system without
interaction, the positron travels on average about 1 millimetre in tissue rapidly (within ' 10−10 s) losing its
energy in Coulomb inelastic collisions with the atomic electrons and suffering several angular deflections.
Once almost at rest the positron either annihilates as a free particle with an electron of the medium into
two photons approximately in 0.2 − 0.4 ns or captures an electron to form an unstable bound state. Two
atomic states called parapositronium and orthopositronium are possible in dependence on the antiparallel
or parallel spin orientation, respectively. Because of the very close ground state energy values (0.84 ·10−3 eV
separation), there is no strong preference for one of the two configurations apart from the 1 to 3 spin
multiplicity ratio. According to quantum-electrodynamic selection rules the parapositronium annihilates
into 2 photons with an intrinsic – i.e. in vacuum – mean lifetime τ = 125 ps, whereas the orthopositronium
can only annihilate into 3 photons with a lifetime τ = 140 ns. However, due to the about 1000 times
longer intrinsic mean lifetime the positron bound to an electron in ortho-state has a high probability to
undergo a fast para-annihilation with an electron of the medium into two γ-rays. This so called electron
pick-off interaction reduces the mean lifetime of the orthopositronium to 0.5− 5 ns in matter [Hau79]. As a
consequence, the 3γ-emission is in practice negligible and all the detectable radiation can be attributed to
the 2 annihilation γ-quanta. According to the momentum and energy conservation law they are emitted at
almost 180◦ in opposite direction and carry each an energy of 511 keV equal to the positron and electron rest
mass. Deviations from collinearity can occur because of the residual energy of the electron-positron system,
leading to emission angles approximately distributed according to a Gaussian centered at 180◦. The width
of the distribution is ' 0.3◦ FWHM for typical residual energy values of about 10 eV [Wie89].
The γ-ray pairs are isotropically emitted in the full solid angle of 4pi and can be detected by couples of
opposite detectors operated in coincidence giving the lines-of-response (LORs) of the system. With tomo-
graphic acquisition techniques and suitable reconstruction algorithms it is possible to retrieve the unknown
spatial distribution of the β+-activity source. The two basic assumptions underlying the reconstruction
approach in PET are that (i) the nucleus from which the positron originated is exactly located along the
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Figure 2–11: Representation of true (left), random (middle) and scattered (right) coincidence events. The
solid lines show the real photon pathways, whereas the dashed line is the assigned line of response to the
detected coincident γ-ray pair.
line at which the two photons are emitted and (ii) the two annihilation photons are emitted at 180◦ oppo-
site [Bend98]. The limited validity of these approximations due the finite distance travelled by the positron
from the creation point as well as the non-collinear emission of the annihilation photons restricts the intrinsic
achievable spatial resolution of PET to 2 − 3 mm [Wie89]. This value is however still below the ' 5 mm
practical spatial resolution of the current commercial full-body PET scanners, which is mainly determined
by the dimension of the single detector units (typically crystals of scintillation materials like bismuth ger-
manate, BGO [Cho77]). Further physical processes affecting the measured data are the reduction of detected
photon pairs along the LORs due to attenuation within the object under investigation as well as the incorrect
assignment of emission lines to photon pairs detected in coincidence but either not originating from the same
annihilation event (random coincidences) or reaching the detector after angular deflection due to scattering
in the object (scattered coincidences), as shown in figure 2–11. However, in conventional PET imaging these
effects can be rather well quantified and corrected for on the basis of experimental measurements like trans-
mission scans with external sources for the problem of attenuation or model calculations for the estimation of
the amount of scattered events in the acquired data. The specific solutions tailored to the dedicated detector
installed at GSI will be briefly addressed in the next section.
2.3.2 The dedicated in-beam positron camera
The in-beam positron camera completely integrated into the treatment unit at GSI Darmstadt is a limited
angle double head scanner developed by FZ Rossendorf [Eng99a]. This geometrical configuration avoids
interference with the fixed horizontal beam line as well as restrictions to the positioning of the patient
(figure 2–12). The two large area (42× 21 cm2) detectors disposed on a portion of a sphere of about 83 cm
diameter are built from components of the commercial ECAT EXACT PET scanner (CTI PET Systems Inc.
Knoxville, TN, USA). Each head consists of 8×4 position sensitive scintillation blocks of bismuth germanate
of 54× 54 mm2 front face and 20 mm interaction depth [Cas86]. The blocks are further subdivided into an
8× 8 crystal matrix of 6.75 mm pitch, resulting in 4 194 304 lines of response in coincidence operation. The
scintillation light is read out by four photomultiplier tubes coupled to each block and a crystal identification
is performed according to a modified Anger principle [Paw95]. On the basis of the scintillation properties of
BGO, the time width for coincidence detection is set to 12 ns. Photon pairs hitting opposite crystals within
either a prompt or a delayed (by 128 ns) coincidence window are acquired. This allows to apply the standard
random correction technique based on subtraction of delayed from prompt coincidences. The acceptance
energy window for scatter discrimination is set to the default 250− 850 keV interval recommended by CTI.
The data acquisition system extends the standard solution implemented by the manufacturer [Jon86].
It enables the storage of events in histogram mode. In addition, list mode acquisition was introduced with
insertion of time labels every 10 ms into the data stream for dynamic imaging. Furthermore, the specific
information on the status of the irradiation (beam on/off) as well as the parameters of the accelerator
(beam energy, focus and intensity) are registered. The former allows to discriminate the highly noisy data
recorded during beam extraction. These events mainly originate from β+-emitters with half-lives in the
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Figure 2–12: Double head positron camera installed in the treatment site at GSI Darmstadt. The exit win-
dow of the horizontal carbon ion beam is visible in the square green area in the centre. The camera heads are
kept fixed in the shown vertical position above and below the patient couch during PET monitoring [Eng04a].
millisecond time scale and corresponding high β+-endpoint energies (section 2.3.1) or from γ-rays following
nuclear reactions and generating random coincidences not properly corrected for by the standard technique of
subtraction of delayed events, as indicated by the investigation presented in Chapter 4. Therefore, these data
are currently discarded from further processing since they either tend to broaden the β+-activity distributions
or do not contain at all information on the dose delivery. Hence, the PET images are reconstructed only from
those annihilation events registered in the beam extraction pauses during the application of the treatment
and, furthermore, during the few minutes immediately following the end of the irradiation. The limited
acquisition time of about 10 min per irradiation field, the average size of the treated volume from 100 to
200 cm3, the total number of delivered ions approximately ranging from 108 to 109 at typical energies between
100 and 300 AMeV as well as the low detection efficiency (' 2.5 %) of the scanner determine the quite small
amount of valuable events. The PET data sets typically contain up to 104 − 105 true coincidences at usual
clinical doses of ' 0.5 − 1 Gy [Eng99b]. This extremely low statistics, orders of magnitude below that in
standard application of PET to nuclear medicine, in combination with the shift-variant response of the limited
angle system demands special effort in image reconstruction. A practicable solution has been found by the
development of a dedicated iterative algorithm [Lau99] implementing the Maximum Likelihood Estimation
Maximisation (MLEM) approach [She82]. Corrections for attenuation and scattering have been included
on the basis of analytical and Monte Carlo calculations, respectively, modelling the annihilation photon
transport within the patient according to the known physical interactions and the anatomical information
given by the planning X-ray CT [Po¨n03a]. Images reconstructed from PET data acquired during fractionated
tumour treatment at GSI Darmstadt have been successfully used for the quality assurance of carbon ion
therapy since the first patient irradiation in 1997 [Gro98], as discussed in the next section. It must be
noticed that the dedicated PET scanner takes full advantage of the completely active beam delivery system
developed at GSI, which avoids contamination of the very low β+-activity count rate due to the absence
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of elements in the beam (e.g. collimators and range shifters) that can be easily activated or influence the
primary beam quality.
2.3.3 Clinical implementation
The spatial distributions of β+-activity and dose are correlated but not identical (figure 2–8), due to the
different nuclear and electromagnetic interactions underlying positron emitter production and energy de-
position, respectively. Therefore, PET monitoring of carbon ion therapy at GSI is based on a comparison
between measured and expected β+-activity distributions. The latter quantity is calculated on the basis
of two dedicated Monte Carlo codes [Has96, Po¨n03a] which realistically describe all the relevant physical
processes from the stopping of the ions in the patient, the production and decay of β+-radioactive nuclei,
the emission, transport as well as annihilation of the positrons and the propagation of the γ-ray pairs until
the coincident detection by the scanner. Actually, the first code calculates the production of positron emit-
ters induced by mono-energetic pencil-like carbon ion beams of tunable lateral size in homogeneous organic
plastic (PMMA). This program has been used to generate a database containing 3D spatial distributions
of β+-emitters for all the 252 discrete energy values delivered by the synchrotron for therapy. In a second
step the database is adapted to the specific patient case by taking into account (i) the particle delivery to
the target volume given by the control parameters of the accelerator and the raster scan unit, (ii) the X-ray
CT, allowing to correct for tissue inhomogeneity and to determine the ion range on the basis of the same
calibration curves [Ja¨k01a] used for treatment planning [Kra¨00a], as well as (iii) the time course of the irra-
diation for each particular treatment fraction of the considered portal. The latter information is necessary
due to the dynamics of the β+-activity formation, decay and washout, which is therefore very sensitive to
the daily variations of the time dependent beam application for the same irradiation field. The output of the
simulation is a list mode data set of predicted annihilation events detected in coincidence with the structure
of the measured data. This allows to reconstruct both measured and simulated data with the same MLEM
algorithm and, therefore, avoid possible influence of different data processing in the final comparison. In or-
der to support visual inspection, the PET images are finally superimposed onto the X-ray CT [Po¨n99]. This
is feasible with high precision on the basis of the accurate stereotactic positioning procedure of the patient
in all the therapy steps, namely diagnostic imaging, treatment planning and irradiation with in-beam PET
acquisition.
In clinical routine the PET quality control is performed for each field of each irradiated patient throughout
the entire therapy, typically consisting of 20 daily dose applications for a fully fractionated carbon ion
treatment or only 5 to 6 sessions for a carbon ion boost combined to conformal photon therapy [Deb00]. The
processing and evaluation of the PET data is completed within few hours after the irradiation, in order to
allow potential discrepancies between real and planned treatment to be compensated in the next fraction.
2.3.4 Clinical results and future perspectives
The first clinical results for more than 200 patients having been treated so far allow to draw first conclusions
on the clinical helpfulness of the PET quality assurance, due to the possibility to (i) monitor the maximum
carbon ion range, (ii) verify the position of the irradiation field and in some cases (iii) detect possible
unpredictable deviations between real and planned treatment. PET is in fact capable of testing the whole
chain from treatment planning to dose application independently from the dose delivery. The extraction of
information on the maximum particle range from the distal edge of the measured β+-activity distribution
allows to validate in-vivo the physical beam models used in both of the PET simulation as well as the
treatment planning code. Systematic deviations between measured and precalculated PET images observed
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Figure 2–13: Left: Planned dose distribution (shown by isodose lines at 10 % separation from 5 to 95 % of
the maximum in colours from blue to red) superimposed onto the frontal slice of the grey scaled X-ray CT for
a cranio-lateral irradiation field stopping in front of the radiosensitive brain stem. Middle: Predicted β+-
activity distribution. Right: Measured β+-activity distribution, found in good agreement with the prediction.
In particular, the distal edge of the measured activity ends in front of the critical organ as planned.
in the early therapy sessions in 1998 indicated a lack of accuracy in the correlation between CT numbers
and carbon ion range, especially in the region of soft-tissue [Eng00]. More precise range measurements
started at GSI on the basis of the PET observation lead to the improved calibration curve currently in
use [Ja¨k01a, Kra¨00a], resulting in the fairly good correspondence between measured and predicted β+-
activity distributions noticed since February 1999 [Eng00].
Consequently, the higher reliability of the precision of the ion range in tissue allowed to extend treatment
plans also to more critical irradiation fields. This is shown in figure 2–13 (left) for a cranio-lateral portal
where the beam has to be stopped precisely in the tumour in front of the organ at risk, i.e. the brain stem.
PET monitoring of such delicate clinical situations is important. For this patient the comparison between
measured and predicted β+-activity distributions shows a good correspondence, indicating a correct delivery
of the treatment and, in particular, the proper sparing of the critical organ as planned (figure 2–13). In-
situ verification of the lateral position of the field can be also a crucial issue, especially in the frequent
case of irradiation adjacent to critical structures. Figure 2–14 shows an example where a cranial portal
has to pass between the eyes without touching the radiosensitive optical nerves. Again the measured PET
distribution is in fairly good agreement with the simulation. However, in some cases deviations between real
and planned treatment may occur because of minor inaccuracies in the positioning of the patient or local
and frequently temporary anatomical modifications (e.g. tissue reduction or cavity filling by mucus) within
the irradiated region [Eng99c]. Such modifications, whereas rather uncritical in conventional radiotherapy,
may severely affect the dose deposition and result in undesirable underdosage within the tumour or critical
overdosage in radiosensitive organs, compromising the effectiveness of the therapy. Hence, in these situations
Figure 2–14: Left: Planned dose distribution superimposed onto the transverse slice of the X-ray CT for
a cranial field passing between the eyes. Middle: Predicted β+-activity distribution. Right: Measured β+-
activity distribution. The radiosensitive optical nerve is spared as planned.
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a quantification of the local dose deviation on the basis of PET data is strongly desired by the radio-
oncologists. The problem has been addressed in this work and the developed interactive approach is described
in the next chapter. However, more accurate solutions still demand higher counting statistics and better
quality of the PET images. Therefore, this issue is connected to the problem of noisy acquisition of the
in-beam positron camera during beam extraction investigated in Chapter 4.
On the basis of the positive clinical impact, in-beam PET monitoring of carbon ion therapy will be
implemented at the proposed ion beam tumour therapy facility of Heidelberg [Gro98]. This hospital-based
centre will have treatment sites resembling the GSI experimental therapy unit but will additionally be able
to deliver particles from protons up to oxygen nuclei. Hence, the possible extension of the PET method to
other ion species is worthwhile of being considered. The investigation on the potential of in-beam PET for
the monitoring of proton therapy is addressed in Chapter 5.
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3 Dose quantification from in-beam PET data
3.1 Motivation
In-beam PET monitoring of carbon ion therapy at GSI Darmstadt is based on the visual inspection of mea-
sured and predicted β+-activity distributions superimposed onto the anatomical information given by X-ray
computed tomograms. If the comparison indicates deviations between planned and really applied treatment,
the radio-oncologist is informed in order to allow a prompt intervention in the delivery of the successive
treatment fraction. However, the clinical relevance of the deviation cannot be easily extracted from PET
images alone. The information demanded with highest priority by the radio-oncologist is the discrepancy in
the delivered dose, especially with respect to the targeted tumour and the radiosensitive critical structures.
In the following, only the physical dose is concerned. Nevertheless, the question has no trivial answer, be-
cause of the different physical mechanisms underlying the atomic and nuclear processes responsible for energy
deposition and positron radioactivity production, respectively. The imaged β+-activity distribution may be
furthermore affected by perfusional and metabolic processes. In addition to the dependence on the time
course of the irradiation and acquisition this results in different PET images for the same dose application.
Hence, uniqueness is not necessarily fulfilled.
The most appropriate solution to the problem would be the development of an algorithm capable of
delivering the most probable dose distribution for a given PET image measured at known boundary conditions
(e.g. time course of the irradiation and acquisition). This requires a solution for the inverse problem from
the positron radioactivity distribution A(r) to the applied dose D(r). Such a relation can be mathematically
described by the equation A = T×D, where the quantity T is the transition matrix giving the probability
that a given dose contribution dD(r) corresponds to the production of an activity density dA(r’). However,
several limitations of the presently available PET images discouraged the attempt to face this challenging
and very ill-posed inverse problem. The β+-activity distributions reconstructed by means of the iterative
MLEM algorithm [Lau99] are not yet quantitative, despite the introduction of attenuation and scatter
corrections [Po¨n03b]. The reason is the normalisation problem at each iteration step. Furthermore, the
extremely low counting statistics in combination with the limited angle geometry of the positron camera
unavoidably deteriorates the image quality. Possible limited angle artifacts propagate in the same way in the
reconstruction of measured and predicted events, hence not affecting the reliability of the PET monitoring
itself. Nevertheless, they further complicate the problem of extracting information on the dose delivery
from the imaged positron radioactivity distributions. Finally, biological pathways washing out the produced
positron emitters [Kau02] are not yet taken into account in the prediction or corrected for in the measured
data. Moreover, the dynamic build-up of the β+-activity throughout the treatment volume due to the active
beam delivery system in use at GSI prevents the alternative possibility to monitor the integrated dose by
monitoring the total number of annihilation events detected as a function of time, as proposed in [Lit99]
for protons. In order to overcome all these limitations and provide a practicable solution for in-beam PET
monitoring with the presently available hardware and software imaging capabilities, an interactive approach
has been developed. The basic idea and the implementation with clinical examples are described in the
following section. The clinical impact and outlook is discussed in the concluding section 3.3.
3.2 The interactive solution
From the clinical experience at GSI, the reasons for unpredictable deviations between planned and delivered
dose distributions have been mostly identified in minor misalignments or local anatomical changes of the
patient with respect to the situation depicted in treatment planning (TP). This is illustrated by means of
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Figure 3–1: Case (a): measured (left) and predicted (right) β+-activity distributions (displayed by coloured
isolines as in figure 2–13 but normalised to the global maximum instead of that in the considered image plane)
superimposed onto the frontal slice of the X-ray CT for a portal entering the patient from the left side (right
in figure). The arrows indicate the discrepancies discussed in the text, suggesting a caudal shift of the patient
in this treatment fraction.
Figure 3–2: Case (b): similar comparison as in figure 3–1 (but normalisation of the β+-activity isolines to
the maximum within the imaged plane) for an oblique portal entering the patient from the right side (left in
figure). Again the arrows point at the discrepancies suggesting a local tissue reduction (cf. text).
two clinical examples which are utilised throughout the whole chapter for explaining the dose quantification
technique. They are given in figures 3–1 and 3–2. In case (a), figure 3–1, a caudal shift of the patient
was particularly indicated by the marked mismatch of the measured β+-activity with respect to the bony
structures, where the activity is accumulated. In case (b), figure 3–2, a tissue reduction was suggested by the
systematic observation of distal β+-activation at longer penetration depth than planned in combination with
an insufficient shaping of the β+-activity contour lines at the right side (left in picture) of the nasal cavity.
As a matter of practical training in inspecting PET images, the two mentioned physical explanations can
be separated from biological effects due to β+-activity washout or perfusion. However, plausible conjectures
for the observed deviations cannot be in general identified and assessed so easily. Hence, in order to support
the PET operator in validating the hypothesis and estimating the corresponding local dose deviation, the
interactive approach illustrated by the flow chart of figure 3–3 has been developed. The software implemen-
tation performed in IDL (Interactive Data Language) and C programming languages has been completely
integrated into the dedicated home-made code VIEW−PCT originally developed for the visualization of the
measured and predicted PET distributions as contour plots superimposed onto X-ray CT images [Po¨n03a].
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Figure 3–3: Flow chart of the interactive approach used for local dose quantification from PET images in
routine monitoring of carbon ion therapy at GSI Darmstadt.
Details on the single steps 3 − 6 of the diagram shown in figure 3–3 are briefly described in the following.
The tool is routineously in clinical use since 2001.
3.2.1 Interactive modification of the patient X-ray CT
A session devoted to the interactive manipulation of the treatment planning X-ray CT can be activated
by the PET operator directly from the slightly modified main menu of the original visualisation program
VIEW−PCT described in [Po¨n03a]. The additional interactive menu “MODIFY CT” appears and guides
the user in the permitted operations, which have to be defined by means of mouse actions (figure 3–4). The
modifications may consist in rigid geometrical transformations (translation, rotation) and, furthermore, in
Figure 3–4: Interactive menu of the PET evaluation tool for the functions for dose quantification. In
dependence on the possible operations the sensitivity of the buttons changes and additional pull-down menus
or sliders may appear. The dialog box on top of the window provides additional information, in this example
the suggestion to press the button “BOX” for initiating Hounsfield units manipulations or PET recalculations
in extended regions or to press the button “Trans/Rot” for geometrical modifications (cf. text).
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Figure 3–5: Example of the application of a translation, requiring the definition of the translation vector by
means of mouse clicks. The selected initial point “ Start” is shown in the left figure, referring to the measured
PET data for the considered case (a) (figure 3–1). The chosen caudal shift resulting in the better match of
the β+-activity distribution with the bony structure (right) corresponds to a cranial shift of the target point,
indicated by the “Original Target Point” and “New Target Point” positions.
local changes of Hounsfield units (HU) in user-selected regions of interest (ROI). The Hounsfield units:
HU = 1000
µ− µH2O
µH2O
(14)
express the X-ray attenuation coefficient µ of the material of a given CT voxel relative to that of water µH2O
and therefore provide information on the patient anatomy.
In principle, geometrical transformations may correspond to a redefinition of the beam orientation with
respect to the same CT image or to an effective modification of the CT image with respect to the fixed
coordinate system specified by the treatment plan. For a practical implementation keeping into account the
available utilities tailored to the horizontal beam line and beam delivery system in use at GSI, rotations have
been chosen to result in really manipulated CT images, in analogy to local Hounsfield unit modifications. On
the contrary, translations lead to a simple redefinition of the target point coordinates in the treatment plan.
The latter choice avoids to deteriorate the CT information (e.g. introducing partial volume effects) for typical
maximum misalignments of 1− 2 mm comparable to the CT voxel size (' 1 mm in the transaxial plane and
' 3 mm along the axis of the X-ray computerised tomograph). As for the original visualisation capabilities
of VIEW−PCT, the definitions of the transformations are restricted to the frontal, transversal and sagittal
planes of the X-ray CT. The result of each operation is always displayed before becoming effective. In this
way the user can always decide whether to apply or reset a given modification. The manipulated CT (or
new target point coordinates) can be finally stored in the same format of the planning CT (or treatment
plan) with additional detailed information on the modification (e.g. axis and angle of rotation or translation
vector). Examples for the two considered clinical cases are given in figures 3–5 and 3–6.
3.2.2 Fast recalculation of β+-activity distributions
In order to assess the plausibility of the interactive modification, a recalculation of the β+-activity distribution
with and without the CT changes has to be performed and compared with the originally measured and
predicted PET images. Since several iterations of the whole procedure may be sometimes necessary before
finding out the most plausible conjecture, the applicability to clinical routine demands the results of each
calculation to be available within few seconds or at the most a few minutes. Hence, the computing time
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Figure 3–6: Example of HU manipulation for the considered case (b) (figure 3–2). The two enlarged
subportions of the CT slice refer to the working area prior to the application of the defined tissue reduction
(left) and the original status (right). The definition of ROI within the working area is done via the mouse,
whereas an additional slider for HU values modification appears in the menu after the ROI definition is
completed. Measured PET data can be additionally superimposed in order to aid the modification.
of the β+-activity recalculation is a crucial issue. This forbids a full simulation with iterative tomographic
reconstruction, requiring at least half an hour for completion (cf. section 2.3.3). Therefore, a dedicated
code partly based on routines of the PET simulation code [Has96] has been implemented. Actually, the
program exclusively computes spatial distributions of β+-decays and does not take into account the complete
PET imaging procedure (e.g. positron annihilation, photon pairs propagation, detection and iterative image
reconstruction) in order to achieve the desired fast response (e.g. 15 s on an Intel Xeon 3.06 GHz CPU for
a 660 cm3 large treatment volume when taking into account all the 1.5 · 108 ions delivered to 3814 different
scan positions). From the control data of the accelerator and raster scan only those pencil-like beams crossing
an user-defined ROI are considered. The depth-distribution of the main β+-isotopes (11C, 15O and 10C) is
extrapolated from the PET database (DB) [Has96] containing the spatial distributions of positron emitters
produced in PMMA (composition: C5H8O2, density: 1.18 g cm
−3) by 12C pencil-like ion beams of all the
energy values used for therapy. The DB information is combined with the beam delivery control data (ion
beam energy, focus, fluence and position) and with the patient anatomical information given by the X-ray
CT. The longitudinal adjustment to the estimated penetration depth in the patient is obtained from the
HU-ion range correlation [Has96, Ja¨k01a, Kra¨00a]. The correction of the distribution according to the tissue
density and the tissue elemental composition for the proper weighting of the target fragments is deduced
from the stoichiometric calibration of the CT numbers suggested in [Schn00]. The lateral distribution of
the induced β+-activation is assumed to be Gaussian with a FWHM dependent on the beam focus and the
average positron range in tissue. The lateral spread of the beam in depth is neglected in analogy to the
treatment planning algorithms, because of the negligible lateral straggling of carbon ions. The spatially
variant amount of β+-decays is finally deduced from the fraction of isotopes decayed within the time interval
between production (coinciding with the application of the considered pencil-like beams) and the end of the
PET acquisition on the basis of the registered time course of the considered irradiation.
The described code, written in C language, has been fully coupled to the IDL visualisation program.
The recalculation is directly activated by the user when pressing the “New PET” button in the “MODIFY
CT” interactive menu. After completing a computation for a given region of interest, the PET operator can
arbitrarily extend it to include further ROI. Results are displayed using the navigation capabilities of the
original VIEW−PCT program reported in [Po¨n03a]. Its basic functionalities have been further enlarged in
order to allow comparison of several quantities (PET recalculated distributions with or without modification,
original PET measurements, predictions and differences) and produce the corresponding graphical documen-
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Figure 3–7: Recalculation of β+-activity distributions with (left) and without (right) the modification,
consisting in the conjectured ' 4 mm caudal shift shown in figure 3–5 for the considered case (a) (top) and
the substantial tissue reduction suggested by the PET measurement in case (b) (bottom).
tation. Satisfactory recalculations for the two considered clinical examples are illustrated in figure 3–7, to
be compared with the original measured and predicted PET images shown in figures 3–5 (right, showing the
PET measurement superimposed onto the translated CT) and 3–2. Despite the absence of imaging effects,
the fast recalculations with the modifications discussed in 3.2.1 can clearly reproduce the trend observed in
the measured data.
3.2.3 Local quantification of the dose deviation
When the PET recalculation supports the conjectured modification, a new dose distribution based on the
manipulated CT (or treatment plan in case of translation) can be directly issued by the PET operator
via the interactive menu. The dose recalculation is accomplished by means of the treatment planning
software [Kra¨00a] with the new input information. As for the PET recalculations, the results can be inspected
and documented according to the visualisation capabilities of the original VIEW−PCT tool. Differences
between the originally planned and the recalculated dose distributions are quantified. As an example, the
resulting dose recalculations and corresponding deviations for the two considered clinical cases are depicted
in figure 3–8 and 3–9. It should be however mentioned that the somehow impressive deviation does not
involve critical structures and is mitigated in both cases by the application of a treatment field from the
opposite direction.
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Figure 3–8: Top: Prescribed dose distribution (left) in comparison to the recalculation following the con-
jectured caudal shift (right) for the considered case (a). The coloured isodose lines (5...95%) are normalised
to the global maximum of 580mGy in both cases. Bottom: Difference between the recalculated and planned
dose. The red and blue coloured isolines correspond to positive and negative differences found to amount to
328 mGy and -326 mGy at maximum, respectively.
3.3 Clinical results and outlook
Dose distributions recalculated on the basis of interactively manipulated X-ray CT cannot be expected
to agree fully with the real dose delivered to the patient. Nevertheless, the described approach offers a
valuable tool providing the radio-oncologist with an indicative but quantitative estimation of possible dose
deviations detected on the basis of the PET monitoring. According to the entity of the modification, the
radio-oncologist may decide whether to initiate more carefully investigations (e.g. a new CT scan when
anatomical modifications are suspected) and eventually define new treatment strategies before delivering the
successive irradiation fraction.
In both of the two presented clinical cases, the described conjectures were assessed by further inves-
tigations following the PET indication. A suboptimal position of the patient (case a) in the considered
treatment fraction was revealed by a more accurate inspection of the orthogonal X-ray verifications taken
prior to the dose application. A caudal shift of about 2 mm is visible in the antero-posterior (AP) image
in comparison to the reference position (figure 3–10), though the real mispositioning might have been more
complex than a simple translation, e.g. connected with some rotation of the patient head inside the mask.
The considerable tissue reduction indicated by the ion over-range in case b was confirmed by a new CT
scan, as shown in figure 3–11. The latter case of tissue modification is often plausible for patients which
have been subject to surgery intervention prior to the radiotherapy, in addition to other possible factors
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Figure 3–9: The same comparison as in figure 3–8 between the planned (top, left) and recalculated dose
distribution with the modified CT (top, right) for the examined case (b). The maximum dose values of the
original and recomputed fields were about 650 mGy. The maximum and minimum values for the difference
between the recalculated and planned dose distributions (bottom) were found to be 495 mGy and -200 mGy.
related to the patient physical condition during the period of therapy (e.g. presence of mucus in respiratory
cavities). Up to December 2003 6 patients out of 205 have been exposed to a new X-ray CT investigation
triggered by the PET monitoring. In 5 cases the investigation confirmed a local anatomical change and for
one of these patients a new treatment plan was elaborated. The remaining false positive was attributed
to another anatomical modification resulting from the fold of the insensitive ear lobe of the patient when
entering the fixation mask. In all the observed cases of deviations, no serious clinical consequences were
encountered. In fact, proper safety margins and careful selection of the beam portals are currently taken
into account in treatment planning in order to avoid too delicate irradiation fields. However, the proven
detectability of positioning inaccuracies or anatomical changes in combination with the possibility of local
dose quantification for a prompt intervention in fractionated radiotherapy might allow to consider in future
reduced safety margin for more delicate irradiation fields.
For sake of objectivity, it has to be pointed out that the information on misalignments or tissue modifica-
tions underlying the described method in routine use for dose monitoring is not exclusive of PET. The new
techniques of image guided radiotherapy [Jaf02] have to be mentioned in this context. By combining X-ray
imaging with radiotherapeutic devices it has become feasible to take an X-ray CT of the patient in treat-
ment position before applying a dose fraction and, furthermore, to obtain real time position information by
exposing X-ray projections during the therapeutic irradiation. The latter issue is of utmost importance for
tumour sites subject to the problem of organ motion. Without entering the discussion whether the improved
accuracy of these techniques justifies the increased radiation burden to the patient, the still unique value of
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Figure 3–10: Left: Reference AP X-ray verification film of the treatment position. Right: X-ray image taken
before starting the irradiation of the considered treatment fraction for which PET indicated a suboptimal
positioning. A caudal shift of the patient of almost 2 mm with respect to the reference position was deduced
from the film projections. Such a small deviation, difficult to be assessed by eyes in the shown images without
any dedicated imaging tool, was e.g. indicated by the distance between the horizontal steel wire of the cross-
hair mounted on the film cassette holder to mark the isocentre (upper arrow) and the position of anatomical
structures close to the nasal region like the cheekbone marked by the circle (cf. also dotted line and lower
arrow). However, further analysis indicate a more complex mispositioning connected also to a rotation of
the patient head within the fixation mask.
Figure 3–11: Left: X-ray CT taken few weeks before starting fractionated carbon ion therapy for treatment
planning purposes. Right: X-ray CT taken after a therapeutic session on the basis of the PET indication.
PET in charged particle therapy has to be stressed. In-beam PET represents the unique available method
for in-vivo, non-invasive monitoring of the ion range. In addition, it is the only currently known technique
allowing to validate in-vivo the beam models implemented in the treatment planning algorithms as well as
33
3 DOSE QUANTIFICATION FROM IN-BEAM PET DATA
the whole chain between treatment planning and irradiation. Furthermore, it does not require any additional
radiation exposure beyond the application of the therapeutic dose. Therefore, PET is still expected to play
an essential role in assuring the potential high precision of particle therapy, especially when starting up a
new treatment facility or introducing into clinical routine new ion species. Finally, the whole potential of
in-beam PET for a direct dose quantification solving the inverse problem from β+-activity to dose and for
an eventual ambitious access to the tumour response during fractionated therapy has not been yet exploited.
With this respect one of the major limitations of the present state of the art is the extremely low counting
statistics of the PET images. Hence, this issue is strictly connected to the investigation reported in the next
chapter.
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4.1 Motivation
The counting statistics of PET imaging for the monitoring of tumour therapy with stable ion beams is
constrained by the relatively small amount of β+-activity induced by the irradiation, estimated to be about
200 BqGy−1 cm−3 for typical therapeutic doses of 0.5− 1 Gy per field in the carbon ion case [Eng04a]. Such
a low signal demands a highly efficient utilization. Currently, the major limitation to this purpose is the low
detection efficiency due to the small solid angle of about 8 % of the limited angle in-beam positron camera
in use at GSI. A further important factor addressed in this chapter is the development of data acquisition
schemes which are optimal for in-beam PET. The installation at the GSI facility, however, relies on the
adaption of data acquisition methods originally developed for radiotracer imaging in nuclear medicine to the
special application of in-beam PET. A high coincidence rate is systematically observed in the data acquired
in the time during particle extraction (spill) from the synchrotron, as shown in figure 4–1. These events
have been demonstrated to deteriorate the image quality and are therefore considered to be corrupted by
a high noise level [Eng99a]. Similar problems were also described in [Lla88] for the unresolvable response
of the scintillation detectors of their planar camera during beam extraction at LBL. The time dependence
of the increased coincidence rate seen by the PET scanner during the beam pulses (figure 4–1, right) is
clearly correlated in shape with the intensity variation of the slowly extracted ion beam from the GSI
synchrotron over the spill [For98]. Hence, most of these coincidences are expected to originate from fast
(at least in the sub-second scale) processes following the beam intensity. They are attributed to the decay
of β+-emitters with half-lives in the millisecond range and correspondingly high β+-endpoint energies or to
γ-rays following nuclear reactions and generating random coincidences. In contrast to the representation of
figure 2–11 (middle), these random coincidences are ascribed to predominantly uncorrelated (in direction
or time) photons not generated by positron annihilation after β+-decay and, furthermore, not necessarily
0 50 100 150 200 250
Time / s
0
10
20
30
40
50
60
70
Co
in
cid
en
ce
s 
pe
r 1
0 
m
s
95 100 105
Time / s
0
5
10
15
20
25
Co
in
cid
en
ce
s 
pe
r 1
0 
m
s
Figure 4–1: Left: Example of coincidence rate acquired in list mode (with time stamps every 10 ms) by the
in-beam positron camera during the delivery of an entire treatment field to a patient at GSI. Right: Enlarged
view for a subset of the same measurement. The rectangular pulses indicate particle extraction. The count
rate increase during the spills as well as the β+-activity decay in the pauses between the pulses is evident.
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produced within the field of view of the detector. Coincidences originating from the decay of short-lived
positron emitters or from beam induced single γ-rays tend either to broaden the spatial distribution of the
induced β+-activity because of the longer positron range (cf. section 2.3.1) or do not bear information on
the dose localisation. At present, these events cannot be separated from the usable decays of long-lived
emitters with half-life T1/2 > 1 s, which generate the build-up of activation visible in the time dependence
of the coincidence rate acquired within the beam pauses in figure 4–1, left. Therefore, all coincidences
detected during beam extraction are currently discarded from the image reconstruction [Eng99a]. With
the present irradiation scheme, consisting of a maximum of 2 s particle extraction followed by a pause of
about 3 s for a total fixed repetition cycle of about 5 s, the rejection of the in-spill data can be estimated
to reduce the counting statistics up to 40% (i.e. 2 /5 ). This rough calculation assumes a constant count
rate over the beam spills and pauses and takes into account only the decay of long-lived positron emitters.
The situation is expected to become even worse in the dedicated Heidelberg facility, where a more efficient
utilisation of the accelerator in combination with the next generation ion beam raster scanner is estimated
to shorten the fraction of total beam pauses during the treatment by about 20% and, in addition, to reduce
the overall treatment time from an average of 250 s to 90 s [Hab00]. In fact there is no clinical as well as
practical advantage in prolonging the treatment time just in order to improve the quality of the PET images.
Therefore, an alternative solution for the next generation in-beam PET scanner has to be found in order
to suppress the noise during beam extraction and recover the usable signal from the decay of the long-lived
positron emitters of interest for the monitoring. As a pre-requisite for such a development, a deeper insight
into the physical reason underlying the noisy in-spill data acquisition is mandatory. This issue has been
addressed in the series of experimental investigations presented in the following sections. This work is the
basis for a new concept of data acquisition tailored to in-beam PET [Eng04b, Cre04].
4.2 The indication from in-beam PET data
4.2.1 Experimental observations
In order to investigate the conjectured role of γ-rays originating from nuclear reactions induced by the beam
and not related to β+-decays (addressed in the further text as “beam induced background”) on the noisy
in-spill PET acquistion, the following initial experiments were performed. Mono-energetic carbon ion beams
of fixed intensity were partially or completely stopped in 9× 9× 20 cm3 blocks of polymethyl methacrylate
(PMMA) placed with the long edge perpendicular to the beam at a distance x {−30, 21, 71, 121, 171} cm
from the centre of the field of view (FOV) of the PET scanner, coinciding with the isocentre of the treatment
unit (figure 4–2). This configuration allows to substantially reduce or rule out the contribution to the
measured events coming from β+-decays due to the position of the activated target outside the positron
Figure 4–2: Experimental set-up for the investigation of the coincidence rate measured by the positron
camera during beam extraction without any β+-activity source in the marked field of view of the tomograph.
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Figure 4–3: True coincidence rate acquired by the positron camera in the same condition of 12C irradiation
(energy: 280.48AMeV, intensity: 2 · 10 7 ions spill−1 ) but different phantom position x of –30 cm (left),
21 cm (middle) and 171 cm (right).
camera FOV. Nevertheless, a non zero coincidence rate was measured during particle extraction, whereas
the activity level correctly drops to zero as soon as the particle extraction stops (figure 4–3). Moreover, the
intensity of the beam induced signal was found to depend not only on the distance of the target from the
detector, but also on its relative position with respect to the beam direction. In particular, the about 3 times
higher count rate registered at a position x = −30 cm against x = 21 cm in the same irradiation condition
suggests a strong background component in the forward emission cone, e.g. due to in-flight de-excitation of
projectile fragments or pair production processes. Because of the absence of β+-activity sources in the field
of view of the tomograph, all these observations lead to the conclusion that the increased coincidence rate
during the beam pulses is due to random coincidences not properly corrected for by the positron camera.
The effect must be furthermore related to the time dependence of the beam intensity. A proper random
correction was observed when placing a 80 MBq positron emitting 68Ge source producing a stationary γ-ray
background at similar distances x from the centre of the FOV. A plausible conjecture on the reason for the
failure of the random correction approach in presence of particle extraction as well as a first validation of
this assumption on the basis of the described experiments is given in the next subsections.
4.2.2 The method of random correction and its failure due to the beam microstructure
For the sake of clarity the definitions of prompt, true and random coincidences extensively used in the
following and already addressed in section 2.3.1 are here briefly reminded. Prompt coincidences P are events
generated by photon pairs of energy within a given acceptance interval firing opposite crystals in a prompt
coincidence time window. A subset of these coincidences originate from photon pairs belonging to the same
annihilation event and are therefore addressed as true coincidences T . The remaining fraction is ascribed
to photon pairs not originating from the same annihilation event or even not related to β+-activity decays
but accidentally falling in the valid time and energy windows for prompt coincidence detection. Therefore,
these are called random coincidences R. Hence, the recovery of the true signal requires a correction for
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Figure 4–4: Typical coincidence spectrum recorded with a time-to-amplitude-converter (TAC) and an
analog-to-digital-converter (ADC) when placing a β+-radioactive source in the field of view of two detec-
tors. The indicated true T , prompt P , random R and delayed D coincidences are explained in the text.
random coincidences. The standard random correction technique implemented by the manufacturer of the
data acquisition system of the in-beam PET scanner (CTI PET Systems Inc. Knoxville, TN, USA) is based
on the subtraction of coincidences detected in a 128 ns delayed window (delayed coincidences D) from all
the prompt coincidences generated by photon pairs within the chosen energy window (250− 850 keV). Both
of the prompt and delayed windows are of the same width (12 ns). The basic assumption underlying such
an approach, always fulfilled in radiotracer imaging, is a γ-ray flux being constant over the delay time and
generating an approximately constant random coincidence rate superimposed onto the true signal (figure 4–
4). Obviously in this condition the amount of delayed coincidences D taken in a time window properly shifted
far away from the desired true signal is a very good approximation of the number of random coincidences R
falling within the prompt window and contributing to the total amount of prompt coincidences P detected.
Hence, the true signal within the prompt window T = P − R can be rather well recovered as T = P −D.
However, a variation of the γ-ray flux on the time scale of the shift between the prompt and delayed
coincidence window will lead to a wrong estimation of the amount of random coincidences superimposed
onto the true signal.
During in-beam PET a non-stationary γ-ray background in the sub-microsecond time scale can be at-
tributed to the micropulsed structure of the beam. Accelerators for ions as well as conventional electromag-
netic radiation sources do not accelerate particles continuously but in packages (bunches) separated in time
from some hundreds of nanoseconds (synchrotrons and cyclotrons for ions) to some hundreds of picoseconds
(linear accelerators for electron and photon radiotherapy) corresponding to the MHz or GHz operation region
of the accelerating radiofrequency (RF) cavities, respectively. According to the parameters of the heavy ion
synchrotron SIS of GSI as well as the 4th harmonics acceleration scheme (i.e. four bunches circulating in
the ring are accelerated by one RF cavity), the periodical repetition of the micropulses varies from 450 ns
to 250 ns in the 88 − 430 AMeV energy range used for carbon ion therapy. This bunched structure is not
destroyed during the extraction procedure because the chosen approach was demonstrated to provide a beam
with reduced intensity fluctuations for optimal coupling to the raster scanning system.
In a first approximation the beam induced background radiation can be assumed to be correlated in
time to the carbon ion microstructure, due to the typically fast (with respect to the nanosecond time scale)
secondary particle production and prompt γ-ray emission processes following nuclear reactions. A model
for such a background based on a realistic description of the beam microstructure with bunches of Gaussian
shape is depicted in figure 4–5. The period of the modulation and the width of the Gaussian bunches directly
reflect the beam microstructure, related to the accelerator RF and to the beam momentum spread resulting
from the longitudinal phase compression, respectively. The bias accounts for a delayed γ-ray component
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Figure 4–5: Model of a γ-ray background varying in time according to the carbon ion beam microstructure.
due to the decay from isomeric excited nuclear states or radioisotopes with half-lives larger than several
hundreds of nanoseconds. Depending on the model parameters, the modulation can result in a reduction
of the delayed coincidence rate leading to an underestimated random correction responsible for the increase
of noise in the data acquired during particle extraction. This is illustrated in figure 4–6 for calculations of
the ratio between the average delayed and prompt random coincidence rates per second generated by the
modelled single γ-ray background at a given period in dependence on the width of the Gaussian bunches at
a fixed bias or vice versa. The simulated values were obtained from the times of detection of single γ-rays
randomly distributed on two detectors according to a probability density function resembling figure 4–5.
In analytical calculations the average prompt and delayed random coincidence rates induced by a flux of
photons distributed in time according to the same probability density function f(t) was estimated as:
P =
1
TRF
∫ TRF
0
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∫ t+τ
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K1f(t)dt
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t
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Figure 4–6: Ratio of delayed and prompt coincidences induced by a background of uncorrelated γ-rays
modulated in time according to the model of figure 4–5. The data were obtained from Monte Carlo simulations
and analytical calculations at a period of 340 ns in dependence on the width of the Gaussian bunches with no
bias (left) and on the bias at the FWHM value of 70 ns marked by the dotted line in the left panel (right).
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where K1 and K2 are normalisation factors to the count rates of photons hitting the two camera heads, τ is
the 12 ns width of the coincidence window, ∆τ is the 128 ns time shift of the delayed window and TRF is the
modulation period. For an uniform probability density function f(t) = 1 the two formulae reproduce the
known expectation of random coincidences induced by stationary single count rates K1 and K2 [Wie89]:
P = D = R = K1 K2 τ (16)
In equation (15) the time dependent prompt and delayed coincidence rates were averaged over one modulation
period, since the coincidences acquired by the positron camera are always separated on a temporal scale
comparable to TRF due to the 256 ns period of the master clock of the coincidence processor [New89].
Furthermore, a limited number of photons per modulation period is expected because of the low amount of
primary carbon ions in the same time interval at the typical intensities of about 107 − 108 ions s−1 used for
therapy. However, these intensity values still provide enough single events per RF period in order to observe
the effect of the modulation for coincidence detection. A first validation of the presented γ-ray background
model on the basis of the coincidence rates measured by the in-beam positron camera in the previously
described experiments is addressed in the next subsection.
It should be remarked there is a second known technique of random correction in addition to the described
method based on the measurement of delayed coincidences. This alternative solution implemented in other
commercial PET scanners is based on the measurement of the single γ count rates and equation (16).
However, for each detector the single count rate information is collected over several seconds in order to reduce
the statistical error. Since this time interval corresponds to millions of modulation periods any possibility of
synchronization with the time of detection of the prompt coincidences affected by the time variant random
background is completely lost, hence resulting in a faulty random correction. Therefore, standard available
techniques for correction of random coincidences based on measurements of delayed coincidences or single γ
count rates fail in presence of a γ-ray background being non-stationary in the sub-microsecond time scale.
4.2.3 A first validation of the conjectured influence of the beam microstructure
The list mode data acquisition of the positron camera allows for the distinction of prompt and delayed
coincidences detected in 10ms wide intervals during beam extraction and extraction pauses (figure 4–7).
From these values average prompt and delayed coincidence rates per second Ps, Pp and Ds, Dp – the
subscripts s and p refer to “spill” and “pause”, respectively – were calculated for each spill and pause. The
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Figure 4–7: Separate prompt (left) and delayed (right) coincidence rate for a 280.48AMeV carbon ion
irradiation at a phantom position x = 21 cm.
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Figure 4–8: Average prompt coincidence rate per second (cps) during particle extraction (Ps) and beam
pauses (Pp) for the same irradiation (cf. figure 4–7) with the target at the edge of the scanner FOV. The
activity build-up due to the small contribution from long-lived positron emitters is visible in the growth of Pp
with the time of irradiation.
observed high prompt and delayed coincidence rate during particle extraction (Ps and Ds, respectively) is
conjectured to originate mostly from the beam induced γ-ray background in addition to the true contribution
from the decay of short-lived (T1/2  1 s) as well as long-lived β
+-emitters in case of activity sources within
the FOV of the positron camera. The latter long-lived positron emitters represent the almost exclusive
source of a detectable signal during the extraction pauses. For the analysis of the experiments described in
section 4.2.1 the beam induced background component, addressed in the following with the index r staying
for “random”, had to be separated from the measured total Ps and Ds count rates. The following approach
was applied. The contribution to Ps and Ds from short-lived isotopes of typical half-lives in the ms time
scale was neglected in first approximation. If detectable in dependence on the phantom position, short-
lived emitters are very roughly estimated to contribute to the coincidence rate in spill in the same order
of magnitude of the long-lived isotopes formed in the same spill, due to the compensation between their
small production cross section and their larger decay constant. Hence, on the basis of the observed strong
count rate variation between particle extraction and extraction pauses in figure 4–7, the contribution of
short-lived positron emitters to Ps and Ds is expected to be rather small in comparison to that induced
by the beam. Moreover, such short-lived isotopes almost entirely decay within the spill in which they are
produced. Thus, their neglection can affect the final estimation of the beam induced random coincidence
rate only by a constant offset in each spill. On the contrary, the contribution to Ps and Ds from long-
lived β+-emitters varies with the time of the irradiation because of the activity build-up process (figure 4–8).
Therefore, this component was subtracted by means of an extrapolation from the corresponding prompt (Pp)
and delayed (Dp) count rates measured in the successive extraction pauses. Hence, the beam induced prompt
and delayed coincidence rate per second was estimated for each spill as Pr = Ps − Pp and Dr = Ds −Dp,
respectively. The resulting ratio of the delayed and prompt beam induced coincidence rates, averaged over
all the spills of the irradiation, was observed to be rather independent on the target position outside the
FOV and on the beam energy at the considered typical intensities of 107 − 108 ions s−1. The latter values
corresponded to prompt count rates in spill Ps from 100 to 1500 cps at the selected distances x. An average
ratio 〈Dr/Pr〉 = (0.040 ± 0.008) was extracted from measurements performed at different days and with
different irradiation parameters (figure 4–9). It should be noticed that a proper random correction should
result in a 〈Dr/Pr〉 ratio of one.
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Figure 4–9: Ratio of the beam induced average delayed and prompt coincidence rate estimated from several
in-beam PET experiments. Measurements at different energies corresponded to a phantom distance x of
21 cm (triangles). The additional values at the energy of 280.48AMeV (squares) were found at different
target positions x of –30 cm and 71 cm.
A first validation of the γ-ray background model illustrated in section 4.2.2 was performed by means of
the described Monte Carlo simulations, trying to reproduce the average beam induced delayed (Dr) and
prompt (Pr) random coincidence rates extracted from the measured PET data. Since the results do not
unambiguously depend on the selection of the bias and FWHM model parameters at a fixed modulation
period corresponding to a given ion energy, the bias was set to 0. This choice allows to investigate the max-
imum width of the Gaussian bunches capable to reproduce the observed suppression of delayed coincidences
(cf. figure 4–6). Indeed the experimental values could be reproduced by means of a proper choice of the
maximum FWHM parameter (figure 4–10, left). However, at energies below 200 AMeV (figure 4–10, right)
the predicted FWHM values were found to be considerably smaller than the measured widths of the beam
bunches within the synchrotron ring before extraction [Eic00]. In order to interpret correctly the reasons for
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Figure 4–10: Left: Beam induced average coincidence rates Dr and Pr extracted from PET measurements
at different initial energies at x = 21 cm in comparison to Monte Carlo simulations based on the model of
figure 4–5 at the period corresponding to the given ion energy and with no bias. Right: Predicted FWHM
values leading to the simulated data presented in the left panel in comparison to the FWHM of the beam
bunches measured in the synchrotron ring before extraction. The disagreement for low energies is evident.
42
4.3 The time microstructure of the carbon ion beam
this disagreement, the microstructure of the carbon ion beam had to be assessed after the extraction and as
much as possible close to the position of the PET scanner. The experiment addressing this issue is presented
in the next section.
4.3 The time microstructure of the carbon ion beam
The residual microstructure of the carbon ion beam after slow resonant extraction in the same condition used
for therapy (i.e. applying a flat top voltage of 2 kV to the RF tank) was measured by means of a standard
plastic scintillator (BC400, decay time of about 2 ns) of 75×75 mm2 surface and 1 mm thickness placed in the
beam line of the medical cave, 50 m downstream of the SIS exit and about 100 m in front of the PET camera
(figure 4–11). The detector was coupled to a fast photomultiplier (PMT, Phillips XP2972), resulting in
pulse widths less than 10 ns. A fast digital storage oscillograph (DSO, 1 GHz maximum sampling frequency)
was used to acquire the PMT pulses simultaneously to the sinusoidal signal coming from the RF cavity.
Data were sampled either at 1 or 5 ns separation for a total of 4 or 20 ms acquisition time, respectively. A
relatively low amount of 106 ions per acceleration cycle was produced in the SIS ring prior to the extraction
in order to limit as far as possible pile-up in the scintillation detector. An example of acquisition is given
in figure 4–12. As indicated by the vertical dotted and dashed lines, the arrival time of the particles on the
detector was identified either with the leading edge position obtained from the derivative of the PMT signal
or with the pulse maxima (inverse polarity) position. In the latter case single and piled-up events could
be distinguished by analysing the pulse amplitude and width, because of the rather constant shape of the
signal induced by mono-energetic carbon ions in the used thin scintillator. Both of the approaches provided
similar results. A rather good time resolution was obtained due to the steep and constant rise time of the
signal. However, the maximum achievable resolution is limited by the finite sampling period of the digital
oscillograph, comparable to the rise time of the scintillator signals. The final time distributions were obtained
by relating all the events to one RF period, exploiting the phase and period information given by the RF
signal. As indicated by figure 4–13, the particle arrival times exhibit a strong correlation with the phase of
the RF signal. The observed phase of maximum occurrence probability varies in dependence on the particle
energy because of the different transit time of the ions to the detector with respect to the constant delay of
the signals fed to the scope via a cable of fixed length. The measured microstructure rather well supports
the approximation of beam bunches of Gaussian shape, in spite of a very slight asymmetry which increases
with the beam energy, as visible in figure 4–13. The average FHWM values obtained from least squares
Gaussian fits of all the performed experiments are summarised in table 4–1. The broadening trend at lower
energies is due to the larger momentum spread, in analogy to the previous values measured in the synchrotron
Figure 4–11: Experimental set-up for the measurement of the carbon ion beam microstructure after extrac-
tion in the beam line downstream from the SIS synchrotron and 100 m before reaching the medical cave where
the PET camera is installed.
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Figure 4–12: Example of the scintillator and RF signals acquired for an irradiation at 88.83AMeV ion
energy (TRF =442.8 ns). The arrival times of the ions deduced from the derivative or maxima (inverse
polarity) of the scintillator pulses are shown by the vertical dotted and dashed lines, respectively.
ring (cf. figure 4–10, right). However, the bunch widths measured after particle extraction are found to be
much smaller than in the SIS ring. Moreover, these new values are well below the maximum FWHM values
which were predicted by the simulations in order to explain the delayed coincidence suppression leading
to the strong noise of the in-beam PET acquisitions. Hence, the experimental beam induced prompt (Pr)
and delayed (Dr) count rates detected by the PET scanner (cf. figure 4–10 in section 4.2.3) could still be
reproduced by simulations using the parameters of table 4–1, provided that a plausible bias of about 1 %
was included in the model. Therefore, as a remaining validation step the γ-ray background reaching the
positron camera detectors during particle extraction had to be measured, as addressed in the next section.
It should be finally mentioned that due to a typical beam momentum spread of ± 0.1 % no debunching of
the measured carbon ion microstructure can be expected in the ' 100 m distance between the location of the
plastic scintillator and the PET camera in the explored full energy range used for therapy, corresponding to
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Figure 4–13: Time correlation of the particle arrival with respect to the phase ϕ = 0 of the synchrotron RF
signal measured at an ion energy of 88.83AMeV (left) and 426.11AMeV (right). The left axis refers to the
ion counts (triangles), whereas the right axis refers to the sinusoidal voltage applied to the RF tank (solid
line). The Gaussian fit of the measured count distribution is shown by the dotted line.
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Table 4–1: Average FWHM values from least squares Gaussian fits of all the ion-RF time correlation
distributions measured after particle extraction at different energies corresponding to different RF periods.
Energy / AMeV RF period / ns FWHM / ns
88.83 442.8 55 ± 4
200.28 318.2 32 ± 3
280.48 282.4 28 ± 3
350.84 262.9 24 ± 2
426.11 248.4 19 ± 2
ion velocities within 0.4− 0.7 c. Furthermore, Schottky spectra measurements excluded also any significant
variation of the bunch widths at the higher intensities of 107 − 108 ions s−1 usually applied for therapeutic
irradiation [Mor00].
4.4 The measured γ-ray background
In order to assess the conjectured failure of the random correction of in-beam PET coincidences acquired
during particle extraction because of a non-stationary γ-ray background correlated in time to the carbon ion
beam microstructure, time spectra of the γ-rays originated by 12C bombardment of organic matter relative
to the synchrotron radiofrequency had to be measured. Since it is impossible to operate the PET camera
for such an investigation, a detector of similar stopping properties as bismuth germanate (BGO) but better
timing performances was chosen. These requirements are rather well fulfilled by gadolinium ortho-silicate
(cf. table 4–2). Hence, a GSO crystal of 20 mm radius and 25 mm thickness (MolTech GmbH, Berlin) coupled
to a fast PMT (Philips XP2020) was selected. This size allows a detection efficiency comparable to that of
a single BGO block detector of the in-beam PET scanner to be achieved. In order to compare the timing
and energy performances, GSO-BGO time coincidence spectra with additional spectroscopic analysis were
measured with a 22Na positron emitting source in a laboratory set-up resembling the scheme of figure 4–4.
The GSO detector was estimated to have a 2.6 ns time resolution (FWHM) against the 5.3 ns of the available
BGO sample. The energy resolution of the GSO detector was found to be about 15% against the ' 25 %
of the BGO crystal at 511 keV. These values support the choice of the GSO detector for the planned energy
and time correlation measurement of the γ-ray background with respect to the RF signal. The experimental
set-up as well as the data analysis and outcome are separately reported in the next subsections. As briefly
addressed in the discussion of the results, an independent spectroscopic investigation of the beam induced
γ-ray background was additionally performed with a Germanium detector of better energy resolution (' 3%
at 511 keV) in the same set-up of the GSO experiment.
Table 4–2: Main properties of the inorganic scintillators bismuth germanate (BGO) and gadolinium ortho-
silicate (GSO): effective atomic number Zeff , density ρ, radiation length X0 , wavelength of maximum emis-
sion λmax , refraction index n, fluorescence time constant τ (doping dependent for GSO), light output η
relative to NaI(Tl) and radiation hardness R. Both crystals are not hygroscopic.
Scintillator Zeff ρ / g cm
−3 X0 / cm λmax / nm n τ / ns η / % R / Gy
Bi4Ge3O12 (BGO) 75 7.13 1.12 480 2.15 300 10− 20 103−4
Gd2SiO5:Ce (GSO) 59 6.71 1.38 440 1.85 30− 60 18− 27 > 106
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4.4.1 Experimental set-up
For the experimental investigation of the beam induced γ-ray background, mono-energetic carbon ion beams
spanning the energy range of therapeutic interest (88.83 − 426.11 AMeV) were completely stopped in 9 ×
9 × 20 cm3 PMMA targets placed at the isocentre of the treatment unit with their long edges parallel to
the beam (figure 4–14). This configuration well resembles typical irradiation conditions during therapy.
Corresponding intensity values from 1 · 108 to 4 · 106 ions per about 2 s spill were selected in order to achieve
a similar dead-time of the data acquisition system [Ess00] for all beam energy values. The GSO detector
coupled to the fast PMT was horizontally placed on the patient couch with the crystal centre aligned to
the isocentre. The couch was mostly positioned perpendicularly to the beam. In few measurements the
angle was varied in order to explore the angular dependence of the γ-ray flux with respect to the beam
direction. The distance between the detector and the isocentre was kept fixed to 41 cm, approximately as
the radius of the PET detector heads. This reproduces the exposure condition of the positron camera to
the beam induced background radiation. For the measurement of the time distribution of the γ-ray flux
with respect to a fixed phase of the synchrotron RF with additional photon energy discrimination the signal
processing scheme shown in figure 4–15 and based on standard NIM and CAMAC electronics was used. The
tunable blocking window of the constant fraction discriminator (CFD) in the time branch of the detector
was used to prevent multiple triggering. The CFD trigger level was adjusted to a lower energy threshold
of about 100 keV. The higher energy threshold resulting from the energy branch in combination with the
ADC was about 3.4 MeV. The TAC settings were chosen in order to have a time range interval of almost
400 ns comparable to the maximum RF period of about 450 ns. The signals from the accelerator control
and beam monitor (ionisation chambers) were used in order to enable the acquisition exclusively during
particle extraction (beam on). Besides the time and energy record, the following additional parameters were
inserted into the list mode data stream. The spill number C1 was registered in order to perform dynamic
acquisition for establishing the relationship between the single photon count rate detected by the GSO
crystal and the prompt as well as delayed coincidence rates simultaneously recorded by the positron camera.
C0 is the number of triggered events detected by the GSO crystal independently on the irradiation status
(beam on/off), in the following distinguished as C0s and C0p for detection during the spills and pauses,
respectively. This record in combination with C1 further enables a more straightforward comparison with
the PET measurement during the pulsed beam delivery. The strobe signal of the ADC C2 provides additional
Figure 4–14: Experimental set-up for the energy and time correlation measurement of the beam induced
γ-ray flux with respect to the synchrotron radiofrequency.
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Figure 4–15: Scheme of the NIM and CAMAC electronics used for the RF-γ time correlation measure-
ment with photon energy discrimination. Where not explicitly referenced, the used electronics modules were
produced by EG&G ORTEC (Oak Ridge, TN, USA). The data were registered using the acquisition system
developed at GSI [Ess00].
statistics information on the electronics dead-time during beam extraction. The count rate capability of the
data acquisition system was about 500− 600 events per second. In the measurements at 90◦ couch angle the
average fraction of events registered in the list mode data file with respect to the amount of triggered events
during beam extraction (C0s) was approximately 15% whereas the ratio C2/C0s was found to be about
80%. Hence, most of the dead-time arises from the ADC and list mode data storage. Time calibrations
performed at the beginning and at the end of the experiments revealed a very high stability with deviations
below 0.1 ns. On the contrary, a ' 10% drift at 500− 600 keV was observed in energy calibration spectra
acquired with 22Na and 207Bi sources prior to and after the experimental run in addition to the phantom
activation measurements. However, this energy uncertainty does not affect the analysed time distributions,
as discussed in the next section.
4.4.2 Results and discussion
The time distribution (figure 4–16) of the detected γ-rays with energy values between 250−850 keV, i.e. within
the acceptance window of the positron camera, confirmed a clear correlation with the RF signal and thus
with the measured microstructure of the primary carbon ion beam. Furthermore, no modification in shape
was observed when shifting the energy window according to the measured energy drift of the electronics. The
depicted time correlation spectra were reversed in time by exchanging the start and stop role of detector and
RF signal with respect to the electronics scheme of figure 4–15. In this more straightforward representation
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Figure 4–16: Left: Energy spectrum detected by the GSO crystal during 500 spills of a 12C irradiation
at an energy of 280.48AMeV (RF period of 282.4 ns) and an intensity of 8 .5 · 10 6 ions spill−1 . Right:
Corresponding RF-γ time spectrum restricted to photons with energy deposition in the 250 – 850 keV interval
marked by the dashed lines in the left panel.
the steep leading edge of the asymmetric peak is attributed to prompt γ-rays following nuclear reactions,
whereas the slope of the falling edge is diminished by a delayed component originating from the decay of
isomeric excited nuclear states and radioisotopes with half-lives in the nanosecond region. The constant bias
consistent with the model predictions is primarily due to the decay of longer-lived isotopes mostly ascribed
to the phantom β+-activation. According to this physical interpretation the measured time distributions
were described by the function:
F (t) = b + a
∫ t
t+δ
B(t′ − δ) e
− (t−t
′)
τeff dt′, t starting time for which B(t) 6= 0, (17)
defined as the convolution of the measured bunched beam flux B(t) presented in section 4.3 (cf. figure 4–13)
with an exponential decay accounting for all γ-ray emission processes with half-lives in the sub-microsecond
time scale in addition to the bias b. The constant term a is a normalisation factor whereas δ compensates
the different delay with respect to the RF signal in the measurement of the carbon ion microstructure and
this experiment. A rather good agreement of the model with the measured time spectra was obtained, as
shown in figure 4–17. An “effective” decay time τeff ranging from 19 to 37 ns in the explored energy interval
Figure 4–17: Measured time spectra (dots) in comparison to a non-linear least squares fit (solid line) based
on the model of equation (17) for 12C irradiation at an energy of 88.83AMeV and intensity of 1 .3 · 10 8
ions spill−1 (left, total of 420 spills) and at 426.11AMeV and 3 .5 · 10 6 ions spill−1 (right, 350 spills).
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Figure 4–18: Left: Prompt coincidence rate detected by the PET scanner during particle extraction (Ps)
and pauses (Pp) for the same 280.48 AMeV irradiation leading to the GSO energy and time distributions
of figure 4–16. Right: Corresponding total (i.e. without energy discrimination) single count rate of GSO
events processed by the whole data acquisition system during ion extraction in comparison to the detection
rate (deduced from C0) during the beam spills and pauses. The count rate dip at about 300 s in both of PET
and GSO data is due to an intensity drop from the accelerator.
from 426.11 down to 88.83 AMeV, respectively, was extracted from the fit of data measured in the same
set-up and under similar condition of data acquisition load. However, an identical average count rate per
second on the detector at different primary carbon ion beam energies corresponds to different conditions of
dead-time during the micropulses within single RF periods. This is supported by the known changes of the
RF period and of the carbon ion bunch widths (table 4–1) in dependence on the beam energy.
The data analysis has been mostly concentrated on the comparison between (i) the calculated prompt
and delayed random coincidence rates induced by a γ-ray flux modulated in time according to the GSO
data in the 250− 850 keV energy window and (ii) the corresponding Pr and Dr count rates extracted from
the simultaneous PET acquisition. In comparison to the previous experiments analysed in section 4.2.3 a
stronger contribution of the activated target placed in the centre of the positron camera field of view was
obviously found in the PET measurements. This is reflected by the build-up of the coincidence rate Ps
detected during the spills visible in figure 4–18 (left) in contrast to figure 4–8. Hence, the fraction of beam
induced coincidence rates Pr and Dr was extrapolated from Ps and Ds by means of a more refined estimation
of the contribution due to long-lived positron emitter, assuming a constant isotope production rate during
the spill and based on the initial and final activity detected by the positron camera shortly before and after
each particle extraction (spill). However, no significant difference (≤ 5 %) was observed in comparison to
the alternative method addressed in section 4.2.3, based on the simple subtraction of the coincidence rates
measured in the pauses (Pp and Dp) from those detected during the precedent spills (Ps and Ds).
The corresponding estimation of the prompt and delayed random coincidence rate induced by the γ-ray
background measured by the GSO detector was based on the RF-γ time correlation curves acquired for each
spill and equation (15) of section 4.2.2 (figure 4–19). However, the GSO measurements were found to be
affected by a minor build-up of the induced target activation as well, as indicated by the increase of C0p with
the time of the irradiation in figure 4–18, right. This is expected to affect the measured time distributions
by means of a bias varying with the time of the irradiation. In order to enable a correction, the subset
of events processed during each spill and originating from the decay of long-lived positron emitters had to
be estimated. In analogy to the original approach used for the PET data, the contribution from long-lived
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Figure 4–19: Measured RF-γ time correlation for the 280.48 AMeV irradiation (left, cf. figure 4–18) and
estimated time dependent prompt (middle) and delayed (right) coincidence rates (integrands in bracket of
equation 15), not yet corrected for the contribution of long-lived β+-emitters (cf. text). The shown data
were obtained from the time spectrum measured over the whole irradiation to reduce statistical fluctuations
for visualisation purposes, whereas single contributions during each spill were considered for data analysis.
(For clarity this figure was included after the defense of the thesis at TU Dresden.)
emitters was deduced from the count rate measured in the beam pauses. This was achieved on the basis of
the following available information. The measured detector count rate during the beam pauses (extracted
from C0p) was corrected for the data acquisition dead-time, which was deduced from the ratio between
the measured amount of processed and detected (C0s) events during particle extraction (figure 4–18). This
approximation, assuming a constant dead-time during beam extraction and extraction pauses, is justified
by the previous dead-time considerations, showing a dominant contribution from the list mode acquisition
rather than the event count rate on the detector. However, this approach does not include any energy
discrimination. Nevertheless, events measured during the beam pauses can be mostly ascribed to positron
emitter decays. Therefore, the fraction of single γ-rays resulting from long-lived β+-decays and falling into
the 250 − 850 keV energy window was deduced from measurements with positron emitting sources. After
this correction, the resulting estimate of the amount of registered events per each spill due to the decay
of long-lived positron emitters was realistically assumed to be uniformly distributed in time within single
RF periods. Therefore, for each irradiated spill a bias was subtracted from the measured time correlation
spectra. Contributions due to short-lived positron emitters were neglected as in the case of the PET data
(cf. section 4.2.3). The corrected time distributions, periodically extended on the basis of the known RF
period, were finally used as probability density function f(t) in order to determine the beam induced prompt
and delayed coincidence rates according to equation (15).
The resulting estimates of the ratio between the delayed (Dr) and prompt (Pr) beam induced coincidence
rates extracted from the PET and the GSO data simultaneously acquired are compared in figure 4–20 for
different initial beam energies. The quantities deduced from the GSO single count rates were normalised to
the average values of the estimated PET coincidence rates in order to compensate for the different detection
efficiency and the different signal processing. Furthermore, a median filter over 10 subsequent spills was
applied in order to reduce statistical fluctuations. Both of the estimates based on the PET and the GSO
acquisitions exhibit a common trend for the increase of the beam induced delayed to prompt coincidence rate
ratio with the time of the irradiation. This is mostly originated by the increase of the delayed coincidence
rate Dr up to a rather constant plateau during the irradiation. Such an observation may be attributed to
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Figure 4–20: Ratios of the beam induced delayed and prompt coincidence rates extracted from the simultane-
ous PET and GSO acquisition for carbon ion irradiation at 88.83, 280.48 and 426.11AMeV. The quantities
extracted from the GSO data (orange curves) were normalised to the average values of those deduced from
the PET measurements (green). For each pair of curves the mean error is given by an error bar. The
acquisitions correspond to the GSO time spectra of figures 4–16, 4–17.
the enhancement of events contributing to the bias b of the γ-ray background model – equation (17) – via
increasingly formed long living isotopes from fragmentation reactions between the 12C projectiles and the
PMMA target until saturation over the time of irradiation. The resulting increase of the delayed to prompt
coincidence rate ratio for an increasing bias can be deduced from figure 4–6. However, an additional effect
may derive from an inefficient subtraction of the β+-activity build-up due to the long-lived β+-emitters.
Nevertheless, the good correspondence between the quantities extracted from the two independent PET and
GSO data sets indeed supports the explanation of the random correction failure of the positron camera due
to the measured γ-ray background correlated in time with the beam microstructure.
Figure 4–20 furthermore indicates a decrease of the average ratio 〈Dr/Pr〉 for increasing carbon ion beam
energies. Such a trend is in agreement with the decrease of τeff – cf. equation (17), suggesting an increase
of the prompt γ-ray component at higher carbon ion beam energies. However, the parameters of the time
correlation spectra measured by the GSO detector (figures 4–16 and 4–17) in combination with the widths
and periods of the particle bunches (table 4–1) cannot explain such a strong dependence of the 〈Dr/Pr〉
ratio on the initial carbon ion beam energy as observed in the PET data. The most plausible explanation
for this discrepancy is a dependence of the Dr/Pr ratio on the coincidence rate measured by the positron
camera due to different conditions of dead-time within the micropulses of the irradiation. The considered
acquisitions at 88.83, 280.48 and 426.11 AMeV were performed at beam intensities of 1.3 · 108, 8.5 · 106 and
3.5 · 106 ions spill−1, respectively. These values corresponded to different average prompt coincidence rates
Ps of 4.5, 2.5 and 1.5 kcps, respectively, detected by the positron camera during particle extraction. In order
to examine this issue more in detail, the dependence of the Dr/Pr ratio on the photon flux reaching the
positron camera has been further investigated in the series of experiments reported in the following.
The beam induced photon flux on the detector heads varies in dependence on the energy and intensity
of the primary carbon ion beam in combination with the characteristics of the irradiated target as well as
its position relative to the positron camera. Hence, several irradiation of PMMA targets were repeated in
the same configuration at given initial energies but with significantly different primary carbon ion beam
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Figure 4–21: Average beam induced delayed to prompt coincidence ratios extracted from PET data measured
for PMMA phantoms centered in the FOV of the positron camera (left) or at the edge of the FOV (x = 21 cm,
right). The carbon ion beam intensity was varied over the whole range 2 · 10 6 – 2 · 10 8 ions spill−1 available
for therapy, corresponding to the depicted total prompt coincidence rate Ps of the positron camera during
beam extraction. The intensity interval explored in the previous measurements (section 4.2.3) suggesting the
average ratio of Dr/Pr ' 0 .04 is marked by the solid line in the right panel.
intensities, spanning the whole interval 2 · 106 − 2 · 108 ions spill−1 available for therapy. Acquisitions with
the target placed in the centre of the positron camera FOV – i.e. resembling realistic conditions for therapy
monitoring – were compared to additional measurements in the set-up of figure 4–2 at a phantom distance
x of 21 cm. This choice provided a comparison of results for two configurations with either a significant
or a marginal influence from the contribution of positron emitters to the total coincidence rate in spill Ps,
respectively. The data shown in figure 4–21 indeed confirm a dependence of the Dr/Pr ratio on the positron
camera count rate (reflecting the photon flux variation in dependence on the beam energy and intensity).
Furthermore, the only difference for the two phantom positions is found to be a stretching factor of the
horizontal axis in the figure. This arises from the different contribution to Ps coming from the decay of
positron emitters (negligible for the phantom position outside the FOV) in addition to the beam induced
component Pr itself. Whereas values at low coincidence rates are affected by the poor counting statistics,
reflected by the large error bars, the observed increase of the Dr/Pr ratio at higher coincidence rates above
about 1− 2 kcps is ascribed to the increasing dead-time of the PET data acquisition during the micropulses.
This mostly affects the detection of the considerably higher prompt coincidence rate. As a rough estimation,
at the lowest energy of 88.83 AMeV the average prompt count rate in spill Ps was found to be 50 cps at
an intensity of 1 · 106 ions spill−1 in the same configuration of the GSO experiment. In this low count rate
measurement an average 〈Dr/Pr〉 ratio of about 0.01 was found. At the increased intensity of 1.3 · 108 ions
spill−1 the expected average coincidence rate in spill Ps would rise up to a maximum of 845kcps. Furthermore,
the average count rate values are estimated to correspond to instantaneous coincidence rates up to a factor
10 times higher during the micropulses, according the measured parameters of the microstructure and of the
beam induced γ-ray background. The resulting maximum value of 8.45Mcps is well above the coincidence
rate processing capability of the positron camera installed at GSI, limited to about 400kcps. Hence, this
rough calculation explains a lower prompt coincidence rate detected by the positron camera during particle
extraction at higher beam intensities. Such a reduction can be therefore responsible for the underestimate
of Pr leading to the higher Dr/Pr ratio reported in figure 4–20 for the considered 88.83 AMeV irradiation
at 1.3 · 108 ions spill−1 intensity. It should be also noticed that this count rate dependence was not observed
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Figure 4–22: Energy spectra acquired by the GSO detector during the first 100 spills of carbon ion irradiation
at 88.83, 280.48 and 426.11AMeV and intensities corresponding to a similar acquisition dead-time in the
same experimental set-up. The data were normalised to the area of the lowest energy spectrum.
in the initial study reported in section 4.2.3. This preliminary investigation was in fact intentionally limited
to the narrow intensity range corresponding to the region marked in figure 4–21 (right) in order to avoid to
exceed the count rate capabilities of the imaging system. Finally, the rough independence of the results of
figure 4–21 on the primary carbon ion energy for both of the experimental configurations at a given photon
flux is in agreement with the measured parameters of the microstructure and of the beam induced γ-ray
background, resulting in variations of the Dr/Pr ratio less than 30% at the considered different energies.
However, it should be stressed once more the high sensitivity of the beam induced delayed to prompt
coincidence ratio on the parameters of the single γ-ray background, especially for small bunch widths and
bias values as illustrated in figure 4–6.
Up to this point the analysis has been focussed on the random coincidence problem for the positron
camera installed at GSI. In the following, additional properties of the beam induced background radiation
are reported. This includes the comparison of the γ-ray flux and energy spectra measured by the GSO
detector in dependence on the primary carbon ion beam energy and on the angle with respect to the beam
direction as well as a deeper spectroscopic insight by means of a Ge detector. The aim is to provide a
more complete information which might be of interest for the definition of the technical specifications of
an in-beam PET tomograph in presence of an ion beam delivery pulsed on the sub-microsecond time scale.
Hence, only technically relevant aspects will be outlined, whereas a detailed understanding of the complex
mixture of physical processes behind the findings of the data analysis is beyond the purpose of this work.
Energy spectra measured by the GSO scintillator during carbon ion irradiation at different initial energies
and intensities corresponding to a similar acquisition dead-time are compared in figure 4–22. The variation
of the height of the 511 keV annihilation peak with respect to the low energy component of the continuous
background in dependence on the carbon ion beam energy is evident. This resulted into a reduced fraction
of photons falling into the 250 − 850 keV energy window at increasing beam energies. Despite the rather
constant ratio of the probability per unit path length for nuclear reactions leading to prompt photon emission
or positron emitter production at different initial beam energies, the data indicate a relative increase of the
prompt photon flux for increasing carbon ion energies. This may imply a further photon flux increase for
higher beam energies at the same primary ion intensity, in addition to the enhancement due to the larger
amount of nuclear reactions along the higher penetration depth. Therefore, different conditions of pile-up
and dead-time on the detectors in dependence on the beam energy and intensity should be taken into account
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Figure 4–23: RF-γ time correlation spectra measured during 200 spills of carbon ion irradiation at
280.48AMeV energy. The left acquisition was performed at a couch angle of 90◦ and an intensity of
8 .5 · 10 6 ions spill−1 . The right one refers to a 34◦ angle and 3 .5 · 10 6 ions spill−1 . The time distribu-
tions of events detected in different energy intervals are shown.
for realistic applications of in-beam PET to therapy monitoring. In particular, the count rate capabilities of
a system intended to be operated also during particle extraction should be designed on the basis of the huge
beam induced γ-ray background component rather than the relatively low amount of positron radioactivity
induced by stable ion beams in typical treatment situations. This suggests special care in the selection of the
energy thresholds for coincidence detection in PET imaging. From figure 4–22 especially the lower value of
250keV seems to be inappropriate and should be increased up to about 350keV. Similarly, the high energy
threshold of 850keV might be decreased to about 650 keV.
GSO measurements performed at different couch angles (cf. set-up of figure 4–14) indicated also an
anisotropic γ-ray fluence distribution peaked in the forward emission cone. As an example the ratio of
registered to detected (C0s) events dropped to 13% at 34
◦ couch angle against the 16 % value at 90◦,
despite the reduction of the primary ion beam intensity by a factor 2.4 for the same irradiation condition at
280.48 AMeV. The explored angular dependence revealed also a variation of the energy spectrum, reflected
by the different contributions to the total time distributions given by photons within, below and above the
energy window for PET monitoring (figure 4–23). Almost no difference can be observed in the shape of the
shown time spectra, apart from the bias reduction in all the considered energy intervals at the 34◦ couch
position. But a considerable and systematic enhancement of the high energy component above 850 keV was
clearly found for detector positions at small angles with respect to the beam axis. Moreover, the observed
fluence enhancement significantly involves also energies well above the upper threshold of the PET energy
window. This is indicated by the increase of the overflow (i.e. amount of depositions above the upper
threshold of about 3.4MeV in the energy acquisition) up to 55% of the energy component above 850 keV
at 34◦ couch angle in comparison to the 32% at 90◦. This suggests also the possible presence of a particle
component due to nucleons, particles and fragments mostly emitted in the forward beam direction in nuclear
interactions [Gun04]. Hence, besides the care in the selection of the upper threshold of the energy window
for PET coincidence detection, consequences of different spatial detector arrangements on pile-up, dead-time
and also possible detector activation have to be considered.
Further information on the complex mixture of the beam induced radiation superimposed onto the back-
ground component from the environment and from the β+-activation of the PMMA target were provided by
the spectroscopic measurements performed with a Germanium detector placed perpendicularly to the beam
in the same configuration of the GSO experiment. In figure 4–24 an in-beam energy spectrum acquired dur-
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Figure 4–24: Left: Energy spectrum recorded by the Germanium detector during 250 spills of a carbon ion
irradiation at 280.48 AMeV and 4 ·10 6 ions spill−1 intensity corresponding to a count rate of about 4000 s−1
and 15 % dead-time. Besides the continuous spectrum, lines ascribed to beam induced processes (dotted-
dashed), detector excitation/activation (dashed) and natural background or positron annihilation (dotted)
are marked. The energy window relevant for PET imaging is indicated by the solid lines. Right: Activation
measurement of the target during the 5min immediately following the end of the beam delivery.
ing 20 minutes of irradiation is compared to a 5minutes long measurement of the target activation started
immediately after finishing the beam delivery. Clearly, in the measurement exclusively performed during
particle extraction the 40K line of 1461keV from the natural background is embedded in a beam induced
continuous background. In this in-beam spectrum lines ascribed to the production of stable but excited
nuclei (e.g. 19F) or radioactive isotopes (e.g. 10C) have been identified. Further lines have been attributed
to deuteron formation or prompt excitation of the beam dump, exclusively consisting of iron [Schar01].
Additional lines falling within the energy window of interest for PET are attributed to emissions from the
Germanium detector, mostly due to (n, n′γ) reactions. However, these events do not obviously pertain to
the GSO experiment. Besides, they can only slightly affect the positron camera measurements, due to the
content of Germanium in BGO. Few lines of the in-beam spectrum (e.g. the one at about 230 keV) could
not be unambiguously identified, due to the limited quality of the detector, the insufficient knowledge of all
background components of the environment as well as the different measuring time between the in-beam
and off-beam acquisition. Nevertheless, they involve energy regions of no interest for PET imaging and
their characterisation is therefore beyond the aim of this study. Instead, it is important to remark that no
significant activation as well as beam induced background radiation was observed after finishing the beam
delivery, as indicated by the off-beam spectrum dominated by the 511 keV annihilation peak and the natural
background. In addition to the shown variation of the flux and energy spectrum of the γ-rays in depen-
dence on the carbon ion beam energy and direction, this spectroscopic investigation furthermore points out
the dependence on the specific target (e.g. each individual patient in the individual treatment position) in
addition to the environment (e.g. the beam dump).
4.5 Conclusion
In summary, all the presented experimental validations support the consistency of the proposed model
which attributes the noise of in-beam PET acquisition at the GSI facility to not properly corrected random
coincidences originating from a γ-ray background correlated in time with the carbon ion beam microstructure.
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The measured time distributions of the γ-rays following the beam appearance indicate that during particle
extraction a rather large fraction of each RF period (from about one third up to an eventual entire period in
case of low beam intensities) contains usable events for PET imaging. These events are currently discarded
according to the present data acquisition scheme, capable to discern only the macroscopic structure of the
irradiation (beam on/off). Standard random correction techniques based on the measurement of delayed
coincidences or single count rates have been demonstrated to be inapplicable due to the time variation of
the γ-ray background during the microbunches of the particle extraction. An alternative exploiting the
periodicity of the γ-ray flux by adjusting the time shift of the delayed window to the RF period of the given
beam energy for each spill is also not practicable. In addition to the technological challenge of such a solution,
the γ-ray flux varies from one microbunch to the next due to statistical fluctuations, intensity instabilities
from the accelerator on the sub-microsecond time scale as well as beam modifications in space and time
due to the raster scanning technique. Therefore, the random coincidences due to the beam induced γ-ray
background have to be suppressed. Hence, on the basis of the presented basic investigation an alternative
solution for in-beam PET acquisition has been proposed [Eng04b] and is currently under implementation
and experimental validation [Cre04]. The aim is to recover the useful signal from long-lived positron emitters
decayed during beam extraction, in order to increase the poor counting statistics of in-beam PET imaging
during therapeutic sessions. In fact, the same beam microstructure is foreseen also for the Heidelberg
facility, despite the planned substitution of the slow resonant extraction with a knock-out technique [Eic01].
However, it has to be finally mentioned that the recovered events will also contain a contribution from the
decay of short-lived positron emitters. As qualitatively addressed in section 4.2.3, the activity contribution
from these short-lived positron emitters with half-lives T1/2  1 s may be not negligible. Since the in-beam
PET monitoring of carbon ion therapy at GSI is presently limited to the processing of data acquired during
the beam pauses, mostly originated from long-lived positron emitters, no deeper insight into this issue has
been performed yet. Therefore, a realistic quantification of the production rate of millisecond short-lived
β+-emitters as well as the consequence of their longer positron range due to the typically higher endpoint
energies on the quality of the PET images for therapy monitoring is a still open question.
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5.1 Motivation
The clinical experience at GSI Darmstadt has demonstrated the important contribution of in-beam PET to
quality assurance of high precision carbon ion therapy, due to the possibility to (i) monitor the maximum
ion range, (ii) verify the field position and in some cases (iii) detect and quantify unpredictable deviations
of the applied dose with respect to the treatment plan, as shown in chapter 3. The physical selectivity
of protons is comparable to carbon ions for realisation of highly conformal radiotherapy. Hence, a similar
clinical benefit is expected from the possibility to control the precision of dose delivery simultaneously to
proton irradiation by means of in-beam PET techniques, at least in delicate clinical cases. However, the
straightforward extension of positron emission imaging to monitor proton therapy is nontrivial. Due to
the absence of projectile fragmentation reactions no pronounced maximum of β+-activity is formed in close
vicinity to the Bragg-peak as in the carbon ion case (cf. section 2.1.4). Additionally, the β+-activation of
the target nuclei vanishes along the last few millimetres of proton penetration due to the energy threshold
for nuclear reactions. Hence, the spatial correlation between the induced β+-activity distribution and the
proton range as well as the dose delivery is poor, as already pointed out by previous investigations [Oel96].
Furthermore, the partial cross sections for proton-nucleus reactions leading to the production of the main
positron emitters of interest for PET monitoring are up to three times lower than the corresponding ones for
carbon-nucleus interactions, according to the available experimental data as well as the formulae of [Sih93]
(cf. sections 2.1.3 and 2.1.4).
Up to now, despite the widespread installation of proton therapy facilities as well as the growing interest
for more strict quality assurance in high precision charged hadron therapy, no definitive conclusion on the
feasibility and value of PET for in-situ control of proton therapy has been drawn. Therefore, the issue has
been addressed again in this work. With respect to the previous investigations mentioned in section 1.2,
more answers on the potentialities and limitations of in-beam PET for quality assurance of proton therapy
have been derived from the comparison with the already clinically implemented carbon ion case as well as the
experimental availability of the unique in-beam PET scanner installed at GSI. The initial feasibility study
reported in section 5.2 has been entirely based on Monte Carlo simulations. Supported by the encouraging
results, very promising in-beam phantom experiments have been carried out at GSI for the first time, as
presented and discussed in section 5.3. The conclusions are drawn in section 5.4.
5.2 Initial predictions
5.2.1 Material and methods
The two main items deciding on the applicability of PET techniques to the monitoring of proton therapy
are the amount and the spatial distribution of the proton induced β+-activity. The former determines the
feasibility of signal detection during or shortly after the irradiation of the patient for on-line or off-line mon-
itoring, respectively. The latter affects the possibility to extract information on the particle range and to
control the precision of the dose delivery. Therefore, the initial feasibility study has investigated the amount
and the spatial distribution of the main positron emitters produced in organic plastic by mono-energetic
pencil-like (non divergent, lateral profile of 10 mm FWHM) proton beams at initial kinetic energy within
the 60− 220 MeV interval of interest for therapy. Polymethyl methacrylate (PMMA, composition: C5H8O2,
density: 1.18 g cm−3) has been selected as target material because of the favourable stoichiometric compo-
sition including the most abundant elements of living tissue, the density similar to that of water as well as
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the practical suitability for further experimental verification. Proton transport has been calculated on the
basis of the FLUKA Monte Carlo code [Fas01a, Fas01b] which is a general purpose program already success-
fully applied to simulation of therapeutic proton beams for dosimetric and radiobiological problems [Bia99].
Besides all main electromagnetic physical processes the code takes into account also hadronic interactions.
Nuclear reactions are treated by means of a model [Fer97] starting from explicit intra-nuclear cascade (INC).
After the full INC treatment stops (when all nucleons have energies below 50 MeV and all particles except
nucleons have been emitted or absorbed) a statistical preequilibrium emission accounts for nuclear thermali-
sation. At the end of the preequilibrium stage the thermalised, but still excited residual nucleus approaches
the final configuration via particle evaporation, γ-ray de-excitation or fragmentation according to the Fermi
Break-up model for light isotopes (A ≤ 17). Hence, among the wide spectra of products the model is capable
of predicting the formation of β+-emitters, too.
For a quantitative estimate of the practicability of β+-activity detection during and shortly after proton
irradiation, the calculated production of the most abundant positron emitters and the resulting number of
decays within a typical average measurement time of five minutes have been compared to the corresponding
amounts induced by the same number of primary 12C ions at energies leading to a similar penetration
depth. The latter values have been obtained from the predictions of the dedicated POSGEN Monte Carlo
code [Has96] developed for calculation of the PET database currently in clinical use for the monitoring of
carbon ion therapy at GSI (cf. section 2.3.3). The qualitative analysis of the β+-activity spatial distribution
has been focussed on the study of positron emitter depth profiles, which determine the feasibility of range
monitoring and control of the correct dose delivery in the most critical distal (i.e. away from the origin of the
radiation in contrast to proximal) part of the irradiation field. Hence, additional dose depth profiles have
been obtained by calculating the energy deposition in cylindrical detectors of 5 mm radius and 1 mm length
along the central beam axis for 106 primary protons and carbon ions (lateral FWHM of 10 mm) by means
of FLUKA and POSGEN, respectively.
5.2.2 Results and discussion
The predicted amount of the most abundant nuclei (15O, 11C and 10C) produced by three mono-energetic
pencil-like proton beams of 70, 140 and 200 MeV (± 0.1 % momentum spread) is presented in table 5–1. The
comparison with the corresponding values for carbon ion irradiation shows a reduction of about one order
of magnitude of the proton induced activation at the same range and number of primary ions. However,
the applicability of positron emission imaging to therapy monitoring demands a comparison for a number
of projectiles leading to the same dose deposition at a given penetration depth. Hence, an increase of the
proton fluence up to a factor of about 20 has to be taken into account in order to compensate the lower
stopping power of protons in comparison to carbon ions at energies corresponding to the same range in a
given material (cf. figure 5–1, figure 5–2 and equation 3 in chapter 2). From these considerations the total
β+-activity signal produced within the treated volume by a therapeutic proton irradiation is expected to
be about two times larger than that measured by the in-beam limited angle positron camera for carbon
ion dose application at GSI. The factor of 2 is expected to increase further in realistic clinical cases on the
basis of considerations on the relative biological effectiveness of carbon ions and protons [Wam99, Kra99].
Therefore, this quantitative analysis supports the feasibility of PET signal detection during or shortly after a
proton therapeutic irradiation. An on-line solution is strongly suggested on the basis of the values presented
in table 5–1. The contribution from 15O is expected to dominate the proton or 12C ion induced β+-activity
signal shortly after production in realistic patient treatments, according to the tissue composition, the
reaction cross sections and the isotope half-life. Hence, an in-beam detector similar to the device used at
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Table 5–1: Positron emitter production predicted by the FLUKA and POSGEN Monte Carlo codes for
proton and 12C ion irradiation, respectively, of thick PMMA targets at typical therapeutic energies E and
ranges R. The amount of 15O (T1/2 = 121.8 s),
11C (T1/2 = 1222.8 s) and
10C (T1/2 = 19.3 s) produced per
106 projectiles and the related number of β+-decays within 5min after production are given.
Protons 12C ions
Isotope E / MeV Amount Decays E / AMeV Amount Decays
R / cm per 106 p in 5 min R / cm per 106 12C in 5 min
15O 200.0 2.071 · 104 1.69 · 104 400.41 1.679 · 105 1.37 · 105
11C ' 22.6 4.572 · 104 7.15 · 103 ' 23.2 4.272 · 105 6.68 · 104
10C 2.171 · 103 2.17 · 103 2.990 · 104 2.99 · 104∑
2.62 · 104 2.34 · 105
15O 140.0 1.230 · 104 1.01 · 104 270.55 1.004 · 105 8.22 · 104
11C ' 12.1 2.665 · 104 4.17 · 103 ' 12.3 2.661 · 105 4.16 · 104
10C 9.46 · 102 9.46 · 102 1.964 · 104 1.96 · 104∑
1.52 · 104 1.43 · 105
15O 70.0 3.919 · 103 3.21 · 103 126.11 2.876 · 104 2.35 · 104
11C ' 3.5 7.595 · 103 1.19 · 103 ' 3.3 8.821 · 104 1.38 · 104
10C 7.0 · 101 7.0 · 101 5.960 · 103 5.96 · 103∑
4.47 · 103 4.33 · 104
GSI should allow the most efficient utilization of the PET signal.
The simulated spatial distribution of the considered positron emitting nuclei, projected onto the penetra-
tion depth and superimposed onto the dose depth profile, is shown in figure 5–2 for the three proton beams
and one carbon ion energy. The proton induced activation is rather constant along the penetration depth and
drops to zero shortly before the Bragg-peak and the primary proton range (listed in table 5–1). The position
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Figure 5–1: Stopping power of protons and carbon ions as a function of the residual range in water according
to the ICRU report 49 [ICR93] and the predictions of the ATIMA code [Schw91], respectively. The ratio of
about 20 decreases for low residual range (< 10−3 cm) due to effective charge effects (eq. 2 in chapter 2).
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Figure 5–2: Depth distribution of 11C, 15O and 10C produced in PMMA by proton irradiation at 70, 140
and 200 MeV initial energy and a 270.55AMeV carbon ion beam, according to the FLUKA and POSGEN
predictions, respectively. The calculated dose depth profile is additionally shown by the dashed-dotted curve.
The factor of about 20 between the dose delivered by the same number (106 ) of primary carbon ions and
protons at initial energies corresponding to the same penetration depth can be noticed from the right panels.
of the distal fall-off is mainly influenced by the 16.6 MeV and 20.3 MeV energy thresholds [Vyn93] for the
main (p, pn) reaction channels leading to the production of 15O and 11C, respectively. This means that the
systematic distance of about 6 mm observed between the 50 % level of the distal edge of the total positron
emitter distribution and the dose maximum could change in other materials than PMMA, depending on
the proton residual range at energies below the reaction thresholds and on the C/O ratio of the medium
composition. A similar spatial correlation between the distal fall-off of the induced positron emitter distri-
bution and the maximum proton range is also expected in more realistic extended treatment fields. This is
supported by a previous off-line PET phantom experiment showing nearly no difference in the shape of the
very distal slope of the β+-activity distribution induced by a mono-energetic and a spread-out Bragg-peak
irradiation [Oel96]. Therefore, despite the absence of β+-emitting projectile fragments in close proximity
to the dose maximum as in the case of heavy ions like carbon (figure 5–2), the extraction of information
on the maximum particle range and Bragg-peak position from the distal fall-off of the activity distribution
as well as the localisation of the beam path and of the delivered dose from the track of activated target
nuclei seems to be possible in the proton case, too. Because of the poor spatial correlation between dose
and positron radioactivity distributions, therapy monitoring has to be performed by comparing measured
PET images with realistic predictions based on the individual treatment plan of the patient and the time
60
5.3 Experimental investigations
course of the specific irradiation, as already done for the quality assurance control of carbon ion therapy at
GSI [Eng99b]. In combination with the predicted increase of counting statistics, a positive clinical impact
of PET is expected from the possibility to check the precise stopping of the protons in the patient, to verify
the correct position of the irradiation field and to control the stability of the treatment over all sessions of
fractionated therapy. However, this conjectured successful applicability of PET to the monitoring of proton
therapy still demands careful experimental verification, as described in the next section.
As a concluding remark it can be noticed that the reliability of the quantitative estimate of the proton
induced activation has been supported by the comparison with a previous off-line phantom experiment [Oel96]
discussed in [Par00]. Considerations on the accuracy of the simulated spatial distribution of positron emitters
will be addressed in the next chapter, where refinements of the calculation model for comparison with the
measured β+-activity profiles are presented.
5.3 Experimental investigations
Following the promising results of the preliminary simulation study, the feasibility of proton therapy moni-
toring by means of PET has been further investigated in a series of in-beam phantom experiments carried
out at the heavy ion synchrotron of GSI Darmstadt. In December 2000 three mono-energetic pencil-like pro-
ton beams with initial energy of 110, 140 and 175 MeV were for the first time delivered to the medical cave
dedicated to carbon ion therapy. They were completely stopped in PMMA targets placed in the centre of the
field of view (FOV) of the in-beam positron camera. Despite the suboptimal quality of the beam, exhibiting
fluctuations in lateral position of about 5mm but stable intensity, the β+-activation of the targets could be
imaged with high statistics. These measurements addressed the same issues like the simulation study: the
amount and the spatial distribution of positron radioactivity induced by mono-energetic proton irradiation
of homogeneous targets. The resulting quantitative comparison with the carbon ion case is presented in
section 5.3.3.1, whereas depth and lateral profiles are shown in section 5.3.3.2 and 5.3.3.3, respectively.
A further set of experiments was carried out in March 2003, when beams of better quality in terms of
focussing stability and better characterisation of the beam parameters became available. This made possi-
ble also the use of the raster scan system for multi-dimensional mono-energetic and spread-out Bragg-peak
(SOBP) irradiation. However, the lowest energy deliverable at the minimum meaningful intensity values
of about 108 p s−1 was limited to about 150 MeV. This second experimental run allowed to complete the
investigation on the spatial distributions of β+-activity induced by irradiation fields extended in the longi-
tudinal (SOBP) and transversal (scanned fields) dimension, as discussed in section 5.3.3.2. Furthermore, it
addressed the more delicate questions on the potential of PET for (i) the monitoring of the proton range,
(ii) the verification of the lateral position of the irradiation field as well as (iii) the detection of possible po-
sitioning inaccuracies or local tissue modifications within the patient during fractionated therapy. The first
topic was deeply investigated by means of mono-energetic and SOBP irradiation of homogeneous PMMA
phantoms at steps of initial kinetic energy values corresponding to range differences less than 1 mm (sec-
tion 5.3.3.2). For the second purpose a special thick plastic phantom with slits for insertion of photographic
emulsions was designed. In this way the spatial distribution of proton induced β+-activity could be detected
simultaneously to the independent film measurement of the dose lateral distribution at several penetration
depths, as illustrated in section 5.3.3.3. The last issue was preliminarily investigated by means of a mono-
energetic irradiation of an inhomogeneous phantom. This allowed to study the production of β+-emitting
target fragments in different materials as well as to assess the sensitivity of the proton induced positron
radioactivity to density gradients and tissue stoichiometry, as reported in section 5.3.3.2.
The description of the experimental set-up and of the common methods used for data analysis are given
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in the following two sections. Details on the specific irradiation are separately reported together with the
presentation of the results in section 5.3.3. The latter has been subdivided into the three major topics for
the purpose of therapy monitoring: 1) the intensity of detectable PET signal produced by proton compared
to carbon ion irradiation as well as 2) the depth and 3) the lateral distributions of the proton induced
β+-activity.
5.3.1 Experimental set-up
In all the measurements pencil-like proton beams of about 10−15 mm diameter (FWHM) with initial energy
ranging within the 110 − 215 MeV interval at intensities of approximately (1 − 5) · 108 p/s were extracted
from the heavy ion synchrotron of GSI. The beams were stopped in targets of organic plastic placed on the
patient couch in the middle of the two in-beam positron camera heads (figure 2–12 and 5–3). In almost all
acquisitions 9×9×20 cm3 PMMA blocks with the long edge parallel to the beam were irradiated. Two special
phantoms were used only for the experiments on lateral position verification with simultaneous exposure of
photographic emulsions and for the activation of an inhomogeneous target. They will be described in a
dedicated section. The irradiation strategy and the vertical position of the targets were always selected in
such a way to produce compact β+-activity distributions in the mid-plane of the PET scanner in order to
avoid limited angle artifacts as far as possible. In most of the measurements the phantom position along
the beam direction was chosen in order to centre the expected β+-activity distribution in the field of view
of the positron camera. Only for the more delicate investigation of the range resolution power of PET the
predicted position of the activity distal edge was carefully adjusted to the centre of the FOV, which exhibits
the best imaging properties (e.g. spatial resolution and sensitivity). In all cases the laser alignment system of
the treatment room was exploited. In addition, a PET scan with a 22Na point source placed on the entrance
face of the targets was performed prior to the irradiation. This allowed to recover with high accuracy the
front face position of the object with respect to the imaged β+-activity depth profile for the data analysis.
The targets were typically irradiated for an average time of 10 minutes. The in-beam PET acquisition was
in general prolonged over 10− 20 minutes after stopping the irradiation. In this way decays of short-lived
(e.g. 10C, 15O) and long-lived (11C) isotopes could be collected with very good statistics (' 106 − 107 true
coincidences, i.e. more than one order of magnitude than in typical treatment situations). The data were
registered in list mode with time stamps every 10 ms for dynamic acquisition. This further enables analysis
in different time windows. In all the irradiation the time structure of the beam was approximately the
same as for carbon ion therapy: about 1 − 2 s particle extraction (spill) and 3 − 4 s extraction pause. The
Figure 5–3: Schematic display of the experimental set-up. Non-scanned pencil-like proton beams were
delivered to the isocentre, coinciding with the centre of the positron camera FOV. In case of scanning, the
beam was moved only in the lateral dimension restricted to the mid-plane of the tomograph.
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proton beam had furthermore a microstructure similar to that of the carbon ion beam, because of the same
longitudinal phase compression and slow resonant extraction procedure from the accelerator. Hence, noise
originating from the physical reason explored in chapter 4 for carbon ions was also observed in the PET
events acquired during proton irradiation. Therefore, the information on the status of the irradiation (beam
on/off) was recorded and used in order to reject the noisy PET events registered during the spills from the
data analysis, as done for the processing of coincidences acquired during carbon ion therapy.
5.3.2 Data analysis
Despite the wide spectrum of measurements performed in order to address several issues, common points
can be identified in the approaches used for data analysis. The study of the spatial distribution of the
proton induced β+-activity in relation to the localisation of the dose and of the maximum proton range
demanded a comparison between the available tools for image reconstruction and a final choice of an optimal
strategy. Because of the particular experimental conditions at GSI, a mathematical description of the isotope
production and decay rate during the pulsed beam irradiation had to be developed. This was used for the
quantitative investigation of the proton and carbon ion induced β+-activity as well as for the estimate of
the ratio between measured events originating from 11C and 15O decays. The latter contributions affect the
position of the β+-activity distal edge related to the maximum proton range. Finally, the feasibility study
of proton therapy monitoring based on the comparison between measured and realistically predicted PET
images required the refinement of the models used for calculation of positron emitter distributions.
5.3.2.1 Reconstruction and presentation of the proton induced β+-activity distributions
The PET images and positron radioactivity distributions of all the performed experiments were obtained
using the backprojection algorithm with corrections for the attenuation of the γ-rays within the phantom as
well as for the spatially variant detection efficiency of the tomograph [Lau99, Hinz00]. Attenuation corrections
were calculated from the linear attenuation coefficient of the 511 keV annihilation photons in the phantom
along each line of response of the positron camera. The position dependent detection efficiency of the scanner
was taken into account by means of weights proportional to the geometrical detection probability. These
weights were normalised to the detection efficiency of the tomograph in the centre of the FOV, measured to
be 2.45 % by means of a 22Na point source of known activity. The backprojection approach was preferred to
a complete iterative MLEM tomographic reconstruction [Lau99] since it is simple, quantitative and artifact
free. This is however true only for the chosen experimental conditions leading to β+-activity distributions
confined to the mid-plane of the PET scanner. An additional remarkable advantage of the selected algorithm
is the low computing time. Only 1 min was necessary against 120 min and even twice the time when using
the MLEM reconstruction without or with scatter corrections [Po¨n03b], respectively, for the processing of
a data set of 5.7 · 106 true coincidences and a typical image space of 230 × 80 × 90 voxels of 1.6875 mm
edge size (i.e. one fourth of the detector crystal pitch) on an Intel Xeon 2.20 GHz CPU. According to
the intrinsic spatial resolution of the positron camera the backprojection algorithm furthermore ensures
a satisfying spatial resolution in the considered central plane. Values of about 7 − 8 mm FWHM against
5− 6 mm after MLEM reconstruction were obtained from measurements with 22Na point sources. However,
for the delicate issue of the range resolving power and lateral position verification, the independence of the
results on the image reconstruction algorithm was carefully checked, as shown in the results. Obviously,
different approaches for data processing may introduce in the final PET images slight discrepancies which
are, however, beyond the purpose of the presented experimental feasibility studies.
In the following the PET images and the β+-activity depth or lateral profiles are always displayed in
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the mid-plane of the positron camera FOV. Depth profiles of activity distributions imaged during the first
experiment were projected onto the central axis, in order to rule out effects due to the slight beam position
instabilities. In all the other cases, the depth profiles were averaged over ± 5 voxels around the central beam
axis.
5.3.2.2 Extraction of isotope production rates from the measured PET data
A quantitative comparison of the proton and carbon ion induced β+-activity distributions requires the
reliable estimation of the production rates of the β+-active isotopes from the measured PET data (figure 5–
4). This procedure has to be independent on the irradiation parameters. Furthermore, the study of the
dynamic variation of the 11C/15O decay ratio during the pulsed beam delivery has to be feasible. For these
purposes attention has been particularly focussed on the production rates of 11C, 15O and 10C, which are
the most abundant positron emitting isotopes formed in the considered irradiation of organic plastic. Due
to the uselessness of the noisy data acquired during the beam bursts as well as the too short duration of the
extraction pauses between the pulses for time analysis of the activity decay (figure 5–4, left), the following
dedicated approach tailored to mono-energetic irradiation has been developed.
(i) The relative amount N11C, N15O and N10C of the isotopes of interest present at the end of the irradiation
t has been deduced from a non-linear fit of the measured activity decay A(t) after stopping the irradiation
(figure 5–4, right):
A(t) = λ11CN11Ce
−λ11C(t−t) + λ15ON15Oe
−λ15O(t−t) + λ10CN10Ce
−λ10C(t−t), t > t (18)
where λ and N are the decay constants and fitting parameters, respectively. The adjective relative emphasizes
the PET-system dependence of this estimate, not yet corrected for the attenuation of the annihilation photons
within the phantom and for the detection efficiency of the tomograph in opposition to the absolute values
discussed later.
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Figure 5–4: Example of coincidence rate acquired at the beginning (left) and at the end (right) of a mono-
energetic proton irradiation. The beam extractions (spills) are marked by the rectangular pulses displayed in
grey.
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(ii) The relation between the isotope abundance at the end of the irradiation and the production rate during
beam extraction has been established by means of a mathematical description of the activity accumulation
and decay during the pulsed beam irradiation. Such a description is particularly feasible in the special
case of mono-energetic irradiation without beam scanning (addressed in the following as 1D), leading to the
same spatial distribution of positron emitters produced at each beam burst. The underlying principle is the
assumption of a constant isotope production rate during particle extraction. This is feasible because of the
much longer half-life of the isotopes of interest in comparison to the time scale of the intensity variations
and fluctuations during the spill. Furthermore, due to the quite stable operation of the synchrotron the
irradiation conditions can be assumed to be constant with fixed duration of spills and pauses as well as the
same number of extracted protons at each pulse. Under these approximations the number Kl,j of nuclei of
species l present at the end of the j-th spill can be described as:
Kl,j = Kl,j−1e
−λl(tp+ts) +
Pl
λl
(1− e−λlts)
Kl,1 =
Pl
λl
(1− e−λlts)
(19)
where Pl is the production rate for the isotopes of interest l {11C, 15O, 10C} and tp and ts are the average
pause and spill duration, respectively. From this recursive system of equations follows a first expression for
the production rate as:
Pl =
λlKl,T
(1− e−λlts)
∑T
i=1 e
−λl(i−1)(tp+ts)
(20)
where Kl,T is the relative amount of isotopes of species l present after the last spill T , hence given by N11C,
N15O and N10C resulting from (i).
In a second more refined approach the specific production rate Pl,j for each j-th spill was deduced from
the total activity Aj measured at the end of the spill and the relative contribution fl of the l-th isotope to
the estimated amount of activity Aj produced in the j-th spill:
Pl,j =
Ajfl
1− e−λlts,j
Aj = Aj −
∑
l
j−1∑
i=1
Pl,i(1− e
−λlts,i)e−λl
∑j−i
m=1(ts,m+i+tp,m+i−1)
(21)
where fl was approximated by the expression λlPl/
∑
k λkPk , with Pl extrapolated from the predictions of
equation (20). This second formula can lead to a slight overestimation of the individual isotope production
rate, since it attributes all the experimental β+-activity to 11C, 15O and 10C. On the other hand, it accounts
for possible changes of the irradiation conditions, since it directly uses the individual time duration ts,j and
tp,j of each spill and pause as well as the coincidence rate measured after each spill and not only the final
activity at the end of the irradiation. For comparison of the two model predictions the measured average
count rate per second cpsj registered within each j-th pause during irradiation was compared to that deduced
from the production rate estimations Ll,j set to Pl ∀j from equation (20) and to the average 〈Pl,j〉 ∀j as well
as to the individual Pl,j from equation (21), respectively, according to the expression:
cpsj =
∑
l
{ j∑
i=1
[Ll,i(1− e−λlts,i)
λl
e−λl
∑j−i
m=1(ts,m+i+tp,m+i−1)
] (1− e−λltp,j )
tp,j
}
(22)
As shown in figure 5–5 a rather good agreement with maximum deviations of about 10 % was found, hence
supporting the reliability and consistency of the models based on equations (20) and (21).
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Figure 5–5: Mean count rate (in counts per second, cps) measured during the beam pauses of a proton
irradiation in comparison to the predictions resulting from the production rate estimates based on equa-
tions (20), (21) and (22).
(iii) For the absolute quantitative comparison of the proton and carbon ion induced β+-activity, the pro-
duction rate estimation relative to the measured PET events had to be corrected for the attenuation of
annihilation photons within the phantom and for the spatially varying detection efficiency of the PET scan-
ner. Furthermore, the different spatial distributions of β+-activity induced by the two different projectiles
had to be taken into account. For this reason a local correction factor c(r) dependent on the position r
within the image-space has been introduced as the ratio of the activity values Au(r) and A(r) obtained from
the measured data by backprojection without and with the two corrections for attenuation and detection
efficiency, respectively:
c(r) =
Au(r)
A(r)
(23)
An average correction factor C has been deduced from the weighted integral of c(r) over the corrected spatial
activity distribution for each measured data set as:
C =
∫
dr c(r) p(r) =
∫
drAu(r)∫
drA(r)
for p(r) =
A(r)∫
drA(r)
(24)
The absolute production rates have been therefore obtained by dividing the relative P values calculated
according to the methods described in (ii) by C. Scatter corrections have not been taken into account for
this estimate, since the number of events located outside the beam path due to Compton scatter has been
found to be negligible in the backprojected images. Furthermore, the contribution of scattering is expected
to be comparable for the proton and carbon ion induced β+-activity distributions considered in the presented
experiments.
(iv) The ratio between 11C and 15O decays has been deduced from the estimate of the average isotope
production rate in spill Pl. This allows to separate the amount Dj,l of isotopes of species l decayed within
each j-th pause according to the expression:
Dj,l =
Pl(1− e−λlts)
λl
[ j∑
i=1
e−λl(i−1)(ts+tp)
]
(1− e−λltp,j ) (25)
For a complete analysis over the entire PET acquisition time, the amount of decays from the l-th isotope
species within a ∆t interval starting at a time t after stopping the irradiation has been simply obtained from
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Figure 5–6: Count rate (cps) contributions derived from the calculated β+-decays of 11C, 15O and 10C
nuclei (left) and comparison of the resulting total value with the coincidence rate measured during and after
approximately 10min proton irradiation of a thick PMMA target (right).
the isotope abundance Nl at the end of irradiation introduced in (i) as:
Dt,l = Nle
−λl(t−t)(1− e−λl∆t), t > t (26)
As an example the predicted contributions of 11C, 15O and 10C decay rates per second detected in the ' 3.5 s
long pauses of the beam delivery and in time windows ∆t of the same duration after the end of a proton
irradiation are depicted on the left side of figure 5–6. The resulting total count rate estimate is compared to
the measured coincidence rate on the right side of the figure. Again the fairly good agreement over the entire
time interval with average deviation below 2 % supports the consistency and reliability of the approach. It
can be noticed that in this study no spatial dependent correction of the relative isotope production rates has
been considered, because of the quite comparable spatial distribution of the 11C and 15O positron emitters
of interest produced by proton irradiation.
5.3.2.3 Calculation of β+-activity distributions induced by proton irradiation
With respect to the first simulation study presented in section 5.2, improved calculation models had to
be investigated in order to achieve a more accurate description of the proton induced positron emitter
production for a more realistic comparison of measured and calculated β+-activity depth profiles. The
previous approach was entirely based on the FLUKA Monte Carlo code. However, the available comparison
between the predictions of the internal models of the program and the experimental partial cross sections
for proton interaction on carbon shows an underestimation (up to 30 %) approximately below 70 MeV and
an overestimation (again up to 30 %) above about 150 MeV for the main 12C(p, pn)11C reaction channel of
interest for positron emitter production (figure 5–7). In the typical energy range of relevance for therapy
the two opposite trends can compensate on average and result in a fairly good prediction of the total
11C production. This is supported by the rather good agreement between calculations based on FLUKA
and off-line PET measurements [Oel96] discussed in [Par00]. Nevertheless, the different dependence of the
predicted reaction cross section on the energy affects the slope of the calculated isotope distribution along the
proton path. Similar uncertainties of the FLUKA internal models can be furthermore expected for positron
emitter production from other reaction channels involving targets different than carbon. The accuracy of
generalised intra-nuclear cascade models for generation of light residuals is intrinsically limited, despite the
considerably advanced implementation in FLUKA including preequilibrium processes and Fermi Break-up for
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Figure 5–7: Comparison of the excitation functions predicted by the FLUKA internal models (solid
lines) [Fer96] with experimental data (points) [Eph67, Ilj91] for the production of different isotopes by proton
bombardment of natural carbon (courtesy of A. Ferrari, CERN).
light nuclei [Fer96, Fer97]. In order to overcome the limitations of nuclear modelling, a more refined approach
tailored to the PET application has been developed, which takes into account available experimental cross
sections. Only 12C(p, pn)11C and 16O(p, pn)15O interactions have been considered. These are the main
reaction channels for the production of the two most abundant positron emitters determining the shape
of the β+-activity profiles measured in the presented experiments, as also expected in typical 5 − 10 min
in-vivo acquisitions during or shortly after a therapeutic session [Vyn93]. This approximation is particularly
meaningful for the mostly considered case of PMMA targets, due to the absence of nitrogen as well as the
higher content of carbon than oxygen. In this material the contribution to 11C production from the second
main 16O(p, 3p3n)11C reaction channel was found to be less than 8 % according to the cross section values
from [Alb62]. Moreover, no significant modification (< 0.2 mm) was observed in the distal edge position of
the total 11C depth distribution when including this contribution, despite the higher energy threshold of the
16O(p, 3p3n)11C reaction. Furthermore, positron emitter production from secondary particles different than
protons was also estimated to be negligible, with the most significant contribution from neutrons limited to
1− 2 %.
The spatial distribution of 11C and 15O nuclei has been obtained by combining internally during run-
time the energy dependent cross sections interpolated from the experimental data extracted from [Nuc00]
(figure 5–8) with the energy and position dependent proton flux given by the FLUKA code. In figure 5–9
the resulting positron emitter depth profile is compared to the predictions entirely based on the internal
models implemented in the two FLUKA versions from 1998 (used for the calculations presented in 5.2) and
1999. The data refer to the simulation of a 140 MeV proton beam (± 0.1 % momentum spread, 10 mm lateral
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Figure 5–8: Interpolated values (lines) from experimental cross sections (points) taken from [Aam52, Cra56,
Cum63, Hin52, Mea66] and [Alb62, Kit90, Saj85, Val65] for the two main (p, pn) reaction channels leading
to the production of 11C and 15O in proton interaction on carbon and oxygen, respectively. The data include
the yield stemming from a (p, d) reaction energetically also possible.
FWHM, no divergence, 106 primaries) stopped in PMMA. Clearly the new approach leads to a considerably
steeper slope of the isotope production along the penetration depth. The improvement will become evident
in section 5.3.3.2 after presentation of the β+-activity depth profiles obtained from the reconstruction of the
measured data. It must be however noticed that the new approach predicts a lower amount of 11C and 15O
isotopes with a global reduction up to ' 10− 20 % in the 110− 175 MeV energy interval. The reason seems
to be the neglection of reaction channels with minor probability in combination with uncertainties (from 5 %
to 30%) as well as discrepancies in the cross sections extrapolated from [Nuc00] and those predicted by the
internal models of FLUKA. Nevertheless, both the old method and the new approach lead to a quantitative
prediction rather close to the corresponding amount of positron emitters extracted from the experimental
data and normalised to the same number of simulated projectiles, as shown in table 5–2. Furthermore, the
new method provides a more satisfactory agreement with the measured data with respect to the 11C to 15O
production ratio.
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Figure 5–9: Projection onto the beam axis of the 11C+15O production calculated using the new approach with
experimental cross sections in comparison to the internal models implemented in FLUKA98 and FLUKA99,
respectively, for 106 primary protons of 140 MeV initial energy stopped in PMMA.
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Table 5–2: Ratios between the predicted and the experimentally deduced 11C and 15O isotope production
in PMMA. The predictions were obtained by means of FLUKA99 simulations using the new approach with
experimental cross sections (rexp) in comparison to the internal models (rint). The absolute isotope produc-
tion deduced from the measured PET data (section 5.3.2.2) was normalised to the same number of simulated
primary projectiles.
E / MeV 11 C 15O
rexp rint rexp rint
110 0.9± 0.2 0.9± 0.3 0.9± 0.3 1.3± 0.5
140 0.8± 0.2 0.9± 0.2 0.8± 0.3 1.2± 0.4
175 0.8± 0.3 0.9± 0.3 0.8± 0.4 1.2± 0.6
It should be mentioned that a recent publication of ICRU [ICR00] has proposed different cross sec-
tions values (figure 5–10), extensively based on calculations generated by the Los Alamos GNASH model
code [You92, Cha99a, Cha99b]. These values have been also addressed as the most reliable source of infor-
mation in [Bee03]. However, [ICR00] itself recommends to prefer experimental data, whenever available, for
PET studies. A comparison of the separate 11C and 15O depth profiles generated by FLUKA when using the
two different cross section data sets from [Nuc00] and [ICR00] is illustrated in figure 5–11. After presentation
of the reconstructed measured data the preference for the selected approach using the experimental data
from [Nuc00] will become evident. Furthermore, the values published by ICRU could not reproduce several
trends observed in the measured PET data, as it will be explicitly pointed out in the text. Nevertheless,
there is a complete agreement with the conclusions of [Bee03] on the still ongoing need to develop a library
of more recent and accurate cross section data for proton induced reactions on the elements of human tissue
in the energy range of relevance for therapy. A work on this issue is currently in progress [IAE97]. This
knowledge should be further validated by means of PET experiments in pure phantoms.
The spatial distributions of positron emitters predicted according to the described method have been
convolved with a Gaussian point spread function of 7 or 5 mm FWHM for comparison with the measured
β+-activity distributions obtained from backprojection or MLEM iterative reconstruction of the acquired
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Figure 5–10: Cross sections values for 11C (solid) and 15O (dashed) production in (p, pn) interaction on
carbon and oxygen targets, respectively, recently published in [ICR00].
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Figure 5–11: Relative depth distributions of 11C (solid) and 15O (dashed) isotopes calculated by means of
FLUKA using cross sections extrapolated from the Nuclear Reaction Data Center (NRDC) [Nuc00] and the
ICRU [ICR00] for a mono-energetic proton irradiation of a thick PMMA target at 173.13 MeV initial energy.
data, respectively. Such an approximation accounts for blurring effects due to the image formation (positron
and photon propagation) and data processing on the basis of measurements with positron emitting point
sources. Although this approach does not include the explicit propagation of the positrons emitted in the
β+-decays as well as the transport of the annihilation γ-rays for the particular activity sources induced by
each specific phantom irradiation, a rather good agreement with the measured data was observed, as shown
in section 5.3.3. In all the simulations the beam momentum spread was fixed to ± 0.1 %, according to the
synchrotron specifications. In the most delicate investigations on activity depth profiles in relation to the
feasibility of PET for proton range monitoring, the ' 2 mm water equivalent material in the beam line
was taken into account by means of a corresponding range reduction. A sub-millimetre accuracy of such
correction is however beyond the purpose of this study. When no detailed information was available, a lateral
beam profile of 10 mm FWHM and no divergence were assumed. In this case only β+-activity depth profiles
projected onto the central beam axis were considered. In the second run of experiments the better beam
quality in combination with a more accurate knowledge of the beam parameters allowed a more realistic
beam characterization in the simulations. In this way expected PET images directly comparable with the
reconstructed measured data could be predicted. Simulations of scanned fields were also possible on the
basis of the FLUKA user-oriented capabilities [Fas02]. In this special case of extended fields the dynamic
time course of the irradiation has been also taken into account. This allowed runtime calculations of the
fraction of isotopes decayed within the time interval between production and end of the PET acquisition for
a better comparison with the measured data. Dose distributions were additionally calculated by means of
FLUKA either in cylindrical detectors of 5 mm (10 mm for E > 180 MeV) radius and 1 mm depth along the
central beam axis or in the same voxel geometry of the PET images for a more straightforward comparison
in the case of a sufficient knowledge of the beam parameters.
5.3.3 Results
5.3.3.1 Comparison of proton and carbon ion induced β+-activity
The β+-activity production rate induced by proton irradiation has been quantitatively estimated for mono-
energetic pencil-like beams stopped in PMMA. Details on the considered irradiation with in-beam PET
acquisition are given in table 5–3. The corresponding spatial distributions of the imaged β+-activity are
depicted in figure 5–12. The absolute 11C, 15O and 10C isotope production rates during particle extraction
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Figure 5–12: Spatial distributions of the β+-activity induced by proton beams of 110MeV (top), 140MeV
(middle) and 175MeV (bottom) in a PMMA phantom. The left blue lines mark the front face of the target
whereas the right red lines indicate the proton range.
have been determined according to the calculation models described in section 5.3.2.2. For comparison with
the carbon ion case, the same analysis has been extended to in-beam PET data acquired during carbon
ion irradiation of PMMA phantoms. These measurements had been previously performed in the same
experimental set-up with comparable irradiation parameters at energies corresponding to similar penetration
depths as in the proton experiment (table 5–4). The estimates of the relative isotope production rates and
resulting relative β+-activity production rates together with the correction factors C required for absolute
quantification are listed in table 5–5. From these values the ratio r of the absolute β+-activity rates produced
by proton and carbon ion bombardment of PMMA targets at the same dose level and projectile range has
been obtained as:
r = 18
dAp
dt
(
dA12C
dt
)−1
C12C
Cp
I12C
Ip
R12C
Rp
(27)
where I indicates the beam intensity in particles per second (I = Is/ts). The factor 18 compensates the
lower energy loss of protons in comparison to carbon ions at energies corresponding to the same penetration
depth. In dependence on the stopping power calculation model this factor is estimated to lie between 18
Table 5–3: Parameters of the irradiation and of the PET acquisition (identifier ID, energy E, range R
from [ICR93], total number T of extracted spills, average beam intensity Is and spill duration ts, irradiation
time tir including the extraction pauses, measuring time tmea and total amount Nev of valid coincidences
detected).
ID E / MeV R / cm T Is / p spill−1 ts / s tir / s tmea / s Nev
(i) 110 7.9 121 (1.4± 0.1) · 108 2.123± 0.020 595.06± 0.01 1958 2734909
(ii) 110 7.9 140 (2.1± 0.2) · 108 2.125± 0.010 688.64± 0.01 1616 3844950
(iii) 140 12.1 119 (2.1± 0.2) · 108 2.129± 0.030 587.22± 0.01 1848 5357535
(iv) 175 17.9 114 (1.0± 0.1) · 109 2.228± 0.090 592.30± 0.01 1777 30348227
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Table 5–4: Parameters of the analysed carbon ion irradiation with in-beam PET acquisition. For explana-
tion of the symbols cf. table 5–3.
ID E / AMeV R / cm T Is /
12C spill−1 ts / s tir / s tmea / s Nev
(1) 204 7.6 50 (1.2± 0.1) · 108 2.188± 0.006 275.58± 0.01 1443 4376057
(2) 212.12 8.1 50 (2.0± 0.1) · 108 2.169± 0.009 222.91± 0.01 399 4844180
(3) 212.12 8.1 50 (1.00± 0.02) · 107 0.798± 0.030 271.39± 0.01 1443 311818
(4) 259.5 11.4 50 (1.2± 0.1) · 108 2.189± 0.019 275.53± 0.01 1380 6538242
(5) 306 15.0 30 (1.2± 0.1) · 108 2.185± 0.008 164.01± 0.01 1288 4516059
(6) 343.46 18.1 39 (2.5± 0.1) · 108 2.180± 0.009 173.50± 0.01 347 8064358
and 21. The lowest value has been used in order to be cautious in the prediction. Following this choice an
average value of (3.2± 0.4) has been found for r, whereas no evident dependence on the initial beam energy
has been assessed.
The observed activity gain for a proton compared to carbon ion irradiation at the same physical dose and
range is in agreement with the expectation of a minimum factor of about 2 predicted in the initial simulation
study presented in section 5.2. The ratio should further increase in real therapeutic applications since the
relative biological effectiveness of carbon ions is considerably higher than that of protons [Wam99, Kra99].
An additional enhancement of the proton induced activity may be also foreseen for PET measurements in
typical 5− 10 minutes acquisition times during a patient treatment, dominated by the contribution of 15O
decays. Such an expectation is supported by the observed higher 15O to 11C production rate ratio in the
same target for proton in comparison to carbon ion irradiation (cf. table 5–5) in combination with the larger
relative abundance of oxygen in tissue than in PMMA (e.g. 65 % oxygen against 18 % carbon in human body
according to [Ose65]).
The reliability of the relative amounts of proton induced positron emitters quoted in table 5–5 is rather
well supported by the comparison with activation measurements performed in Brookhaven [Ben75]. In this
experiment the authors irradiated for a short period (30 µs) three samples of PMMA of 1 cm3 dimension
using protons of 200 MeV. The decay curves acquired starting within one minute after the irradiation end
were fitted by means of a function resembling equation (18). The decay constants of 11C and 15O were set
Table 5–5: Relative isotope production rates P with corresponding uncertainties ∆ and relative β+-activity
production rates dA/d t deduced from the measured PET events for proton and carbon ion irradiation of
PMMA phantoms. Division of the relative values by the correction factors C produces absolute estimates.
Proj. E ID C P11C ∆ P15O ∆ P10C ∆ dA/dt
/ AMeV ×10−3 / s−1 / % / s−1 / % / s−1 / % / Bq s−1
p 110 (i) 8.3± 0.4 12726 10 4342 15 321 35 43± 8
p 110 (ii) 8.2± 0.4 17984 10 6546 15 723 30 73± 14
12C 204 (1) 7.3± 0.4 39607 8 7664 15 2984 20 173± 29
12C 212.12 (2) 7.9± 0.3 76525 10 15419 12 5778 40 339± 95
12C 212.12 (3) 7.9± 0.3 10099 4 1909 15 754 30 44± 10
p 140 (iii) 7.8± 0.3 26120 5 9440 10 1138 15 109± 12
12C 259.5 (4) 7.3± 0.4 58611 5 12325 10 4590 20 268± 41
p 175 (iv) 7.2± 0.3 150670 10 51209 15 5518 35 575± 120
12C 306 (5) 6.6± 0.3 66485 5 14806 15 5303 15 312± 43
12C 343.36 (6) 6.9± 0.3 157213 10 39816 5 12052 20 749± 107
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by the authors to (29.47 min)−1 and (2.98 min)−1, respectively. The third one was left as a free parameter
accounting for a background component afterwards identified with 10C on the basis of the fitted half-life of
0.3 min. From the analysis the authors obtained an average value of (3.4± 0.2) for the ratio N˙15O/N˙11C of
the 15O and 11C decay rates at the end of the irradiation. This estimate refers to a proton beam not stopped
in the thin target. However, a comparison with the 15O to 11C activity ratio averaged on all the penetration
depth in the presented in-beam PET experiment is still meaningful, because of the comparable energy
dependence of the cross sections for the 12C(p, pn)11C and 16O(p, pn)15O reaction channels (cf. figure 5–8).
Neglecting the decay within the extremely short irradiation time τ of 30 µs, the expected 15O to 11C decay
rate ratio was deduced from the proton induced isotope production rates given in table 5–5 as:
N˙15O
N˙11C
=
(2.98)−1
(29.47)−1
P15O τ
P11C τ
(28)
The resulting values of (3.5±0.9), (3.6±0.5) and (3.4±0.8) for the 110, 140 and 175 MeV proton irradiation,
respectively, are in good agreement with the work of [Ben75]. The same approach has been also applied
to the estimate of the initial 10C to 15O decay rate ratio, using for consistency the (ln 2/0.3) min−1 value
adopted in [Ben75] for the decay constant of 10C. This latter comparison is however more affected by the
different experimental conditions. In fact the qualitatively different energy dependence of the cross sections
in combination with the higher energy threshold for 10C with respect to 15O generation in proton interaction
on carbon and oxygen, respectively (cf. figure 5–7 and figure 5–8), leads to the reduction of the 10C to 15O
production ratio along the penetration depth in thick PMMA targets. This can explain the lower N˙10C/N˙15O
mean values of (0.6± 0.3), (0.8± 0.2) and (0.7± 0.4) deduced from the PET measurements at 110, 140 and
175 MeV initial proton energies in comparison to the average ratio of 1.6 obtained at 200 MeV in [Ben75].
Furthermore, the accuracy of 10C identification from time analysis of activity decay curves dominated by 15O
and 11C contributions has unavoidable limitations in this work as well as in [Ben75]. Hence, the presented
comparison is still satisfactory and indeed supports the reliability of the relative isotope production rates
deduced from the proton experiment. Finally, it should be also reminded the rather good correspondence
shown in table 5–2 for the absolute estimate of 11C isotope production deduced from the measured PET
data in comparison to the FLUKA predictions. The latter have been found in the same order of magnitude
of experimental values extracted from [Oel96], as pointed out in [Par00].
5.3.3.2 Proton induced β+-activity depth distributions
The depth distribution of positron emitting nuclei activated by proton irradiation is the most crucial quantity
for therapy monitoring since it carries the most valuable information on the longitudinal localisation of the
beam and of the dose delivery. In particular it determines the possibility of in-vivo range monitoring.
This is of utmost importance in delicate irradiation fields in close vicinity to critical organs. As in the
carbon ion case, the precision of proton range calculations in treatment planning is conditioned by the
unavoidable limitations in the use of CT calibration curves, especially in presence of tissue inhomogeneities in
the beam path. Average uncertainties of 1−3 mm in typical treatment situations have been reported [Scha98].
Therefore, the potential benefit of PET for this critical issue has been the subject of the most extensive
experimental investigations. In the following measured and predicted β+-activity depth profiles induced by
proton irradiation of homogeneous targets are presented and compared, starting from mono-energetic pencil-
like beams up to the more realistic case of SOBP and scanned (2D) fields. The corresponding achievable
resolution for range monitoring is separately addressed in a dedicated section. Finally, the impact of dynamic
effects due to different 11C/15O ratio as well as a mono-energetic irradiation of an inhomogeneous target
with tissue equivalent inserts are described and discussed.
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Figure 5–13: Measured β+-activity depth profiles (solid line) for proton (left) and carbon ion (right) ir-
radiation of PMMA targets at 140MeV and 259.5AMeV initial energy, respectively. The dotted line shows
the calculated relative dose distributions.
Non-scanned mono-energetic irradiation
The depth distribution of the imaged positron radioactivity induced by a 140 MeV pencil-like proton beam
is compared in figure 5–13 to the one produced by a carbon ion irradiation of similar penetration depth. The
corresponding dose distributions calculated by means of the FLUKA and POSGEN codes in the proton and
the carbon ion case, respectively, are additionally displayed. The much poorer spatial correlation between
the β+-activity and the dose depth profiles in the proton case is evident. Due to the lack of projectile
fragments no maximum of positron radioactivity is formed at the end of the primary proton range (figure 5–
13, left) in contrast to the carbon ion case (figure 5–13, right). Furthermore, the proton induced activation
of the target nuclei of the irradiated medium vanishes in the last few millimetres of the primary particle
path (figure 5–13, left) as expected, because of the energy thresholds of the nuclear reactions. However,
there is still a unique relation between the location of the β+-activity distal fall-off and the position of the
Bragg-peak as well as the primary proton range. In order to assess the feasibility of PET monitoring based
on the comparison between measured and predicted positron radioactivity distributions, the reconstructed
depth profiles of β+-activity have been compared to those calculated on the basis of the approach described
in section 5.3.2.3. A rather good agreement was observed, as shown in figure 5–14. First investigations on
0 50 100 150
Penetration depth / mm
0.0
0.2
0.4
0.6
0.8
1.0
1.2
Ac
tiv
ity
 / 
a.
u. Range
Measurement
Simulation
Figure 5–14: Measured (solid line) and predicted (dotted line) β+-activity profile along the penetration
depth for a 140MeV proton beam stopped in PMMA. The expected range from [ICR93], corrected for the
material in the beam path as the simulated data (cf. section 5.3.2.3), is shown by the dashed line.
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Figure 5–15: The influence of the different (p, pn) excitation functions for 12C and 16O targets on the
β+-activity depth profiles induced in PMMA by protons at initial energies of 110 MeV (left) and 175 MeV
(right). The thick solid and dashed-dotted lines show profiles of β+-activity measured by means of PET
during the 10min of irradiation and later than 10min after stopping the beam delivery, respectively. The
dashed and dotted lines (referring to the right axis scale) depict the calculations including or ruling out the
15O contribution, respectively.
the influence of the 11C to 15O ratio on the β+-activity distributions were also performed by reconstructing
only two subsets of the acquired data: one for coincidences detected during the 10 minutes of irradiation
and the other for the events recorded later than 10 minutes after finishing the irradiation. According to
this selection the first data set mainly contains decays from 15O and 11C, whereas the contribution from
15O is drastically reduced in the second one. The comparison with predicted positron emitter distributions
containing 15O or not, respectively, showed again a fairly good agreement, as illustrated in figure 5–15. The
larger discrepancy between measurement and prediction occurs for the highest beam energy in the entrance
channel and is ascribed to the poor knowledge of cross sections in this energy range (cf. figure 5–8). In
both measurements and calculations the presence or absence of 15O mostly influences the proximal slope of
the β+-activity depth profiles. Despite the about 3.5− 3.8 MeV higher energy threshold of the main (p, pn)
reaction channel on 12C in comparison to 16O targets according to [Vyn93, Oel96, Bee03] and the used
experimental data from [Nuc00], only minor deviations of less than 0.25 mm were observed for the position
of the 50 % level of the distal fall-off. The latter was found at about 5 − 6 mm lower penetration depth
than the primary proton range, in consistency with previous off-line phantom investigations performed with
PET scanners of comparable 5 − 8 mm FWHM spatial resolution for mono-energetic proton irradiation in
a similar 62 − 110 MeV energy range [Vyn93, Oel96]. Although effects due to the 11C/15O ratio will be
more extensively addressed in a dedicated section, the capability of the model calculation to reproduce the
experimental trend should be emphasised (cf. separation in the proximal part of the calculated isotope depth
distributions in figure 5–15). The same would not be true when using the cross section values extracted
from [ICR00], as evident from the separate 11C and 15O depth profiles illustrated in figure 5–11, showing
an almost identical relative production in the entrance channel for an irradiation at a similar energy as in
figure 5–15, right.
Non-scanned SOBP irradiation
Non-scanned (1D) SOBP dose distributions have been dynamically formed by repainting a proper sequence
of mono-energetic pencil-like proton beams. At each repaint the energies were delivered in increasing order,
as done for patient treatments in carbon ion therapy at GSI. Figure 5–16 shows the β+-activity depth profile
measured for an irradiation field built by 11 energy steps ranging between 156.06 MeV and 171.62 MeV and
corresponding to 3 mm range separation in water. Clearly the superimposition of several pencil-like beams
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Figure 5–16: Measured β+-activity depth profile (solid line) for a 1D SOBP field formed by 11 mono-
energetic pencil-like beams of initial energies within the 156.06 – 171.62 MeV interval stopped in PMMA.
The dotted lines show the predicted dose (left) and positron emitter (right) depth distributions.
results in a much smoother fall-off of the positron emitter depth profiles in comparison to the previously
analysed mono-energetic case. The effect is furthermore enhanced by the underweighting of the highest
energy contributions, indicated by the decreasing distal slope of the dose in the SOBP region (figure 5–
16, left). However, the considered distribution is close to realistic treatment situations according to the
treatment planning techniques for multifield irradiation. Moreover, the smoothness of the β+-activity distal
shoulder strongly depends on the width of the SOBP region, only approximately 26 mm wide in the presented
experiment. The implications on the possibility of range monitoring will be addressed in a following dedicated
section. However, it should be noticed the observed reasonable agreement with the prediction (figure 5–16,
right).
Scanned mono-energetic and SOBP fields
Two-dimensional mono-energetic and SOBP irradiation of (maximum) energy of 171.62 MeV were delivered
by means of the raster scanning system moved at lateral steps of 4 mm from −20 mm to 20 mm with respect
to the isocentre (figure 5–3 and table 5–6). The corresponding 2D dose distributions are shown in figure 5–17.
The measured PET images are compared in figure 5–18 to those predicted including the dynamic effects of
the beam delivery in the calculation. A reasonable agreement is observed, especially with respect to the
lateral extension of the irradiated fields. However, the results are affected by the not yet optimal experimental
conditions for scanned beams. In fact the proton intensity provided by the GSI synchrotron is in general
low and the beam delivery control and raster scan system are optimised for operation with carbon ions.
Table 5–6: Parameters of the beam delivery and PET acquisition (beam energy E, maximum range R,
number of repaints P times the number of energy steps E for each repaint, number of primary protons
Np, irradiation time tir, measuring time tmea and amount of detected coincidences Nev) for the 2D mono-
energetic (first row) and SOBP irradiation (second row). Each energy step was delivered to 11 lateral scan
positions at 4mm separation.
E / MeV R / cm P × E Np tir / s tmea / s Nev
171.62 17.35 10× 1 1.1 · 1010 307.65± 0.01 1312 2298396
156.06− 171.62 17.35 3× 11 9.3 · 109 434.20± 0.01 1383 1926558
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Figure 5–17: Calculated dose distributions for the 2D mono-energetic (left) and SOBP (right) irradiation
of PMMA phantoms at (maximum) energy of 171.62 MeV.
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Figure 5–18: Measured PET images (top) and expected spatial distributions of detected decays from the
produced β+-emitters (bottom) for the 2D mono-energetic (left) and SOBP (right) irradiation of PMMA.
During the experimental run a compromise had to be found for the amount of particles applied to each scan
position, which determines the scanning speed at the given low beam intensity. The number of deliverable
protons per scan position was however limited by the sensitivity of the beam monitor, especially for the
detection of the up to one order of magnitude reduced amount of low energy protons with respect to the
beams of maximum energy forming the SOBP field. As a first consequence of these experimental constraints,
the position accuracy of the beam delivery could not be optimal [Nau03]. This affected in particular the
SOBP irradiation, resulting in the observed pronounced lateral asymmetry of the measured β+-activity
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Figure 5–19: Top: PET image reconstructed from the data exclusively measured during the ' 300 s delivery
of the mono-energetic scanned field (left) in comparison to the predicted spatial distribution of the amount
of detected decays from 11C and 15O (right). Bottom: Lateral profile of the measured (solid) and predicted
(dashed) β+-distribution along the corresponding region marked in the upper figures.
distribution visible in figure 5–18 (top, right). Therefore, the following analysis will be concentrated on the
mono-energetic case, less affected by the suboptimal beam delivery (figure 5–18, left). In addition to the
problem of the position inaccuracy, the scanning speed was much lower than in the conventional carbon ion
case. About 30 s were necessary for the completion of the very distal 11 scan positions to be filled by 1 · 108
protons each at every repaint in both of the mono-energetic and SOBP case. Despite the same amount of
produced positron emitters, the longer time interval introduces larger differences in the number of detectable
decays, especially from short-lived isotopes formed in the first and last scan positions, respectively. The
effect of this time dependence on the measured β+-activity becomes observable for acquisitions stopped
shortly after the beam delivery. This is illustrated by the reconstruction of a subset of data measured during
the mono-energetic irradiation, ruling out the decays after the irradiation end (figure 5–19). The measured
lateral profile shown in figure 5–19, bottom, indicates a slightly higher activity signal for the first irradiated
scan positions, corresponding to negative values starting from −20 mm. The same trend was rather well
reproduced also by the prediction taking into account the registered time course of the irradiation as well as
the reduced time window of the PET acquisition. However, the observed slight lateral asymmetry pertains
only to the intensity of the β+-activity, while not affecting the fall-off position of the positron radioactivity
distal edge related to the maximum proton range.
The depth profile of the β+-activity induced by the scanned mono-energetic irradiation along the central
beam axis is compared to that produced by a non-scanned pencil-like beam at the same initial energy in
figure 5–20. Larger discrepancies between the one-dimensional and two-dimensional field occur only in the
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Figure 5–20: Measured (left) and predicted (right) β+-activity depth profiles along the central beam axis
for a 1D and 2D mono-energetic proton irradiation of a PMMA target at initial energy of 171.62 MeV.
proximal slope of the depth distributions along the central beam axis. In fact, for one-dimensional fields
the cross section increase along the penetration depth is somehow compensated by the reduction of particles
along the central beam axis due to lateral scattering. In the inner part of scanned fields particles scattered
away from the central beam axis are replaced by contributions coming from the adjacent pencil-like beams.
This compensation results in a slightly steeper increase of the β+-activity distribution along the penetration
depth, as shown in figure 5–20. Apart from the rather good correspondence between measurement and
prediction, it should be pointed out that the distal edges of the β+-activity depth profiles induced by
the one- and two-dimensional irradiation fields are almost identical (figure 5–20). Therefore, all the range
considerations addressed in the next section for one-dimensional mono-energetic and SOBP irradiation can
be also extended to the case of multi-dimensional scanned fields.
The resolving power of PET for proton range monitoring in homogeneous phantoms
The achievable accuracy of PET for proton range monitoring has been investigated by means of non-scanned
(1D) mono-energetic as well as SOBP exposures of PMMA phantoms at energy steps resulting in range
differences of about 0.9 mm. This corresponds approximately to 1 mm separation in water, which is the
finest grid used at GSI for depth adjustment of the Bragg-peak position within the tumour in carbon ion
therapy. The range information has to be extracted from the distal edge of the proton induced positron
radioactivity. Hence, the data analysis has been particularly focussed on the position of the 50 % level of
the distal fall-off (addressed in the following as d50%) and the study of the first derivative (in space) of the
β+-activity depth profiles. For data with a sufficient signal to noise ratio, the latter approach provides a
precise information on the localisation of the β+-activity distal edge. This is particular evident for the steeper
fall-off induced by mono-energetic irradiation, as illustrated in figure 5–21. Furthermore, the independence
of the results on the reconstruction algorithms has been also carefully proven, as briefly addressed in the
following section.
i) The mono-energetic case
The β+-activity depth profiles obtained after backprojection as well as MLEM tomographic reconstruction
of the PET events measured in the first of the two sets of mono-energetic irradiation listed in table 5–7
are shown in figure 5–22. In comparison to the simpler backprojection approach the iterative reconstruc-
tion produces, as expected, β+-activity distributions of steeper rising and falling edges. The inclusion of
scatter corrections mostly lowers the activity level in the entrance channel. However, the distal fall-offs of
the distributions are clearly resolved independently on the used reconstruction algorithm and in spite of
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Figure 5–21: Measured (top) and predicted (bottom) PET images (left) and corresponding absolute values
of the first derivative (right) of the spatial distributions induced by a pencil-like beam of 171.62 MeV initial
energy stopped in PMMA.
the moderate spatial resolution of the in-beam positron camera installed at GSI. Hence, only backprojected
profiles will be considered in the following. The distinction of adjacent contributions becomes particularly ev-
ident when plotting the derivative of the depth distributions, found in good agreement with the expectations
(figure 5–23). The average separation between contiguous positions of the 50 % distal fall-offs as well as of
the peaks of the derivatives was found to be (0.9± 0.3) mm for both lower and higher energy data sets listed
in table 5–7. This value is in good agreement with the expected range differences of 0.9mm (cf. table 5–7).
Hence, this phantom experiment demonstrates the potential of PET for millimetre range monitoring. In
Table 5–7: Parameters of the beam delivery and PET acquisition for the 1D mono-energetic irradiation.
For explanation of the symbols cf. table 5–3.
E / MeV R / cm T Is / p spill−1 ts / s tir / s tmea / s Nev
171.62 17.35 120 (1.9± 0.2) · 108 1.095± 0.018 548.43± 0.01 1949 5731951
172.13 17.44 120 (2.2± 0.2) · 108 1.140± 0.023 548.37± 0.01 1813 5975083
172.63 17.53 120 (2.1± 0.2) · 108 1.124± 0.019 548.42± 0.01 1824 5785082
173.13 17.62 118 (2.6± 0.2) · 108 1.170± 0.019 548.96± 0.01 1744 7061593
156.06 14.69 120 (9.4± 0.1) · 107 1.13± 0.03 531.42± 0.01 1870 2330723
156.60 14.78 120 (1.0± 0.1) · 108 1.13± 0.04 531.37± 0.01 1833 2517791
157.13 14.87 120 (8.3± 0.1) · 107 1.09± 0.04 531.16± 0.01 1887 2138937
157.66 14.96 120 (1.0± 0.1) · 108 1.129± 0.025 531.28± 0.01 1874 2610920
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Figure 5–22: Depth profiles of β+-activity obtained after backprojection (left) and MLEM reconstruction
with scatter corrections (right) for proton beams stopped in PMMA at ranges differing less than 1 mm.
the following, the important factors influencing the achievement of such potential in real clinical situations
will be addressed. These include the influence of the counting statistics as well as the consideration of more
realistic non-mono-energetic irradiation fields and the impact of different target fragments in dependence
on the time course of the irradiation and PET acquisition in combination with the elemental composition
(stoichiometry) of the irradiated target.
The sensitivity of the PET method to the counting statistics for proton range monitoring was studied
by analysing several subsets of the list mode data acquired for the 171.62− 173.13 MeV irradiation given in
table 5–7. The degradation of the statistical significance of the range resolvability for data sets corresponding
to a reduced amount of detected events is illustrated by the depth profiles of figure 5–24, corresponding to
the data acquired during the delivery of the first 5 and 50 spills of the irradiation, respectively. In the
data analysis, very noisy and highly fluctuating profiles resulting from the low statistics of the measured
PET events (cf. figure 5–24, left) were internally smoothed with a box car average for the search of the
activity distal maximum necessary for the d50% determination. Despite such a dedicated procedure, the
significance of the estimate is unavoidably influenced by the signal to noise ratio of the considered data sets.
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Figure 5–23: Absolute value of the derivatives of the measured (left) and predicted (right) β+-activity depth
profiles induced by the four mono-energetic proton beams at 171 .62 − 173 .13 MeV initial energy.
82
5.3 Experimental investigations
0 50 100 150 200
Penetration depth / mm
0
1
2
3
4
5
Ac
tiv
ity
 / 
a.
u.
 
171.62 MeV
172.13 MeV
172.63 MeV
173.13 MeV
0 50 100 150 200
Penetration depth / mm
0.0
0.2
0.4
0.6
0.8
1.0
1.2
Ac
tiv
ity
 / 
a.
u.
 
171.62 MeV
172.13 MeV
172.63 MeV
173.13 MeV
Figure 5–24: Comparison of β+-activity depth profiles backprojected from PET events measured during the
beam pauses between the first 5 (left) and 50 (right) spills for the 171 .62 − 173 .13 MeV proton irradiation.
This is indicated in table 5–8 by the higher uncertainties of the d50% values for those profiles reconstructed
from the few events measured during only about 18 s total pause duration between the first 5 beam pulses.
Increasing the statistics considerably improves the accuracy of the 50 % fall-off position identification, with
uncertainties falling well below the average separation of the distal profiles corresponding to adjacent energy
Table 5–8: Position of the 50% distal fall-off d50% of the β
+-activity profiles reconstructed from different
subsets of the data recorded during the delivery of the first 5, 50 and 120 (118) spills as well as over the
entire PET acquisition for the 171 .62 − 173 .13 MeV proton irradiation. Increasing numbers of delivered
spills correspond to the estimated maximum Bragg-peak dose values Dpk additionally given.
E / MeV T Dpk / Gy tmea / s Nev d50% / mm
171.62 5 1.4 23.02± 0.01 17539 164.8± 0.9
50 14 229.97± 0.01 579708 165.7± 0.3
120 33 548.43± 0.01 2139829 166.0± 0.2
120 33 1949.07± 0.01 5731951 166.0± 0.2
172.13 5 1.6 22.93± 0.01 14365 165.8± 0.9
50 16 229.93± 0.01 628654 166.5± 0.3
120 38 548.37± 0.01 2308781 166.8± 0.2
120 38 1812.63± 0.01 5975083 166.8± 0.2
172.63 5 1.5 23.01± 0.01 13088 166.2± 0.9
50 15 229.84± 0.01 585329 167.5± 0.3
120 36 548.42± 0.01 2215589 167.8± 0.2
120 36 1823.66± 0.01 5785082 167.9± 0.2
173.13 5 1.8 23.00± 0.01 16161 167.4± 0.9
50 18 230.15± 0.01 713097 168.5± 0.3
118 43 548.96± 0.01 2718882 168.7± 0.2
118 43 1743.85± 0.01 7061593 168.8± 0.2
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steps. Referring to table 5–8 it should be noticed that the chosen larger subsets of data correspond to
increasing levels of the applied dose. However, the delivered dose is not the only factor influencing the
PET counting statistics. The measuring time is in fact the other critical parameter determining the amount
of detectable decays from the positron emitters created at a given dose. On the basis of the production
rate estimates relative to the limited angle positron camera in use at GSI for a similar 175 MeV PMMA
irradiation (cf. table 5–5), the amount of events Nev detected in a typical acquisition time of 5minutes at a
typical therapeutic dose of 3Gy is estimated to be about (3.5−4.0) ·105 coincidences. Hence, the comparison
with the values reported in table 5–8 for the data sets corresponding to the delivery of the first 50 spills
suggests a relatively low uncertainty of the corresponding d50% estimation. Moreover, the estimated counting
statistics could be further improved in future application of PET to proton therapy monitoring. An increase
is expected for a new generation in-beam PET scanner of higher detection efficiency due to a larger solid
angle coverage as well as an optimal data acquisition (cf. conclusions of chapter 4). In addition, different
fractionation schemes might lead to a higher applied dose per treatment fraction. Finally, a further activity
increase in typical 5 − 10 minutes acquisition times is also foreseen due to the typically larger production
of 15O in real tissue with respect to PMMA. Therefore, all these considerations on the counting statistics
still support the potential millimetre precision of PET for proton range monitoring in more realistic clinical
applications.
From the data reported in table 5–8 for different subsets of the same PET acquisition at a given beam
energy it should be finally pointed out the variation of the d50% value itself beyond the discussed variation
of the error due to the different counting statistics. The observed systematic changes of the distal fall-off
positions for depth profiles reconstructed from different subsets of the same irradiation are ascribed to the
dynamic process of the β+-activity build-up and decay during acquisition. This mostly results in different
ratios of 11C to 15O decays (cf. figure 5–6, left) in the subsets of events measured in the different time
windows of the same list mode data. The consequence of this effect on the possibility of range monitoring
will be more deeply addressed in the dedicated section following the presentation of the results for the more
realistic case of SOBP irradiation.
ii) The SOBP case
Four extended dose distributions of maximum range differing less than 1 mm in PMMA were formed by
a sequence of 11 mono-energetic pencil-like beams with increasing energies in the intervals of 156.06 −
171.62 MeV, 156.60− 172.13 MeV, 157.13− 172.63 MeV and 157.66− 173.13 MeV, respectively (table 5–9).
The chosen spacing of the 11 contiguous energy steps corresponded to 3 mm range separation in water. The
SOBP sequences were repeated 10 times. Despite the discussed smoother fall-off of the β+-activity depth
distributions in the SOBP case, the distal edges of the profiles could be still resolved (figure 5–25). This
supports the feasibility of range monitoring by means of PET also in more realistic extended treatment fields,
provided that enough statistical significance is gained. For the last issue PET distributions formed after the
Table 5–9: Parameters of the irradiation and of the PET measurement for the 1D SOBP experiments. For
explanation of the symbols cf. table 5–6.
Emin −Emax / MeV R / cm P × E Np tir / s tmea / s Nev
156.06− 171.62 17.35 10× 11 1.4 · 1010 793.17± 0.01 1726 3201783
156.60− 172.13 17.44 10× 11 1.4 · 1010 757.40± 0.01 1713 3207279
157.13− 172.63 17.53 10× 11 1.4 · 1010 712.74± 0.01 1714 3226331
157.66− 173.13 17.62 10× 11 1.4 · 1010 765.86± 0.01 1668 3198891
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Figure 5–25: Depth distributions of β+-activity (left) and corresponding absolute derivative (right) for 1D
SOBP irradiation of PMMA targets at maximum penetration depths differing less than 1mm.
delivery of complete SOBP fields at different dose levels and different amounts of measured events could be
compared because of the selected repainting technique. The depth profiles backprojected from approximately
1.2 · 105 coincidence events detected during the first ' 150 s of the irradiation corresponding to the delivery
of 2 repaints (i.e. maximum dose of about 2.2 Gy) are shown in figure 5–26. For this data set of lower
statistics an average distal edge separation of (1.0 ± 0.8) mm was found against the (0.9 ± 0.4) mm value
for the profiles obtained from the entire acquisition. This confirms the increasing accuracy and reliability of
PET for millimetre range monitoring when increasing the image counting statistics, as already discussed in
the mono-energetic case. The comparison of the average distal edge separation of (0.9 ± 0.4) mm with the
value of (0.9±0.3) mm obtained in the mono-energetic case (cf. previous section) for data sets of comparable
high statistics indicates only a minor degradation in the accuracy of the 50 % fall-off position identification
for SOBP fields. Hence, all statistics considerations reported in the previous section can be extended to the
more realistic case of non-mono-energetic irradiation fields. The slightly higher uncertainty of the 50 % fall-
off position for SOBP fields arises from the smoother distal slope of the β+-activity depth profile, resulting
also in a backwards shift of about 6.5 mm for the d50% value in the considered experiment with respect to
the mono-energetic case (figure 5–27, left). Moreover, the d50% value itself and its related error is influenced
by the width of the SOBP, which affects the smoothness of the distal fall-off of the β+-activity distribution.
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Figure 5–26: Depth distributions of β+-activity reconstructed from the subset of data measured during the
delivery of the first 2 repaints of the 4 SOBP irradiation at maximum ranges differing less than 1 mm.
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Figure 5–27: Depth distribution of β+-activity measured for the 156 .06 − 171 .62 MeV SOBP irradiation
(dashed line) in comparison to that acquired for the pencil-like beam contribution of highest energy (solid
line). The two profiles were normalised either to the same maximum (left) or to the ' 35 % ratio between
the amount of highest energy protons with respect to the total projectiles building the SOBP (right).
Hence, the d50% quantity is a worse estimator for extracting information on the maximum proton range in
the case of extended treatment fields. The very distal slope of the distribution is a more reliable quantity for
this purpose. This is shown in figure 5–27 (right) for the comparison of the measured SOBP profile with the
one induced by the most energetic beam, properly normalised to its relative contribution to the extended
irradiation field. An even more effective representation is provided by the derivative (figure 5–28), clearly
exhibiting in the distal peak a superposition of several Gaussian shapes of increasing amplitudes at increasing
depths (i.e. energies) corresponding to the contributions of the mono-energetic beams forming the SOBP field.
It follows that the very distal slope of the total β+-activity (figure 5–27, right) and corresponding derivative
(figure 5–28) depth distribution is determined by the highest energy component and can be resolved for data
of sufficient statistics. This is in agreement with the expectations discussed in [Par02]. Since a reasonable
energy step spacing was used for the build-up of the SOBP irradiation imaged in this experiment, similar
considerations are expected to apply also to more realistic extended treatment fields. Hence, these results
support the feasible extraction of information on the maximum proton range from the very distal edge of
the total β+-activity distribution by means of PET.
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Figure 5–28: Measured (left) and predicted (right) absolute derivative of the β+-activity depth profiles
induced by a SOBP irradiation (dashed line) in comparison to the highest energy contribution (solid line).
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The influence of the 11C to 15O production and decay ratio on the feasibility of proton range monitoring
The study of dynamic effects due to different ratios of detected events mainly originating from 11C and 15O
decays has been restricted to mono-energetic irradiation without beam scanning, which allows the use of
the mathematical formalismus described in section 5.3.2.2. The data presented in table 5–8 already pointed
out an increase of the 50 % fall-off position for β+-activity profiles reconstructed from larger subsets of the
same PET acquisition corresponding to longer measuring time intervals. Following equations (25) and (26)
increasing values of 0.28, 0.38, 0.55 and 1.7 were assigned to the mean 11C to 15O decay ratio for all the
considered data sets measured during the delivery of the first 5, 50 and 120 (118) spills as well as over the
entire PET acquisition, respectively. This analysis might be however affected by statistics effects due to the
increasing number of coincidences in the chosen acquisition windows. In order to rule out the dependence
on the counting statistics, several subsets of the same acquisition were selected, each corresponding to the
same amount of detected events but different 11C to 15O decay ratios. However, a wide range of 11C to
15O decay ratios could be accessed only when considering subsets of low (' 1.6 · 104) statistics. In fact,
small 11C/15O decay ratios are possible only for few events registered at the beginning of the irradiation.
Since the statistics determines the accuracy of the fall-off position identification (cf. table 5–8), additional
subsets of higher statistics were also included in the study in order to increase its significance. The results
confirmed an influence of the 11C to 15O decay ratio on the β+-activity distal edge independently on the
used reconstruction algorithm. An example is shown in figure 5–29 for the analysis of the PET acquisition
induced by the 173.13 MeV irradiation given in table 5–8. The statistics of the considered subsets of the
same list mode data acquisition is reflected by the error bars of the d50% values (triangles) extracted from the
backprojected β+-activity depth profiles. The position of the 50 % distal fall-off is found to be systematically
reduced for low 11C/15O decay ratios in spite of the almost 4MeV lower energy threshold for production
(cf. section 5.2.2) as well as the almost 1 MeV higher maximum energy of the emitted positron for 15O
with respect to 11C. The effect can be explained by the higher energy of the cross section maximum for the
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Figure 5–29: Position of the 50% distal fall-off of the β+-activity depth profiles reconstructed from several
subsets of the same PET acquisition corresponding to different 11C/15O decay ratios (triangles) in comparison
to expectations based on calculations using experimental cross sections from [Nuc00] (solid) and [ICR00]
(dashed) for a 173.13 MeV proton irradiation of a PMMA target. Filled circles and open squares refer to the
same calculations corrected for the 10C contribution (cf. text).
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Figure 5–30: Solid: Estimation of the time-integrated 11C/15O decay ratio for the events measured by the
positron camera over the entire acquisition time for the 173.13 MeV proton irradiation of a thick PMMA
phantom. Dotted, dashed, dotted-dashed lines: Extension to other materials of therapeutic interest and to
a typical head and neck (H&N) patient obtained from the normalisation of the estimated isotope production
rates in PMMA to the different carbon to oxygen nuclei abundance taking into account only the (p, pn)
reaction channels.
16O(p, pn)15O in comparison to the 12C(p, pn)11C reaction channel, in consistency with the experimental data
from [Nuc00] used for the calculation (figure 5–8). A similar trend is in fact also reproduced by the fall-off of
the profiles obtained from the superposition of the predicted 11C and 15O depth distributions (figure 5–11,
left) properly normalised to the given decay ratio. The discrepancy between the measured and predicted
data at the lower 11C/15O decay ratios can be attributed to the 10C contribution, which is not negligible for
short acquisitions at the very beginning of the irradiation (cf. figure 5–6, left). This effect was investigated
by including in the prediction the 10C distribution obtained from the FLUKA internal models (cf. figure 5–2)
and normalised to the 10C/15O decay ratio deduced from the experimental data. The resulting data points
(black filled circles) at increasing 11C/15O decay ratio depicted in figure 5–29 were estimated to correspond
to a decreasing 10C/15O decay ratio of 0.71, 0.59, 0.19, 0.14 and 0, respectively. Despite the rather large
uncertainties of the fall-off position identification from measured and predicted β+-activity profiles at small
11C/15O decay ratios and correspondingly large 10C/15O values, the 10C correction indeed provides a better
agreement. On the contrary, the lower penetration depth of 15O target activation indicated by the d50%
reduction at low 11C/15O decay ratios in the PET measurements (cf. figure 5–29) would not be explained by
the cross section values proposed in [ICR00] (cf. figure 5–11, right). This is illustrated by the calculations
reported in figure 5–29 independently whether including (squares) or not (dashed line) the correction for the
10C contribution.
The observed sensitivity of the β+-activity distal edge to the 11C to 15O decay ratio implies a dependence
on the time course of the irradiation and the in-beam PET acquisition. In order to address this issue, the
time-integrated 11C/15O decay ratio has been estimated for the given time structure of the 173.13 MeV
PMMA irradiation, very much resembling that in use for carbon ion treatment at GSI. The result, found to
be independent on the beam intensity, is displayed by the solid line in figure 5–30. The corresponding d50%
variations can be extrapolated from figure 5–29. For a rough comparison the time dependence of the 11C/15O
decay ratios in other materials of therapeutic relevance was approximately estimated by normalising the
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isotope production rate in PMMA to the corresponding carbon to oxygen abundance (figure 5–30). Values for
fat (adipose tissue), bone (compact) and muscle (striated) were taken from [ICR93]. The average composition
of real tissue (patient) was deduced from X-ray CT of head tumour patients irradiated at GSI by means
of a segmentation and stoichiometric calibration according to [Schn00] of the Hounsfield numbers located
within the treatment field. However, the corresponding d50% variation for these material cannot be directly
extrapolated from that reported in figure 5–29 for PMMA, due to the different stopping properties resulting
in different residual ranges at energies below the threshold for positron emitter production. Furthermore, the
presented analysis has focussed only on (p, pn) reaction channels on carbon and oxygen, which is a reasonable
approximation for PMMA. However, for example in materials more rich in oxygen than carbon (e.g. muscle)
the increasing role of the 16O(p, 3p3n)11C reaction channel should not be neglected. The resulting higher 11C
production would correspond to a steeper 11C/15O decay ratio increase during irradiation with respect to the
given estimate. Nevertheless, this effect might be compensated by the reduced d50% separation between
11C
and 15O depth profiles which can be expected because of the higher energy of the cross section maximum as
well as of the threshold for the 16O(p, 3p3n)11C reaction in comparison to the 12C(p, pn)11C channel [Alb62].
In addition, it has been already shown in the 10C case that even minor reaction channels may have a time
dependent and not negligible impact on the distal edge of the total β+-activity distributions. Hence, all
these considerations address once more the need of as much as possible accurate knowledge of the tissue
stoichiometry in combination with detailed and experimentally validated description of cross sections for all
the reaction channels leading to positron emitter production.
Millimetre accuracy for on-line range monitoring might still be achieved at least in regions of interest when
properly selecting the time structure of the irradiation as well as the PET acquisition window. The criterion
would be to minimise d50% variations in dependence on the estimated unavoidable sources of uncertainties,
maintaining at the same time a reasonable counting statistics. For beam delivery systems with dynamic
energy variation (e.g. from the accelerator or dynamic range shifters) the increasing or decreasing order of
the energy steps should be also concerned. In particular, a sequence of decreasing energies would maximise
the 11C/15O decay ratio at the most critical distal edge, hence minimising the d50% uncertainties. However,
the benefit of such selection in real clinical cases should be carefully investigated taking into account also
the effect of a longer time interval on perfusion and washout processes after the β+-activity formation at the
distal edge. Obviously, the 11C/15O problem does not affect off-line imaging starting few minutes after the
irradiation end. This is however at the expense of a loss of counting statistics, affecting the accuracy of the
50 % fall-off position identification at comparable acquisition times. A further drawback of off-line techniques
is the higher sensitivity to blurring effects due to biological pathways washing out the produced isotopes
and to possible movement of the patient with respect to the treatment position. Finally, off-line detection
precludes the possibility to differentiate tissues of similar density but different stoichiometric composition,
as addressed in the next section.
Mono-energetic proton irradiation of an inhomogeneous target
A one-dimensional (non-scanned) mono-energetic irradiation of an inhomogeneous phantom has been per-
formed in order to investigate the sensitivity of the proton induced positron radioactivity to different tissue
density values and stoichiometry. This determines the feasibility of PET for proton range monitoring in
tissue heterogeneities as well as for detection of possible field misalignments or local anatomical modifica-
tions during fractionated therapy. A pencil-like beam of 156.06 MeV was extracted over 120 spills for a
total irradiation time of (530.49± 0.01) s. PET data were acquired over a total 1321 s long acquisition time.
The material penetrated by the beam (cf. figure 5–31) is summarised in table 5–10. The corresponding
composition is given in table 5–11. It follows that apart from the lateral lung/PE gradient and the small
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Figure 5–31: X-ray CT of the inhomogeneous target in the imaged mid plane of the positron camera in
the experimental configuration. The enumeration refers to the different inserts described in table 5–10. The
arrow shows the beam position and direction.
Table 5–10: Constituents of the irradiated inhomogeneous phantom. The numbers 3 and 4 correspond to a
lateral gradient in the plane parallel to the two positron camera heads, with [−28 , 2 ] mm PE and [2 , 42 ] mm
lung equivalent with respect to the beam axis (cf. figure 5–31).
Number Material Thickness / mm
1 Polyethylene (PE) 20
2 Bone equivalent 2
3 Polyethylene (PE) 29
4 Lung equivalent 29
5 Muscle equivalent 5
6 Polyethylene (PE) 20
7 Polymethyl methacrylate (PMMA) 50
8 Muscle equivalent 40
9 Polyethylene (PE) 55
Table 5–11: Composition (fraction by weight) and density of the materials assembled in the inhomogeneous
phantom [ICR93, Has96, Hinz03]. Some uncertainties in the stoichiometry of the tissue equivalent materials
have to be taken into account because of a lack of an unequivocal source of information.
Medium H C N O Mg Si Cl Ca ρ
/ % / % / % / % / % / % / % / % / g cm−3
PE 14.37 85.63 – – – – – – 0.93
PMMA 8.05 59.99 – 31.96 – – – – 1.18
Bone eq. 3.10 31.26 0.99 37.57 – – 0.05 27.03 1.89
Muscle eq. 8.41 67.97 2.27 18.87 – – 0.13 2.35 1.00
Lung eq. 8.36 60.41 1.67 17.33 11.36 0.72 0.15 – 0.30
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Figure 5–32: Estimated count rate (cps) contribution from 15O (left, solid), 11C (left, dotted) and 10C (left,
dashed) and resulting total decay rate (right, dashed-dotted) compared to the measured count rate (right, solid)
from proton induced activation in ROI set in PE (top), PMMA (middle) and muscle equivalent (bottom).
bone equivalent insert, only smooth density gradients but different stoichiometry especially with respect
to the C/O composition were encountered by the beam, stopped shortly after the last muscle insert. The
CT scan of the phantom shown in figure 5–31 was used for calculation of attenuation corrections for PET
imaging [Po¨n03b]. In order to estimate the 11C, 15O and 10C production rates in the different materials
on the basis of the measured data the models described in 5.3.2.2 were applied to subsets of PET events
detected in lines of response unambiguously intersecting properly set regions of interest [Hinz00]. Results of
this investigation are shown in figure 5–32 for PE (first insert), PMMA and muscle equivalent (last insert).
The worse agreement in the last material probably originates from the neglection of contributions from other
positron emitters, e.g. 13N. However, due to the low statistics the fitting procedure turned out to be unstable
when attempting to include more parameters accounting for other isotopes. Predictions of the positron
emitter distributions were based on both of the FLUKA internal models, keeping into account all possible
reaction channels, as well as the approach described in section 5.3.2.3, focussed only on (p, pn) interaction on
carbon and oxygen nuclei. Due to the lack of information on the stopping properties of the tissue equivalent
materials, the necessary density effect parameters and ionisation potentials were derived from [Ste84]. Hence,
minor inaccuracies in the position of the predicted activity distal edge can be ascribed to this approxima-
tion. The resulting positron emitter distributions are shown in figure 5–33. Despite the lower amount of
isotopes predicted by the dedicated approach (cf. section 5.3.2.3), a similar trend with dominant role of 11C
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Figure 5–33: Positron emitter production in the inhomogeneous phantom calculated by means of FLUKA
internal models (left) and the approach described in section 5.3.2.3 (right). To reduce statistical fluctuations
a median filter over 2 bins (each 1 mm wide) was applied to the internal model predictions for the minor
production of isotopes different than 15O and 11C in the left panel.
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Figure 5–34: Depth variation of the 10C/11C (left) and 15O/ 11C (right) production deduced from the PET
data (points) and predicted by the FLUKA internal models (solid) and the dedicated approach (dashed, right).
and 15O was observed. The predicted 15O/11C and 10C/11C production values were also compared to the
corresponding isotope production ratios deduced from the measured PET data, as shown in figure 5–34. In
particular, the predictions from the dedicated approach are found in rather good agreement with the exper-
imental data, except that in the last muscle insert. Since this latter region corresponds to the distal part of
the proton penetration, the reason for the disagreement can be an underestimate of the used experimental
cross sections for the 16O(p, pn)15O reaction at the lower energies close to the energy threshold. This is
suggested by the more recent measurements of [Kit90] in comparison to the chosen interpolated cross section
values (figure 5–8). Furthermore, the 15O estimation from the time analysis of the measured decay curves
can be also overestimated in muscle, due to the neglection of other short-lived components (e.g. 14O, 13N)
in the fitting parameters. Nevertheless, considering the uncertainties in the stoichiometric composition of
the tissue equivalent mixtures and the unavoidable limitations for identification of pure isotope production
rates in different materials from the measured coincidence lines, an overall fairly reasonable agreement was
found.
The sensitivity of the proton induced activation to the inhomogeneous target structure has been investi-
gated in relation to the main 11C to 15O decay ratio. For this purpose PET images were reconstructed from
subsets of 2.5 · 105, 2.2 · 105 and 2.2 · 106 events registered during the delivery of the first 50 spills, the decay
starting 10 minutes after the irradiation end as well as the complete PET acquisition, respectively. This
selection corresponds to an estimated 11C to 15O decay ratio in PMMA of 0.4, 27.1 and 1.4, respectively.
The 2D PET images are compared in figure 5–35 to the predictions calculated by means of the dedicated
92
5.3 Experimental investigations
0 50 100 150
Penetration depth / mm
-15
-10
-5
0
5
10
15
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
La
te
ra
l d
im
en
sio
n 
/ m
m
1 2 3 5 6 7 8 9
4
    
-15
-10
-5
0
5
10
15
1 2 3 5 6 7 8 9
4
0 50 100 150
Penetration depth / mm
-15
-10
-5
0
5
10
15
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
La
te
ra
l d
im
en
sio
n 
/ m
m
1 2 3 5 6 7 8 9
4
    
-15
-10
-5
0
5
10
15
1 2 3 5 6 7 8 9
4
0 50 100 150
Penetration depth / mm
-15
-10
-5
0
5
10
15
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
La
te
ra
l d
im
en
sio
n 
/ m
m
1 2 3 5 6 7 8 9
4
    
-15
-10
-5
0
5
10
15
1 2 3 5 6 7 8 9
4
Figure 5–35: Measured (upper) and predicted (lower) PET images during the delivery of the first 50 spills
(top, left), starting 10 minutes after the end of the irradiation (top, right) as well as over the complete
measurement (bottom). The dashed blue lines delimit the different materials of the composite phantom.
0 50 100 150 200
Penetration depth / mm
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
Ac
tiv
ity
 / 
a.
u.
0
500
1000
1500
H
U 
0 50 100 150 200
Penetration depth / mm
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
Ac
tiv
ity
 / 
a.
u.
0
500
1000
1500
H
U 
0 50 100 150 200
Penetration depth / mm
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
Ac
tiv
ity
 / 
a.
u.
0
500
1000
1500
H
U 
Figure 5–36: Measured (blue) and predicted (green) β+-activity depth profiles for the same data-set pre-
sented in figure 5–35. The black line, referring to the right axis scale, additionally shows the depth profile of
the Hounsfield units from the available CT.
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approach and normalised to the estimated 11C to 15O decay ratio in PMMA. The corresponding depth pro-
files are shown in figure 5–36. Despite the discussed worse agreement in the last muscle insert as well as the
neglection of minor positron emitters (e.g. 10C, 13N, 14O and 38K), mostly affecting the acquisition during
the first 50 spills due to the half-lives, a similar trend between measurement and expectation was observed.
In particular, the sharp lateral density gradient results in the visible range spike nicely reproduced in both of
the measurement and simulation (figure 5–35). Structures of similar density but different C/O concentration
can be differentiated only at low 11C to 15O decay ratios, as indicated by the smoother activity variation at
the borders between PE, PMMA and muscle on the right side with respect to the left side of figure 5–36, top.
This points out once more the sensitivity of the proton induced positron radioactivity to the time structure
of the irradiation and of the PET acquisition. With respect to the latter issue, on-line monitoring offers the
advantage to detect short-lived isotopes, hence improving the image contrast of different tissues. In addition
to the range considerations reported in the previous section, these results strongly suggest the selection of
proper time windows in off-line analysis, aiming either to achieve high precision in range monitoring or allow
distinction of tissues of similar density but different elemental composition.
5.3.3.3 Proton induced β+-activity lateral distributions
The lateral distribution of the proton induced positron radioactivity conveys information on the transver-
sal localisation of the beam and of the dose delivery for in-vivo verification of the lateral position of the
irradiation field. This issue can be of particular importance for portals passing adjacent to radiosensitive
structures. Protons exhibit more pronounced lateral scattering in comparison to heavier ions. Furthermore,
the description of the beam lateral broadening has often limited accuracy in conventional treatment plan-
ning systems based on analytical models, especially in presence of transversal heterogeneities. Hence, on-line
monitoring of the amount of laterally scattered dose to critical organs can be also a crucial issue in real
therapeutic irradiation.
The width of the lateral profiles of the β+-activity induced in PMMA by pencil-like proton beams at
initial energy of 110, 140 and 175 MeV is plotted along the penetration depth on the left side of figure 5–
37. The sketched FWHM is mostly determined by the lateral dimension of the beam. Further smaller
contributions come from the spatial resolution of the imaging system in addition to the slight fluctuations of
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Figure 5–37: Left: Width (FWHM) of the lateral β+-activity profiles along the penetration depth for three
proton irradiation of PMMA targets. Right: Lateral broadening of the β+-activity induced by the 175 MeV
proton beam, corrected for the system spatial resolution (points), in comparison to calculations [Hab94] of
the lateral spread of an energetic proton beam (solid line).
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Figure 5–38: PMMA phantom with air gaps for insertion of radiographic emulsions.
the beam position for the considered irradiation from the first experimental run. The lateral broadening of
the β+-activity distribution produced by the 175 MeV proton beam was found in rather good agreement with
calculations [Hab94] of the beam spread due to increasing lateral scattering along the proton penetration
(figure 5–37, right). However, despite such a good correspondence a further experimental validation has
been desirable due to the uncertainties in the experimental conditions (e.g. the lack of information on the
real beam spot size and position) and the approximations behind the calculation from [Hab94].
In order to overcome constraints from the experimental conditions, an alternative to pure activation
experiments of PMMA phantoms had to be found. The aim was to assess the spatial correlation between the
lateral distribution of the proton induced positron radioactivity and the irradiation field independently on the
beam quality and the limited knowledge of the beam parameters. For this purpose a special 10×10×27.3 cm3
PMMA phantom with 10 slits of 0.2 cm width at 2.5 cm separation along the long edge was designed. This
geometry allows insertion of photographic emulsions (silver bromide Kodak X-Omat V films of 0.18 mm
thickness in a 0.25 mm thick package) for the independent measurement of the lateral beam dimension
simultaneously to the in-beam PET acquisition (figure 5–38). In the experiment mono-energetic pencil-like
beams of 214.53 and 190.37 MeV initial energy were either partially or completely stopped in the stacked
phantom. Details are given in table 5–12. The radiographic emulsions were removed immediately after
the end of the irradiation, in order to prevent their exposure to the γ-radiation coming from the activated
target as well as reduce the attenuating medium within the positron camera FOV during the remaining
time of the PET measurement. Long acquisition times as well as adequate decay time between successive
irradiation with the same phantom were necessary in order to gain sufficient counting statistics and limit the
contamination of residual target activation in the PET images. For data analysis the films were developed
shortly after exposure with the Kodak M35 machine. The optical density was read out using a FIPS Plus
(PTW Freiburg) laser scanner operated at an intermediate resolution of 0.4 mm. Attenuation corrections for
PET imaging were calculated on the basis of the phantom geometry, neglecting the presence of the film in the
short fraction of acquisition during irradiation. The lateral width of the backprojected as well as iteratively
reconstructed β+-activity distributions was estimated in the inner part of the PMMA slabs, in order to
avoid the influence from possible reconstruction artifacts in proximity of the phantom slits. Simulations
were additionally performed according to the calculation models described in 5.3.2.3. Due to a lack of
accurate information on the lateral dimension of the beam, the prediction was obtained for a value of 10 mm
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Table 5–12: Parameters of the irradiation (identifier, energy, number of extracted spills, total number of
protons and irradiation time) and of the PET measurement (duration and amount of detected coincidences)
for the experiment with the PMMA phantom stacked with X-ray films. The roman numbers distinguish
successive irradiation at the same initial energy. The time difference between the start of a new irradiation
and the end of the previous one within the same experimental run is additionally given by ∆tpre.
ID E / MeV T Np tir / s tmea / s Nev ∆tpre / min
(I) 214.53 10 (4.9± 0.9) · 109 42.59± 0.01 897 1255895 –
(II) 214.53 10 (4.9± 0.9) · 109 42.58± 0.01 388 1105725 14
(III) 214.53 10 (4.9± 0.9) · 109 42.57± 0.01 390 1386853 6
(IV) 214.53 10 (4.9± 0.9) · 109 42.57± 0.01 300 1360907 6
(I) 190.37 4 (1.2± 0.2) · 109 14.70± 0.01 3099 428682 –
(II) 190.37 8 (3.0± 0.4) · 109 32.53± 0.01 1498 850836 51
lateral FWHM. The necessary information on the composition and stopping properties of the photographic
emulsions were taken from [ICR93] and [Ste84]. However, the insertion of the films mostly affects the particle
range while playing only a minor role on the lateral spread of the beam.
The irradiation parameters were chosen in order to rule out possible influence of the dose dependent
response of the films on the lateral broadening of the optical density in depth beyond the investigated effect
due to the beam lateral scattering. The two beam energies allowed to acquire data at different variation of the
dose exposure of the films along the penetration depth avoiding the highest dose values of the Bragg-peak (see
figure 5–39). In addition, the relatively low amount (with respect to the previous phantom experiments) of
protons delivered to the target was selected in order to prevent the saturation of the radiographic emulsions.
Preliminary test irradiation showed only minor deviations below 6 % of the relative lateral broadening in
depth of the optical density of films placed at different penetration depths (1st, 9th and 10th slit) and exposed
to 2, 5 and 10 spills (i.e. to a dose varying by a maximum factor of 5) at 214.53 MeV with similar irradiation
parameters as in table 5–12, respectively. Furthermore, also the experimental curves reported in [Spi01]
suggest a film response still in the approximately linear regime well below saturation for the applied dose
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Figure 5–39: Calculated dose depth distribution for 106 protons at 190.37 MeV (thick line) and 214.53 MeV
(thin line) stopped in a thick target resembling the stacked phantom. The dotted lines mark the slit positions.
The dashed line shows the exit face of the real target.
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Figure 5–40: Top: Lateral broadening (FWHM) of the measured (left: backprojection, right: iterative
reconstruction) and predicted β+-activity in comparison to the optical density of the exposed radiographic
emulsions for the 214.53 MeV (I) irradiation. Bottom: Corresponding depth profiles of the measured (thick)
and predicted (narrow) PET distributions. The dotted and dashed lines mark the position at which the data
points (top) of the measured PET and film lateral distributions have been estimated, respectively.
values estimated to be within 1− 2 Gy.
The broadening of the width (FWHM) of the measured β+-activity and optical density lateral distribu-
tions along the penetration depth is compared in figure 5–40 and 5–41 for the 214.53 MeV (I) and 190.37 MeV
(II) irradiation, respectively. It can be noticed that the average lateral width of the distributions in general
differs due to the different system response, dependent on the used image reconstruction algorithm and on
the dose for the PET and film measurement, respectively. Therefore, in the data analysis the broadening in
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Figure 5–41: Same comparison of figure 5–40 for the 190.37 MeV (II) irradiation. An additional film in
the entrance of the phantom was used for compensation of the lower penetration of the beam in the target.
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Figure 5–42: Top: Lateral profiles of the optical density and backprojected (bp) as well as iteratively
reconstructed (MLEM) positron radioactivity distributions measured at 25 and 12.5mm penetration depth,
respectively, for the 214.53 MeV (I, left) and 190.37 MeV (II, right) irradiation. Bottom: Skewness of the
lateral distributions along the penetration depth for the two irradiation (cf. top).
depth of the measured β+-activity and optical density lateral distributions was compared after adjustement
to the same mean FWHM by means of a maximum shift of about 2 mm, eliminating the constant offset
due to the different response. Good agreement between PET and film measurements with maximum dif-
ferences of 0.40 mm and 0.15 mm standard deviations was found for the two irradiation, respectively. The
lateral spread of the measured β+-activity was furthermore observed in good agreement with the predic-
tion, already adjusted to the the same average FWHM of the measured activity with a maximum shift of
1.5 mm in figures 5–40 and 5–41. Differences below 0.2 mm standard deviation were observed between PET
measurements and calculations.
The slightly worse experimental results for the 214.53 MeV irradiation reflect the larger uncertainties in
the FWHM estimation for the asymmetric profiles originating from the suboptimal beam focussing stability
in that experimental run. This is illustrated on the top of figure 5–42, showing the measured β+-activity and
optical density lateral profiles corresponding to the FWHM data points for the first PMMA slot and film slit of
figure 5–40 and 5–41. The asymmetry of the beam shape in the 214.53 MeV irradiation is visible in both of the
film and PET signals, the latter independently on the used reconstruction algorithm. A good correspondence
was furthermore observed for the skewness of the lateral profiles along the penetration depth (figure 5–42,
bottom). In summary, β+-activity and optical density distributions as well as PET measurements and
predictions were found in general good agreement with sub-millimetre standard deviations. Hence, these
results strongly support the feasibility of positron emission tomography for millimetre verification of the
lateral position of the irradiation field and of the dose delivery.
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5.4 Conclusions
The presented feasibility study based on simulations and extensive phantom experiments carried out at GSI
Darmstadt strongly supports the positive impact of in-beam PET on quality assurance of proton therapy. In
comparison to carbon ion irradiation at the same range and applied physical dose an increase of the proton
induced β+-activity signal by a factor of about 3 has been quantified. This indicates the detectability of
a usable signal during a therapeutic session even by an in-beam PET scanner of low detection efficiency
(< 3 %) as the device installed at GSI. A good correspondence between measured and predicted depth
and lateral β+-activity distributions could be achieved. The lateral distribution of the proton induced
β+-activity was found in millimetre agreement with the independent film measurement of the dose lateral
distribution. This suggests the reliability of PET for accurate verification of the lateral position of the
irradiation field and dose delivery. The activation study of an inhomogeneous phantom has also supported
the usefulness of PET for assessment of local tissue modifications or field misalignments leading to strong
density gradients in the beam path during fractionated therapy. Moreover, depending on the time course
of the irradiation and acquisition, in-beam PET monitoring can allow differentiation of tissues of similar
density but different stoichiometry. For the most challenging issue of range monitoring, millimetre resolution
has been demonstrated in mono-energetic as well as SOBP irradiation of homogeneous PMMA phantoms
without and with beam scanning. However, the extension of such precision to real clinical cases requires
a detailed knowledge of the tissue stoichiometry and of all reaction channels leading to the production
of positron emitters. In addition, the imaging process has to be more carefully modelled, e.g. including
the explicit propagation of the positrons and annihilation photons and applying the same reconstruction
algorithm, for a more realistic prediction of PET images to be compared with the measured ones. The
presented 11C/15O ratio analysis has also pointed out the sensitivity of the β+-activity distal edge to the
time structure of the irradiation and of the PET acquisition for accurate range monitoring. Hence, the
optimum conditions minimising the unavoidable sources of uncertainties should be investigated. Such an
analysis should involve the irradiation strategies especially for dynamic dose delivery systems in combination
with the effects due to biological pathways washing out the produced positron emitters. The latter problem
has not been addressed in the performed phantom experiments. Nevertheless, the presented results already
suggest that an appropriate off-line analysis of in-beam PET acquisitions taken with tomographs of moderate
spatial resolution should allow millimetre range monitoring even in clinical applications at least in regions
of interest, especially for low perfused tissues.
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6 Summary
The physical advantages of light ions in combination with technological advances like intensity controlled
raster scanning offer a unique tool for high precision radiotherapy. This is particularly applied to delicate
clinical situations of inoperable tumours growing in close proximity to critical organs. The potential benefit
of such a high selectivity of ion beam therapy demands the complex and strictly conformal dose delivery to
be monitored in-situ and non-invasively in three dimensions. In contrast to conventional photon radiation,
light ions exhibit a well defined range which determines the position of the maximum dose delivery in
the inhomogeneous tumour target. This requires a monitoring technology along the ion trajectory offering
millimetre precision. Additionally, accurate control of the lateral position of the irradiation field within the
patient can be a crucial issue for the frequent case of portals passing adjacent to organs at risk. At present,
positron emission tomography (PET) represents the only feasible method fulfilling these requirements. For
this purpose a dedicated in-beam positron camera has been completely integrated into the experimental
heavy ion treatment site at the Gesellschaft fu¨r Schwerionenforschung (GSI) Darmstadt. This allows to
measure the minor amount of β+-activity produced in nuclear reactions between the projectiles and the
target nuclei of the tissue simultaneously to the tumour irradiation. The emitted signal is correlated but
not directly proportional to the spatial pattern of the delivered dose. Hence, therapy control is achieved
by comparing the measured β+-activity distribution with a prediction based on the treatment plan and the
specific time course of the particular irradiation.
The routine monitoring of fractionated carbon ion therapy for more than 200 head and neck tumour
patients treated at GSI since December 1997 has indicated the capability of the PET method (i) to validate
the physical beam models used in treatment planning, (ii) to verify the whole chain from the planning
to the application of the treatment independently on the beam delivery hardware and software as well as
(iii) to detect unpredictable deviations in the maximum ion range. The reasons for the latter accidental
deviations have been identified in minor positioning errors or local modifications of the patient anatomy with
respect to the density information deduced from the planning X-ray computed tomograms (CT). Following
the promising clinical results achieved so far at the experimental treatment facility at GSI, the in-beam PET
methodology will also be established at the planned ion beam tumour therapy facility in Heidelberg, which
will be capable to treat about 1000 patients per year.
This thesis has contributed to the achievement of in-beam PET as a promising clinical monitoring tech-
nique. In response to a pressing medical demand, this work has provided a tool for quantification of local
dose deviations in case of observed discrepancies between the measured and expected PET images. The
implemented interactive approach described in chapter 3 is in clinical use since 2001. It provides the radio-
oncologist with a valuable feedback which may allow a prompt reaction in the strategy of the therapy prior
to the delivery of the successive treatment fraction in case of significant deviations between planned and
actually applied dose.
In order to allow an improved performance of the next generation in-beam PET scanner to be installed at
the hospital-based Heidelberg facility, basic investigations on the reason for the increased noise of the PET
data acquired during particle extraction from the GSI synchrotron have been carried out in this work. This
problem currently prevents the use of coincidences registered during the beam bursts for image reconstruction,
hence further constricting the already intrinsically extremely poor counting statistics of PET imaging for
tumour therapy monitoring. The experimental investigations presented in chapter 4 show evidence that
the reason is the failure of the standard random correction techniques implemented in positron emission
tomographs designed for radiotracer imaging. These apply to situations where the γ-ray background can
be assumed to be stationary on the microscopic time scale. However, at a particle accelerator like the
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synchrotron of GSI a non-stationary background radiation caused by interactions induced by the beam has
been demonstrated during particle extraction. This has been proven to be correlated in time with the
measured microstructure of the extracted carbon ion beam. Hence, the results obtained in this work provide
the basis for a novel data acquisition technology tailored to the non conventional application of in-beam
PET imaging at accelerator facilities delivering therapeutic radiation pulsed on the sub-microsecond time
scale [Eng04b], [Cre04].
Since the new generation tomograph will be implemented at a beam line capable to deliver the entire
variety of ions planned at the Heidelberg facility (p, He, C, O), this work has finally investigated the
possible extension of in-beam PET to the monitoring of the lightest and worldwide most frequently used
protons. Novel information with respect to previous investigations from the literature result from (i) the
experimental availability of the unique in-beam tomographic positron camera installed at GSI as well as
(ii) the comparison with the already clinically implemented carbon ion case. The phantom experiments
presented in chapter 5 have confirmed the predicted increase of the proton induced β+-activity signal by a
factor of about 3 with respect to carbon ion irradiation at the same range and applied dose. This proves
the possible detection of a usable signal during a therapeutic proton application even by a limited angle
in-beam PET scanner of low detection efficiency as the one installed at GSI. Furthermore, the increase of
counting statistics is expected to improve the sensitivity of the PET method for detection and quantification
of deviations between prescribed and actually delivered dose. Moreover, millimetre accuracy for verification
of the lateral field position and for the most challenging issue of range monitoring has been demonstrated
in non-scanned and scanned mono-energetic as well as extended spread-out Bragg-peak (SOBP) proton
irradiation of polymethyl methacrylate (PMMA) targets. The additional irradiation of an inhomogeneous
phantom with tissue equivalent inserts in combination with further dynamic analysis has also supported
the possible extension of such millimetre precision to real clinical cases, at least in regions of interest and
especially for low perfused tissues. Furthermore, the developed modelling, capable to reproduce all the
experimental investigations rather well, is going to be extended to other ion species [Fie04] in order to
provide a general and versatile tool for the establishment of the PET methodology at the future clinical
operation of the Heidelberg facility.
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A Table of abbreviations
1D, 2D and 3D : One-, two- and three-dimensional
ADC : Analog to digital converter
AP : Antero-posterior
ATIMA : Atomic interaction with matter (computer code)
BGO : Bismuth Germanate (Bi4Ge3O12)
CAMAC : Computer aided measurement and control
CERN : Conseil Europe´en pour la Recherche Nucle´aire (Geneva, Switzerland)
CFD : Constant fraction discriminator
CPU : Central processing unit
CT : Computerised tomography
CTI : Computer Technology Inc., Knoxville (USA)
D : Delayed coincidence
DB : Database
DKFZ : Deutsches Krebsforschungszentrum (Heidelberg, Germany)
DNA : Deoxyribonucleic acid
DSO : Digital storage oscillograph
ENLIGHT : European Network for research in Light ion Therapy
ESTRO : European Society for Therapeutic Radiology and Oncology
FLUKA : Fluktuierende Kaskade (particle physics Monte Carlo code)
FOV : Field of view
FWHM : Full width at half maximum
FZR : Forschungszentrum Rossendorf, Dresden (Germany)
GSI : Gesellschaft fu¨r Schwerionenforschung Darmstadt (Germany)
GSO : Gadolinium Ortho-Silicate (Gd2SiO5:Ce)
HCL : Harvard Cyclotron Laboratory (USA)
HIMAC : Heavy Ion Medical Accelerator in Chiba (Japan)
HU : Hounsfield unit
ICRU : International Commission on Radiation Units and Measurements
IDL : Interactive Data Language
IMRT : Intensity modulated radiotherapy
INC : Intra-nuclear cascade
LBL : Lawrence Berkeley Laboratory (USA)
LLUMC : Loma Linda University Medical Center (USA)
LOR : Line of response
MLEM : Maximum Likelihood estimation maximisation
NIM : Nuclear instrument module
NRDC : Nuclear Reaction Data Center network
P : Prompt coincidence
PE : Polyethylene (C2H4)n
PET : Positron emission tomography
PMMA : Polymethyl methacrylate (C5H8O2)n
PMT : Photomultiplier tube
PSI : Paul Scherrer Institut (Switzerland)
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R : Random coincidence
RF : Radiofrequency
ROI : Region of interest
SIS : Schwerionensynchrotron at GSI Darmstadt
SOBP : Spread-out Bragg-peak
T : True coincidence
TAC : Time to amplitude converter
TP : Treatment Planning, Treatment Plan
TRiP : TReatment planning for Particles (computer code)
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